Enhanced Production of Fatty Acid Derivatives

ABSTRACT

Genetically engineered cells and microorganisms are provided that produce fatty alcohols from the fatty acid biosynthetic pathway, as well as methods of their use.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. Ser. No. 14/661,219, filedMar. 18, 2015, now pending, which is a continuation of U.S. Ser. No.13/529,990 filed Jun. 21, 2012, now U.S. Pat. No. 9,017,984, which is acontinuation of U.S. Ser. No. 13/099,986 filed May 3, 2011, now U.S.Pat. No. 8,283,143, which is a continuation of U.S. Ser. No. 12/278,960,filed Aug. 8, 2008, now U.S. Pat. No. 8,110,670 which is the NationalStage of International Application PCT/US08/58788, filed Mar. 28, 2008,which claims the benefit of U.S. Provisional Application No. 60/989,798,filed Nov. 21, 2007 and the benefit of U.S. Provisional Application No.60/908,547, filed Mar. 28, 2007 and which is a continuation in part ofPCT/US2007/011923, filed May 18, 2007, which claims the benefit of U.S.Provisional Application No. 60/908,547, filed Mar. 28, 2007, the benefitof U.S. Provisional Application No. 60/802,016, filed May 19, 2006 andthe benefit of U.S. Provisional Application No. 60/801,995, filed May19, 2006, each of which are herein incorporated by reference in theirentirety.

TECHNICAL FIELD

Genetically engineered cells and microorganisms are provided thatproduce products from the fatty acid biosynthetic pathway (i.e., fattyalcohols), as well as methods of their use. The products areparticularly useful as biofuels.

INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY

Incorporated by reference in its entirety herein is a computer-readablenucleotide/amino acid sequence listing submitted concurrently herewithand identified as follows: One 33,526 Byte ASCII (Text) file named“LS00004_PCT_SeqLstg.TXT,” created on Jun. 8, 2017.

BACKGROUND

Developments in technology have been accompanied by an increasedreliance on fuel sources. Such fuel sources are becoming increasinglylimited and difficult to acquire. With the burning of fossil fuelstaking place at an unprecedented rate, it is likely that the world'sfuel demand will soon outweigh current fuel supplies.

As a result, efforts have been directed toward harnessing sources ofrenewable energy, such as sunlight, water, wind, and biomass. The use ofbiomasses to produce new sources of fuel which are not derived frompetroleum sources, (i.e., biofuel) has emerged as one alternativeoption. Biofuel is a biodegradable, clean-burning combustible fuel whichcan be comprised of alkanes and esters. An exemplary biofuel isbiodiesel. Biodiesel can be used in most internal combustion dieselengines in either a pure form, which is referred to as “neat” biodiesel,or as a mixture in any concentration with regular petroleum diesel.

Biodiesel offers a number of interesting and attractive beneficialproperties compared to petroleum-based diesel, including reducedemissions (e.g., carbon monoxide, sulphur, aromatic hydrocarbons, sootparticles, etc.) during combustion. Biodiesel also maintains a balancedcarbon dioxide cycle because it is based on renewable biologicalmaterials. Biodiesel is non-toxic, completely biodegradable, and verysafe due to its high flash point and low flammability. Furthermore,biodiesel provides good lubrication properties, thereby reducing wearand tear on engines.

Current methods of making biodiesel involve transesterification oftriacylglycerides from vegetable oil feedstocks, such as rapeseed inEurope, soybean in North America, and palm oil in South East Asia.Industrial-scale biodiesel production is thus geographically andseasonally restricted to areas where vegetable oil feedstocks areproduced. The transesterification process leads to a mixture of fattyesters which can be used as biodiesel. An undesirable byproduct of thetransesterification process is glycerin. To be usable as biodiesel, thefatty esters must be further purified from the heterogeneous product.This increases costs and the amount of energy required for fatty esterproduction and, ultimately, biodiesel production as well. Furthermore,vegetable oil feedstocks are inefficient sources of energy because theyrequire extensive acreage for cultivation. For example, the yield ofbiodiesel from rapeseed is only 1300 L/hectare because only the seed oilis used for biodiesel production, and not the rest of the rapeseedbiomass. Additionally, cultivating some vegetable oil feedsocks, such asrapeseed and soybean, requires frequent crop rotation to preventnutrient depletion of the land.

Therefore, there is a need for an economically- and energy-efficientbiofuel and method of making biofuels from renewable energy sources,such as biomass.

SUMMARY

This invention relates to the production of fatty acid derivatives fromrecombinant cells. Generally, the fatty acid derivatives are produced byexpressing or over-expressing at least one gene encoding a fatty acidderivative enzyme. In addition, a gene encoding an acyl-CoAdehydrogenase enzyme can be modified in the recombinant cell such thatexpression of the gene is attenuated.

In one aspect, the invention provides a recombinant cell comprising atleast one of (a) at least one gene encoding a fatty acid derivativeenzyme, which gene is modified such that the gene is over-expressed, and(b) a gene encoding an acyl-CoA dehydrogenase enzyme, which gene ismodified such that expression of the gene is attenuated. The modifiedgene encoding a fatty acid derivative enzyme gene may be a gene encodingan acyl-CoA synthase, a thioesterase, an ester synthase, an alcoholacyltransferase, an alcohol dehydrogenase, an acyl-CoA reductase, or afatty-alcohol forming acyl-CoA reductase. In one embodiment, themodified gene encodes an acyl-CoA synthase, a thioesterase or an estersynthase. In some embodiments, the acyl-CoA synthase and a thioesteraseand/or an ester synthase are modified. In some embodiments, the cellalso comprises a gene encoding a transport protein.

The recombinant or host cell of the invention may be a Saccharomycescerevisiae, Candida lipolytica, E. coli, Arthrobacter, Rhodotorulaglutinins, Acinetobacter, Candida lipolytica, Botryococcus braunii,Vibrio furnissii, Micrococcus leuteus, Stenotrophomonas maltophilia orBacillus subtilis cell, e.g., an Arthrobacter AK 19, Acinetobacter sp.strain M-1, E. coli B, E. coli C, E. coli K or E. coli W cell. In otherembodiments, the recombinant cell is a cyanobacteria cell, e.g., aSynechocystis sp. PCC6803 or Synechococcus elongatus PCC7942 cell. Instill other embodiments, the recombinant cell is a plant, animal orhuman cell. Alternatively, the recombinant cell is a microorganism cellfrom a bacteria, yeast, or filamentous fungi.

In a second aspect, the invention provides a recombinant cell capable ofproducing a fatty acid derivative, wherein the cell is modified toinclude at least one exogenous nucleic acid sequence encoding a fattyacid derivative enzyme. The exogenous nucleic acid sequence may encodean acyl-CoA synthase, a thioesterase, an ester synthase, an alcoholacyltransferase, an alcohol dehydrogenase, an acyl-CoA reductase or afatty-alcohol forming acyl-CoA reductase. In some embodiments, the cellis modified to include at least two exogenous nucleic acid sequencesencoding a fatty acid derivative enzyme, e.g., a first exogenous nucleicacid sequences encodes an acyl-CoA synthase and a second exogenousnucleic acid sequence encodes a thioesterase or an ester synthase. Inother embodiments, the gene encoding a fatty acid derivative enzyme ismodified to optimize a codon for expression in the recombinant cell.

In one embodiment, the recombinant cell comprises a modified geneencoding an acyl-CoA synthase, such as fadD, fadK, BH3103, yhfL,Pfl-4354, EAV15023, fadD1, fadD2, RPC_4074, fadDD35, fadDD22, faa3p orthe gene encoding the protein ZP_01644857. Examples of the acyl-CoAsynthase genes are fadDD35 from M. tuberculosis HR7Rv [NP_217021], yhfLfrom B. subtilis [NP_388908], fadD1 from P. aeruginosa PAO1[NP_2519891], the gene encoding the protein ZP_01644857 fromStenotrophomonas maltophilia R551-3, or faa3p from Saccharomycescerevisiae [NP_012257].

In a second embodiment, the recombinant cell comprises a modified geneencoding a thioesterase, such as tesA, ′tesA, tesB, fatB, fatB2, fatB3,fatB [M141T], fatA or fatA1.

In a third embodiment, the recombinant cell comprises a modified geneencoding an ester synthase, such as an ester synthase gene obtained fromAcinetobacter spp., Alcanivorax borkumensis, Arabidopsis thaliana,Saccharomyces cerevisiae, Homo sapiens, Simmondsia chinensis,Mortierella alpina, Cryptococcus curvatus, Alcanivorax jadensis,Alcanivorax borkumensis. Acinetobacter sp. HO1-N or Rhodococcus opacus.Examples of ester synthase genes include wax/dgat, a bifunctional estersynthase/acyl-CoA:diacylglycerol acyltransferase from Simmondsiachinensis, Acinetobacter sp. strain ADP1, Alcanivorax borkumensis,Pseudomonas aeruginosa, Fundibacter jadensis, Arabidopsis thaliana, orAlkaligenes eutrophus.

In one embodiment, the recombinant cell of the invention furthercomprises at least one of a pdh, panK, aceEF, fabH, fabD, fabG, acpP,and fabF gene that is modified to be expressed or overexpressed. In asecond embodiment, the recombinant cell further comprises at least oneof a fadE, gpsA, ldhA, pflB, adhE, pta, poxB, ackA, and ackB gene thatis modified such that expression of the gene is attenuated. In a thirdembodiment, the recombinant cell further comprises at least one modifiedgene of plsB and sfa.

In other embodiments, the gene encoding an acyl-CoA dehydrogenase enzymeis deleted.

Recombinant cells according to the invention produce more acyl-CoArelative to a non-recombinant cell, e.g., an otherwise identicalnon-recombinant cell or a cell of similar lineage and phenotype.

The invention further provides compositions produced by the recombinantcells disclosed herein. The compositions comprising fatty acidderivatives produced from a recombinant cell may comprising less than orequal to about 50 ppm arsenic, about 30 ppm, about 25 ppm, or betweenabout 10-50 ppm arsenic; less than or equal to about 200 ppm calcium,about 150 ppm calcium, about 119 ppm calcium or between about 50-200 ppmcalcium; less than or equal to about 200 ppm chlorine, about 150 ppmchlorine, about 119 ppm chlorine or between about 50-200 ppm chlorine;less than or equal to about 50 ppm copper, about 30 ppm copper, about 23ppm copper, or between about 10-50 ppm copper; less than or equal toabout 300 ppm iron, about 200 ppm iron, about 136 ppm iron, or betweenabout 50-250 ppm iron; less than or equal to about 50 ppm lead, about 30ppm lead, about 25 ppm lead, or between about 10-50 ppm lead; less thanor equal to about 50 ppm manganese, about 30 ppm manganese, about 23 ppmmanganese, or between about 10-50 ppm manganese; less than or equal toabout 50 ppm magnesium, about 30 ppm magnesium, about 23 ppm magnesium,or between about 10-50 ppm magnesium; less than or equal to about 0.5ppm mercury, about 0.1 ppm mercury, about 0.06 ppm mercury or betweenabout 0.01-0.2 ppm mercury; less than or equal to about 50 ppmmolybdenum, about 30 ppm molybdenum, about 23 ppm molybdenum or betweenabout 10-50 ppm molybdenum; less than or equal to about 2% nitrogen;about 1% nitrogen, about 0.5% nitrogen, or between about 0.1-1%nitrogen; less than or equal to about 200 ppm potassium, about 150 ppmpotassium, about 103 ppm potassium, or between about 50-200 ppmpotassium; less than or equal to about 300 ppm sodium, 200 ppm sodium,about 140 ppm sodium, or between about 50-300 ppm sodium; less than orequal to about 1 ppm sulfur, less than or equal to about 1% sulfur,about 0.14% sulfur, or between about 0.05-0.3% sulfur; less than orequal to about 50 ppm zinc, about 30 ppm zinc, about 23 ppm zinc, orbetween about 10-50 ppm zinc; or less than or equal to about 700 ppmphosphorus, about 500 ppm phosphorus, about 350 ppm phosphorus, orbetween about 100-700 ppm phosphorus.

In one aspect, the composition produced by a recombinant cell of theinvention comprises a fatty acid having a double bond at position 7 inthe carbon chain (between C₇ and C₈) from the reduced end of the fattyacid derivative. In some embodiments, the composition comprises C₅-C₂₅fatty esters, or C₁₀-C₂₀ fatty esters, or C₁₂-C₁₈ fatty esters. In otherembodiments, the fatty acid derivatives comprise straight chain fattyacid derivatives, branched chain fatty acid derivatives, cyclicmoieties. In still other embodiments, the fatty acid derivatives areunsaturated (e.g., monounsaturated) or saturated.

In other aspects, the composition comprises a fatty ester that isproduced from an alcohol and an acyl-CoA, wherein the alcohol is atleast about 1, about 2, about 3, about 4, about 5, about 6, about 7,about 8, about 10, about 12, about 14, about 16, or about 18 carbons inlength, and the acyl-CoA is at least about 2, about 4, about 6, about 8,about 10, about 12, about 14, about 16, about 18, about 20, about 22,about 24, or about 26 carbons in length. In some embodiments, thealcohol and acyl-CoA from which the fatty ester are produced vary byabout 2, about 4, about 6, about 8, about 10, about 12 or about 14carbon atoms.

In one embodiment, the composition produced by a recombinant cell ofthis invention has a fraction of modern carbon of about 1.003 to about1.5.

In other aspects, the invention provides a method for producing fattyacid derivatives in a recombinant cell comprising a) obtaining arecombinant cell; b) culturing the recombinant cell, and c) producingfatty acid derivatives.

In further aspects, the invention provides a method of increasingproduction of fatty acid derivatives in a recombinant cell comprisingintroducing an exogenous nucleic acid encoding a fatty acid derivativeenzyme into the recombinant cell, and expressing the exogenous nucleicacid, wherein expression of the nucleic acid in the recombinant cellresults in increased production of fatty acid derivatives relative to anon-recombinant cell, e.g., an otherwise identical non-recombinant cellor a cell of similar lineage and phenotype. In some embodiments, theexogenous nucleic acid encodes an acyl-CoA synthase, a thioesterase oran ester synthase. In other embodiments, exogenous nucleic acid encodingan acyl-CoA synthase, a thioesterase and an ester synthase areintroduced into the recombinant cell. In other embodiments, a method forincreasing the production level of fatty acid derivatives in arecombinant cell is provided, the method comprising: introducing anucleic acid construct into a host cell, the nucleic acid constructcomprising (a) a nucleic acid sequence encoding a fatty acid derivativeenzyme of SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO: 6, SEQ ID NO:9 or SEQ IDNO:13, and (b) regulatory sequences for expression of the nucleic acidsequence; expressing the nucleic acid sequence; and obtaining the fattyacid derivatives.

In still further aspects, the invention provides a recombinant constructcomprising a nucleic acid sequence encoding a fatty acid derivativeenzyme, wherein the nucleic acid sequence is modified to over-expressthe gene encoding a fatty acid derivative enzyme. In one embodiment, thenucleic acid sequence is modified to over-express the gene encoding anacyl-CoA synthase, a thioesterase, or an ester synthase. In a secondembodiment, the nucleic acid sequence is modified to over-express (1)the gene encoding an acyl-CoA synthase, and (2) the gene encoding athioesterase or an ester synthase. In a third embodiment, the nucleicacid sequence is modified to over-express the gene encoding (1) anacyl-CoA synthase, (2) a thioesterase, and (3) an ester synthase. In afourth embodiment, the construct further comprises a nucleic acidsequence encoding an acyl-CoA dehydrogenase which is modified such thatexpression of the acyl-CoA dehydrogenase is attenuated. Vectorscomprising these recombinant constructs are also provided by theinvention. In some embodiments, the vector further comprises astructural gene providing for selection of transformed cells.

In another aspect, the invention provides a method for increasingproduction of fatty acid derivatives in a host cell, comprising:transforming the host cell with a nucleotide sequence so that the hostcell expresses or over-expresses a fatty acid derivative enzyme gene,wherein the production of fatty acid derivatives in the host cell hasbeen increased relative to a cell that has not been transformed. In sucha method, the host cells may be harvested and lysed to obtain the fattyacid derivatives that have been produced. Alternatively, the host cellis transformed with a nucleotide sequence encoding a transport proteinand the host cell releases the fatty acid derivatives extracellularly.

In still another aspect, the invention provides a vector comprising anucleic acid sequence encoding a fatty acid derivative enzyme operablylinked to a promoter that is functional in a host cell, wherein thenucleic acid sequence comprises a first nucleic acid sequence encodingan acyl-CoA synthase and a second nucleic acid sequence encoding athioesterase or ester synthase. The vector may further comprise anucleic acid sequence encoding a transport protein. In one embodiment,the second nucleic acid sequence encodes a thioesterase and the vectorfurther comprises a third nucleic acid sequence encoding an estersynthase. In a second embodiment, the vector further comprises a nucleicacid sequence encoding a transport protein.

In a still further aspect, the invention provides a method of producingfatty acid derivatives comprising: (a) providing a host cell comprisingthe vector of the invention, and (b) culturing the host cell to producefatty acid derivatives. In some embodiments, a supernatant from theculturing of the host cell is collected to obtain the fatty acidderivatives that have been produced. Fatty acid derivatives produced bysuch methods are also provided by the invention.

In one aspect, fatty acid derivatives produced in accordance with theinvention may be used as biofuel compositions. The fatty acidderivatives may be used as a biodiesel, fatty alcohol, fatty ester,triacylglyceride, gasoline or jet fuel.

In another aspect, the compositions produced by a recombinant cell ofthe invention comprise fatty esters and free fatty acids. For example,in one embodiment, the percentage of free fatty acids by weight is atleast about 1%, about 2%, about 3%, about 4%, about 5%, about 6%, about7%, about 8%, about 9%, about 10%, about 15%, about 20%, or about 25%.In another embodiment, the percentage of fatty esters produced by weightis at least about 50%, about 55%, about 60%, about 65%, about 70%, about75%, about 80%, about 85%, or about 90%. In a further embodiment, theratio of fatty esters to free fatty acids is about 10:1, about 9:1,about 8:1, about 7:1, about 5:1, about 2:1 or about 1:1.

In one embodiment, the composition produced in accordance with theinvention includes a fatty ester, wherein the fatty ester is at leastone of: ethyl dodecanoate, ethyl tridecanoate, ethyl tetradecanoate,ethyl pentadecanoate, ethyl cis-9-hexadecenoate, ethyl hexadecanoate,ethyl heptadecanoate, ethyl cis-11-octadecenoate, ethyl octadecanoate,or a combination thereof.

In a second embodiment, the composition produced in accordance with theinvention includes a free fatty acid, wherein the free fatty acid is atleast one of: dodecanoic acid, tetradecanoic acid, pentadecanoic acid,cis-9-hexadecenoic acid, hexadecanoic acid, cis-11-octadecenoic acid, orcombinations thereof.

The compositions of these embodiments may also be used as biofuels, forexample, as a biodiesel, fatty alcohol, fatty ester, triacylglyceride,gasoline or jet fuel. In some embodiments, the compositions disclosedherein contain a percentage by weight of C₁₂ free fatty acids relativeto the total free fatty acids of at least about 5%, 10%, or 15%. Inother embodiments, the compositions disclosed herein contain apercentage by weight of C₁₄ free fatty acids relative to the total freefatty acids of at least about 20%, 30%, or 40%. In other embodiments,the compositions disclosed herein contain a percentage by weight of C₁₅free fatty acids relative to the total free fatty acids of at leastabout 1% or 2%. In other embodiments, the compositions disclosed hereincontain a percentage by weight of C₁₆ free fatty acids relative to thetotal free fatty acids of at least about 20%, 30%, or 40%. In otherembodiments, the compositions disclosed herein contain a percentage byweight of C₁₈ free fatty acids relative to the total free fatty acids ofat least about 15%, 20%, or 25%.

In some embodiments, the compositions disclosed herein contain apercentage by weight of C₁₂ fatty esters relative to the total fattyesters of at least about 1%, 2%, or 3%. In other embodiments, thecompositions disclosed herein contain a percentage by weight of C₁₄fatty esters relative to the total fatty esters of at least about 10%,15%, or 20%. In other embodiments, the compositions disclosed hereincontain a percentage by weight of C₁₆ fatty esters relative to the totalfatty esters of at least about 30%, 40%, or 50%. In other embodiments,the compositions disclosed herein contain a percentage by weight of C₁₈fatty esters relative to the total fatty esters of at least about 20%,30%, or 40%.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a table identifying various genes that can be over-expressedor attenuated to incrase fatty acid derivative production. The tablealso identifies various genes that can be modulated to alter thestructure of the fatty acid derivative product. Some of the genes thatare used to alter the structure of the fatty acid derivative will alsoincrease the production of fatty acid derivatives.

FIG. 2 is a diagram illustrating the beta-oxidation pathway, includingsteps catalyzed by the following enzymes (1) acyl-CoA synthase (EC6.2.1.-), (2) acyl-CoA dehydrogenase (EC 1.3.99.3), (3) enoyl-CoAhydratase (EC 4.2.1.17), (4) 3-hydroxybutyryl-CoA epimerase (EC5.1.2.3), and (5) 3-ketoacyl-CoA thiolase (EC 2.3.1.16). This finalreaction of the β-oxidation cycle, releases acetyl-CoA and an acyl-CoAfatty acid two carbons shorter, ready to go through β-oxidationreactions again.

FIG. 3 is a diagram illustrating the FAS biosynthetic pathway.

FIG. 4 is a diagram illustrating biosynthetic pathways that producefatty esters depending upon the substrates provided.

FIG. 5 is a diagram illustrating biosynthetic pathways that producefatty alcohols.

FIG. 6 is a diagram illustrating biosynthetic pathways that producefatty esters.

FIG. 7 is a graph depicting fatty alcohol production by the strain,described in Example 5, co-transformed with pCDFDuet-1-fadD-acr1 andplasmids containing various thioesterase genes. Saturated C₁₀, C₁₂, C₁₄,C₁₆ and C₁₈ fatty alcohol were identified.

FIG. 8 is a graph depicting the release of fatty alcohols from theproduction strain. Approximately 50% of the fatty alcohol produced wasreleased from the cells when they were grown at 37° C.

FIG. 9A-D are plots depicting GS-MS spectra of octyl octanoate (C₈C₈)produced by a production host expressing alcohol acetyl transferase(AATs, EC 2.3.1.84) and production hosts expressing ester synthase (EC2.3.1.20, 2.3.1.75). FIG. 9A is a GC-MS spectrum showing ethyl acetateextract of strain C41(DE3, ΔfadE/pHZ1.43)/pRSET B+pAS004.114B) whereinthe pHZ1.43 plasmid expressed ADP1 ester synthase (EC 2.3.1.20,2.3.1.75). FIG. 9B is a GC-MS spectrum showing ethyl acetate extract ofstrain C41(DE3, ΔfadE/pHZ1.43)/pRSET B+pAS004.114B) wherein the pHZ1.43plasmid expressed SAAT. FIG. 9C is a GC-MS spectrum showing acetylacetate extract of strain C41(DE3, ΔfadE/pHZ1.43)/pRSET B+pAS004.114B)wherein the pHZ1.43 plasmid did not contain ADP1 (ester synthase) orSAAT. FIG. 9D is a GC-MS spectrum showing the mass spectrum andfragmentation pattern of C₈C₈ produced by C41(DE3, ΔfadE/pHZ1.43)/pRSETB+pAS004.114B wherein the pHZ1.43 plasmid expressed SAAT).

FIG. 10 is a graph depicting the distribution of ethyl esters made whenthe ester synthase from A. baylyi ADP1 (WSadp1) was co-expressed withthioesterase gene from Cuphea hookeriana in a production host.

FIG. 11 is a graph depicting the production of ethyl esters by variousester synthases at 25° C. The ethyl esters were produced by recombinantE. coli strains carrying various ester synthase genes. The recombinantstrains were 1. C41 (DE3, ΔfadEΔfabR)/pETDuet-1-tesA+pCDGFDuet-1-fadDwith 1 pHZ1.43; 2. pHZ1.97_377; 3. pHZ1.97_atfA2; 4. pHZ1.97_376; 5.pHZ1.97_atfA1; 6. No plasmids (control).

FIG. 12 is a graph depicting the acyl composition of fatty acid ethylesters (FAEE) produced from various E. coli strains. The recombinantstrains are 1. C41 (DE3, ΔfadEΔfabR)/pETDuet-1-tesA+pCDFDuet-1-fadD with1 pHZ1.43; 2. pHZ1.97_377; 3. pHZ1.97_atfA2; 4. pHZ1.97_376; 5.pHZ1.97_atfA1; 6. No plasmids (control).

FIG. 13 is a graph depicting the production of ethyl esters by variousester synthases at 37° C. The ethyl esters were produced by recombinantE. coli strains carrying various ester synthase genes. The recombinantstrains were 1. C41 (DE3, ΔfadEΔfabR)/pETDuet-1-tesA+pCDFDuet-1-fadDwith 1 pHZ1.43; 2. pHZ1.97_377; 3. pHZ1.97_atfA2; 4. pHZ1.97_376; 5.pHZ1.97_atfA1; 6. No plasmids (control).

FIG. 14 is a graph depicting concentrations of free fatty acids (FFA)and fatty acid ethyl esters (FAEE) produced from three individualcolonies from the transformants, C41 (DE3,ΔfadEΔfabR)/pETDuet-1-tesA+pCDFDuet-1-fadD+pHZ1.97_atfA2 t. The FFA wasconverted to fatty acid ethyl ester (FAEE) and quantified by GC/MS.

FIG. 15 is a diagram depicting the control region for FabA (SEQ ID NO:15) and FabB (SEQ ID NO: 16). The FadR and FabR consensus binding sitesare shown in bold. Vertical arrows indicate the positions wheremutations can be made to alter fabA expression. The proposed base foreach position is also indicated by the brackets. The two regions thatconstitute the −35 and −10 regions of the typical E. coli promoter areindicated by the brackets. The proposed mutations that make the promotercloser to the consensus promoter sequence are also shown.

FIG. 16A and FIG. 16B are chromatograms depicting GC/MS analysis. FIG.16A is a chromatogram depicting the ethyl extract of the culture of E.coli LS9001 strain transformed with plasmids pCDFDuet-1-fadD-WSadp1,pETDuet-1-′tesA. FIG. 16B is a chromatogram depicting ethylhexadecanoate and ethyl oleate used as reference.

FIG. 17 is a map of the pOP-80 plasmid.

FIG. 18 is SEQ ID NO: 1, the full DNA sequence of the pOP-80 plasmid.

FIG. 19 is SEQ ID NO: 2, the DNA sequence for the E. colicodon-optimized fadD35 gene (accession code NP_217021).

FIG. 20 is SEQ ID NO: 3, the DNA sequence for the E. colicodon-optimized fadD1 gene (accession code NP_251989).

FIG. 21 is SEQ ID NO: 4, the BsyhfLBspHIF primer based on the DNAsequence deposited at NCBI with the accession code NC_000964.

FIG. 22 is SEQ ID NO: 5, the BsyhfLEcoR primer based on the DNA sequencedeposited at NCBI with the accession code NC_000964.

FIG. 23 is SEQ ID NO: 6, the DNA sequence for the yhfL gene fromBacillus subtilis.

FIG. 24 is SEQ ID NO: 7, the Scfaa3pPciF primer based on the DNAsequence deposited at NCBI with the accession code NC_001141.

FIG. 25 is SEQ ID NO: 8, the Scfaa3pPciI primer based on the DNAsequence deposited at NCBI with the accession code NC_001141.

FIG. 26 is SEQ ID NO: 9, the DNA sequence for the FAA3 gene fromSaccharomyces cerevisiae (NP_012257).

FIG. 27 is SEQ ID NO: 10, the Smprk59BspF primer based on the DNAsequence deposited at NCBI with the accession code NZ_AAVZ01000044.

FIG. 28 is SEQ ID NO: 11, the Smprk59HindR primer based on the DNAsequence deposited at NCBI with the accession code NZ_AAVZ01000044.

FIG. 29 is SEQ ID NO: 12, the PrkBsp primer.

FIG. 30 is SEQ ID NO: 13, the DNA sequence encoding the proteinZP_01644857 from Stenotrophomonas maltophilia R551-3.

FIG. 31 is SEQ ID NO: 14, the protein sequence of ZP_01644857 fromStenotrophomonas maltophilia ATCC 17679.

ABBREVIATIONS AND TERMS

The following explanations of terms and methods are provided to betterdescribe the present disclosure and to guide those of ordinary skill inthe art in the practice of the present disclosure. As used herein, thesingular forms “a” or “an” or “the” include plural references unless thecontext clearly dictates otherwise. For example, reference to “a cell”or “the cell” includes one or a plurality of such cells. The term “or”refers to a single element of stated alternative elements or acombination of two or more elements, unless the context clearlyindicates otherwise. For example, the phrase “thioesterase activity orfatty alcohol-forming acyl-CoA reductase activity” refers tothioesterase activity, fatty alcohol forming acyl-CoA reductaseactivity, or a combination of both thioesterase activity and fattyalcohol forming acyl-CoA reductase activity. Additionally, throughoutthe specification, a reference may be made using an abbreviated genename or enzyme name, but it is understood that such an abbreviated geneor enzyme name represents the genus of genes or enzymes. For example“fadD” refers to a gene encoding the enzyme “FadD,” as well as genesencoding acyl-CoA synthase (EC 6.2.1.-). Such gene names include allgenes encoding the same peptide and homologous enzymes having the samephysiological function, and enzyme names include all peptides thatcatalyze the same fundamental chemical reaction or have the sameactivity. FIG. 1 provides various abbreviated gene and peptide names,descriptions of their activities, and their enzyme classificationnumbers. These can be used to identify other members of the class ofenzymes having the associated activity and their associated genes, whichcan be used to produce fatty acid derivatives.

Unless explained otherwise, all technical and scientific terms usedherein have the same meaning as commonly understood to one of ordinaryskill in the art to which this disclosure belongs. Although methods andmaterials similar or equivalent to those described herein can be used inthe practice or testing of the present disclosure, suitable methods andmaterials are described below. The materials, methods, and examples areillustrative only and not intended to be limiting. Other features of thedisclosure are apparent from the following detailed description and theclaims.

Accession Numbers: The accession numbers throughout this description arederived from the NCBI database (National Center for BiotechnologyInformation) maintained by the National Institute of Health, U.S.A. Theaccession numbers are as provided in the database on Mar. 27, 2007.

Enzyme Classification Numbers (EC): EC numbers are established by theNomenclature Committee of the International Union of Biochemistry andMolecular Biology (NC-IUBMB). The EC numbers provided herein are derivedfrom the KEGG Ligand database, maintained by the Kyoto Encyclopedia ofGenes and Genomics, sponsored in part by the University of Tokyo. The ECnumbers are as provided in the database on Mar. 27, 2007.

Attenuate: To weaken, reduce or diminish. In one example, thesensitivity of a particular enzyme to feedback inhibition or inhibitioncaused by a composition that is not a product or a reactant (non-pathwayspecific feedback) is reduced such that the enzyme activity is notimpacted by the presence of a compound. In another example, theexpression of fabH gene is temperature sensitive and its sequence can bealtered to decrease the sensitivity to temperature fluctuations.Expression of the fabH gene can be attenuated when branched amino acidsare desired. In another example, an enzyme that has been modified to beless active can be referred to as attenuated.

A functional modification of the sequence encoding an enzyme can be usedto attenuate expression of an enzyme. Sequence modifications mayinclude, for example, a mutation, deletion or insertion of one or morenucleotides in a gene sequence or a sequence controlling thetranscription or translation of a gene sequence, which modificationresults in reduction or inhibition of production of the gene product, orrenders the gene product non-functional. For example, functionaldeletion of fabR in E. coli reduces the repression of the fatty acidbiosynthetic pathway and allows E. coli to produce more unsaturatedfatty acids (UFAs). In some instances a functional deletion is describedas a knock-out mutation.

Other methods are available for attenuating expression of an enzyme. Forexample, attenuation can be accomplished by modifying the sequenceencoding the gene as described above; placing the gene under the controlof a less active promoter, expressing interfering RNA, ribozymes orantisense sequences that target the gene of interest; by changing thephysical or chemical environment, such as temperature, pH, or soluteconcentration, such that the optimal activity of the gene or geneproduct is not realized; or through any other technique known in theart.

Biofuel: The term “biofuel” refers to any fuel derived from biomass.

Biomass is a biological material that can be converted into a biofuel.One exemplary source of biomass is plant matter. For example, corn,sugar cane, and switchgrass can be used as biomass. Another non-limitingexample of biomass is animal matter, for example cow manure. Biomassalso includes waste products from industry, agriculture, forestry, andhouseholds. Examples of such waste products which can be used as biomassare fermentation waste, straw, lumber, sewage, garbage and foodleftovers. Biomass also includes sources of carbon, such ascarbohydrates (e.g., sugars).

Biofuels can be substituted for petroleum based fuels. For example,biofuels are inclusive of transportation fuels (e.g., gasoline, diesel,jet fuel, etc.), heating fuels, and electricity-generating fuels.Biofuels are a renewable energy source. Non-limiting examples ofbiofuels are biodiesel, hydrocarbons (e.g., alkanes, alkenes, alkynes,or aromatic hydrocarbons), and alcohols derived from biomass.

Biodiesel: Biodiesel is a biofuel. Biodiesel can be a substitute ofdiesel, which is derived from petroleum. Biodiesel can be used ininternal combustion diesel engines in either a pure form, which isreferred to as “neat” biodiesel, or as a mixture in any concentrationwith petroleum-based diesel.

Biodiesel can be comprised of hydrocarbons or esters. In one embodiment,biodiesel is comprised of fatty esters, such as fatty acid methyl esters(FAME) or fatty acid ethyl esters (FAEE). In a preferred embodiment,these FAME and FAEE are comprised of fatty acyl moieties having a carbonchain length of about 8-20, 10-18, or 12-16 carbons in length. Fattyesters used as biodiesel may contain carbon chains which are saturatedor unsaturated.

Biocrude: Biocrude is a biofuel. Biocrude can be used as a substitutefor petroleum based fuels. In addition, biocrude, like petroleum crude,can be converted into other fuels, for example gasoline, diesel, jetfuel, or heating oil. Moreover, biocrude, like petroleum crude, can beconverted into other industrially useful chemicals for use in, forexample, pharmaceuticals, cosmetics, consumer goods, industrialprocesses, etc.

Biocrude may include, for example, hydrocarbons, hydrocarbon products,fatty acid esters, and/or aliphatic ketones. In a preferred embodiment,biocrude is comprised of hydrocarbons, for example aliphatic (e.g.,alkanes, alkenes, alkynes) or aromatic hydrocarbons.

Carbon source: Generally refers to a substrate or compound suitable tobe used as a source of carbon for prokaryotic or simple eukaryotic cellgrowth. Carbon sources can be in various forms, including, but notlimited to polymers, carbohydrates, acids, alcohols, aldehydes, ketones,amino acids, peptides, gases (e.g., CO and CO₂), etc. These include, forexample, various monosaccharides such as glucose, fructose, mannose andgalactose; oligosaccharides such as fructo-oligosaccharide andgalacto-oligosaccharide; polysaccharides such as xylose, and arabinose;disaccharides such as sucrose, maltose and turanose; cellulosic materialsuch as methyl cellulose and sodium carboxymethyl cellulose; saturatedor unsaturated fatty acid esters such as succinate, lactate and acetate;alcohols such as ethanol, etc., or mixtures thereof.

The carbon source can additionally be a product of photosynthesis,including, but not limited to glucose.

Cloud point of a fluid: The temperature at which dissolved solids are nolonger completely soluble, precipitating as a second phase giving thefluid a cloudy appearance. This term is relevant to several applicationswith different consequences.

In the petroleum industry, cloud point refers to the temperature belowwhich wax or other heavy hydrocarbons crystalizes in a crude oil,refined oil or fuel to form a cloudy appearance. The presence ofsolidified waxes influences the flowing behavior of the fluid, thetendency to clog fuel filters/injectors etc., the accumulation of wax oncold surfaces (e.g., pipeline or heat exchanger fouling), and even theemulsion characteristics with water. Cloud point is an indication of thetendency of the oil to plug filters or small orifices at cold operatingtemperatures.

The cloud point of a nonionic surfactant or glycol solution is thetemperature where the mixture starts to phase separate and two phasesappear, thus becoming cloudy. This behavior is characteristic ofnon-ionic surfactants containing polyoxyethylene chains, which exhibitreverse solubility versus temperature behavior in water and therefore“cloud out” at some point as the temperature is raised. Glycolsdemonstrating this behavior are known as “cloud-point glycols” and areused as shale inhibitors. The cloud point is affected by salinity, beinggenerally lower in more saline fluids.

Cloud point lowering additive: An additive which may be added to acomposition to decrease or lower the cloud point of a solution, asdescribed above.

Detectable: Capable of having an existence or presence ascertained. Forexample, production of a product from a reactant (e.g., the productionof C18 fatty acids) is detectable using the methods provided below.

Endogenous: As used herein, with reference to a nucleic acid moleculeand a particular cell or microorganism, “endogenous” refers to a nucleicacid sequence or peptide that is in the cell and was not introduced intothe cell using recombinant engineering techniques. For example, a genethat was present in the cell when the cell was originally isolated fromnature. A gene is still considered endogenous if the control sequences,such as a promoter or enhancer sequences that activate transcription ortranslation, have been altered through recombinant techniques.

Ester synthase: An ester synthase is a peptide capable of producingfatty esters. More specifically, an ester synthase is a peptide whichconverts a thioester to a fatty ester. In a preferred embodiment, theester synthase converts the thioester, acyl-CoA, to a fatty ester.

In an alternate embodiment, an ester synthase uses a thioester and analcohol as substrates to produce a fatty ester. Ester synthases arecapable of using short and long chain acyl-CoAs as substrates. Inaddition, ester synthases are capable of using short and long chainalcohols as substrates.

Non-limiting examples of ester synthases are wax synthases, wax-estersynthases, acyl-CoA:alcohol transacylases, acyltransferases, and fattyacyl-coenzyme A:fatty alcohol acyltransferases. Exemplary estersynthases are classified in enzyme classification number EC 2.3.1.75.Exemplary GenBank Accession Numbers are provided in FIG. 1.

Exogenous: As used herein, with reference to a nucleic acid molecule anda particular cell, “exogenous” refers to any nucleic acid molecule thatdoes not originate from that particular cell as found in nature. Forexample, “exogenous DNA” could refer to a DNA sequence that was insertedwithin the genomic DNA sequence of a microorganism, or an extrachromosomal nucleic acid sequence that was introduced into themicroorganism. Thus, a non-naturally-occurring nucleic acid molecule isconsidered to be exogenous to a cell once introduced into the cell. Anucleic acid molecule that is naturally-occurring also can be exogenousto a particular cell. For example, an entire coding sequence isolatedfrom an E. coli DH5alpha cell is an exogenous nucleic acid with respectto a second E. coli DH5alpha cell once that coding sequence isintroduced into the second E. coli DH5alpha cell, even though both cellsare DH5alpha cells.

Expression: The process by which the inheritable information in a gene,such as the DNA sequence, is made into a functional gene product, suchas protein or RNA.

Several steps in the gene expression process may be modulated, includingthe transcription step, the translational step, and thepost-translational modification of the resulting protein. Generegulation gives the cell control over its structure and function, andit is the basis for cellular differentiation, morphogenesis and theversatility and adaptability of any organism. Gene regulation may alsoserve as a substrate for evolutionary change, since control of thetiming, location, and amount of gene expression can have a profoundeffect on the functions (actions) of the gene in the organism.

Expressed genes include genes that are transcribed into messenger RNA(mRNA) and then translated into protein, as well as genes that aretranscribed into types of RNA, such as transfer RNA (tRNA), ribosomalRNA (rRNA), and regulatory RNA that are not translated into protein.

Fatty ester: A fatty ester is an ester. In a preferred embodiment, afatty ester is any ester made from a fatty acid, for example a fattyacid ester.

In one embodiment, a fatty ester contains an A side (i.e., the carbonchain attached to the carboxylate oxygen) and a B side (i.e., the carbonchain comprising the parent carboxylate). In a preferred embodiment,when the fatty ester is derived from the fatty acid biosyntheticpathway, the A side is contributed by an alcohol, and the B side iscontributed by a fatty acid.

Any alcohol can be used to form the A side of the fatty esters. Forexample, the alcohol can be derived from the fatty acid biosyntheticpathway. Alternatively, the alcohol can be produced through non-fattyacid biosynthetic pathways. Moreover, the alcohol can be providedexogenously. For example, the alcohol can be supplied in thefermentation broth in instances where the fatty ester is produced by anorganism. Alternatively, a carboxylic acid, such as a fatty acid oracetic acid, can be supplied exogenously in instances where the fattyester is produced by an organism that can also produce alcohol.

The carbon chains comprising the A side or B side can be of any length.In one embodiment, the A side of the ester is at least about 1, 2, 3, 4,5, 6, 7, 8, 10, 12, 14, 16, or 18 carbons in length. The B side of theester is at least about 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, or 26carbons in length. The A side and/or the B side can be straight orbranched chain. The branched chains may have one or more points ofbranching. In addition, the branched chains may include cyclic branches.Furthermore, the A side and/or B side can be saturated or unsaturated.If unsaturated, the A side and/or B side can have one or more points ofunsaturation.

In one embodiment, the fatty ester is produced biosynthetically. In thisembodiment, first the fatty acid is “activated.” Non-limiting examplesof “activated” fatty acids are acyl-CoA, acyl ACP, and acyl phosphate.Acyl-CoA can be a direct product of fatty acid biosynthesis ordegradation. In addition, acyl-CoA can be synthesized from a free fattyacid, a CoA, and an adenosine nucleotide triphosphate (ATP). An exampleof an enzyme which produces acyl-CoA is acyl-CoA synthase

After the fatty acid is activated, it can be readily transferred to arecipient nucleophile. Exemplary nucleophiles are alcohols, thiols, orphosphates.

In another embodiment, the fatty ester can be derived from a fattyacyl-thioester and an alcohol.

In one embodiment, the fatty ester is a wax. The wax can be derived froma long chain alcohol and a long chain fatty acid. In another embodiment,the fatty ester is a fatty acid thioester, for example fatty acylCoenzyme A (CoA). In other embodiments, the fatty ester is a fatty acylpanthothenate, an acyl acyl carrier protein (ACP), or a fatty phosphateester.

Fatty esters have many uses. For examples, fatty esters can be used as abiofuel or a surfactant.

Fatty acid derivative: The term “fatty acid derivative” includesproducts made in part from the fatty acid biosynthetic pathway of theproduction host organism. “Fatty acid derivative” also includes productsmade in part from acyl-ACP or acyl-ACP derivatives. The fatty acidbiosynthetic pathway includes fatty acid synthase enzymes which can beengineered as described herein to produce fatty acid derivatives, and insome examples can be expressed with additional enzymes to produce fattyacid derivatives having desired carbon chain characteristics. Exemplaryfatty acid derivatives include for example, short and long chainalcohols, hydrocarbons, and fatty alcohols and esters, including waxes,fatty acid esters, or fatty esters.

Fatty acid derivative enzymes: All enzymes that may be expressed orover-expressed in the production of fatty acid derivatives arecollectively referred to herein as fatty acid derivative enzymes. Theseenzymes may be part of the fatty acid biosynthetic pathway. Non-limitingexamples of fatty acid derivative synthases include fatty acidsynthases, thioesterases, acyl-CoA synthases, acyl-CoA reductases,alcohol dehydrogenases, alcohol acyltransferases, fatty alcohol-formingacyl-CoA reductase, and ester synthases. Fatty acid derivative enzymesconvert a substrate into a fatty acid derivative. In some examples, thesubstrate may be a fatty acid derivative which the fatty acid derivativeenzyme converts into a different fatty acid derivative.

Fatty alcohol forming peptides: Peptides capable of catalyzing theconversion of acyl-CoA to fatty alcohol, including fatty alcohol formingacyl-CoA reductase (FAR, EC 1.1.1.*), acyl-CoA reductase (EC 1.2.1.50)or alcohol dehydrogenase (EC 1.1.1.1). Additionally, one of ordinaryskill in the art will appreciate that some fatty alcohol formingpeptides will catalyze other reactions as well. For example, someacyl-CoA reductase peptides will accept other substrates in addition tofatty acids. Such non-specific peptides are, therefore, also included.Nucleic acid sequences encoding fatty alcohol forming peptides are knownin the art and such peptides are publicly available. Exemplary GenBankAccession Numbers are provided in FIG. 1.

Fraction of modern carbon: Fraction of modern carbon (f_(M)) is definedby National Institute of Standards and Technology (NIST) StandardReference Materials (SRMs) 4990B and 4990C, known as oxalic acidsstandards HOxI and HOxII, respectively. The fundamental definitionrelates to 0.95 times the ¹⁴C/¹²C isotope ratio HOxI (referenced to AD1950). This is roughly equivalent to decay-corrected pre-IndustrialRevolution wood. For the current living biosphere (plant material),f_(M) is approximately 1.1.

Hydrocarbon: includes chemical compounds that contain the elementscarbon (C) and hydrogen (H). All hydrocarbons consist of a carbonbackbone and atoms of hydrogen attached to that backbone. Sometimes, theterm is used as a shortened form of the term “aliphatic hydrocarbon.”There are essentially three types of hydrocarbons: (1) aromatichydrocarbons, which have at least about one aromatic ring; (2) saturatedhydrocarbons, also known as alkanes, which lack double, triple oraromatic bonds; and (3) unsaturated hydrocarbons, which have one or moredouble or triple bond between carbon atoms and include: alkenes (e.g.,dienes) and alkynes.

Isolated: An “isolated” biological component (such as a nucleic acidmolecule, protein, or cell) is a biological component that has beensubstantially separated or purified away from other biologicalcomponents in which the biological component naturally occurs, such asother chromosomal and extra-chromosomal DNA sequences; chromosomal andextra-chromosomal RNA; and proteins. Nucleic acid molecules and proteinsthat have been “isolated” include nucleic acid molecules and proteinspurified by standard purification methods. The term embraces nucleicacid molecules and proteins prepared by recombinant expression in aproduction host cell as well as chemically synthesized nucleic acidmolecules and proteins.

In one example, isolated refers to a naturally-occurring nucleic acidmolecule that is not contiguous with both of the sequences with which itis directly adjacent to (i.e., the sequence on the 5′ end and thesequence on the 3′ end) in the naturally-occurring genome of theorganism from which it is derived.

Microorganism: Includes prokaryotic and eukaryotic microbial speciesfrom the domains Archaea, Bacteria and Eucarya, the latter includingyeast and filamentous fungi, protozoa, algae, or higher Protista. Theterms “microbial cells” and “microbes” are used interchangeably with theterm microorganism.

Nucleic Acid Molecule: Encompasses both RNA and DNA sequences including,without limitation, cDNA, genomic DNA sequences, and mRNA. The termincludes synthetic nucleic acid molecules, such as those that arechemically synthesized or recombinantly produced. The nucleic acidmolecule can be double-stranded or single-stranded. Whensingle-stranded, the nucleic acid molecule can be the sense strand orthe antisense strand. In addition, a nucleic acid molecule can becircular or linear.

Operably linked: A first nucleic acid sequence is operably linked to asecond nucleic acid sequence when the first nucleic acid sequence isplaced in a functional relationship to the second nucleic acid sequence.For instance, a promoter is operably linked to a coding sequence if thepromoter is in a position to affect the transcription or expression ofthe coding sequence. Generally, operably linked DNA sequences arecontiguous and may join two protein coding regions, in the same readingframe. Configurations of separate genes which are operably linked andare transcribed in tandem as a single messenger RNA are denoted asoperons. Placing genes in close proximity, for example in a plasmidvector, under the transcriptional regulation of a single promoter,constitutes a synthetic operon.

ORF (open reading frame): A series of nucleotide triplets (i.e., codons)coding for amino acids without any termination codons. These sequencesare usually translatable into a peptide.

Over-express: When a peptide is present in a greater concentration in arecombinant host cell compared to its concentration in a non-recombinanthost cell of the same species.

Over-expression can be accomplished using any method known in the art.For example, over-expression can be caused by altering the controlsequences in the genomic DNA sequence of a host cell, introducing one ormore coding sequences into the genomic DNA sequence, altering one ormore genes involved in the regulation of gene expression (e.g., deletinga repressor gene or producing an active activator), amplifying the geneat a chromosomal location (tandem repeats), introducing an extrachromosomal nucleic acid sequence, increasing the stability of the RNAtranscribed via introduction of stabilizing sequences, and combinationsthereof.

Examples of recombinant microorganisms that over-produce a peptideinclude microorganisms that express nucleic acid sequences encodingacyl-CoA synthases (EC 6.2.1.-). Other examples include microorganismsthat have had exogenous promoter sequences introduced upstream to theendogenous coding sequence of a thioesterase peptide (EC 3.1.2.-).Over-expression also includes elevated rates of translation of a genecompared to the endogenous translation rate for that gene. Methods oftesting for over-expression are well known in the art. For example,transcribed RNA levels can be assessed using rtPCR and protein levelscan be assessed using SDS page gel analysis.

Partition coefficient: The partition coefficient, P, is defined as theequilibrium concentration of a compound in an organic phase divided bythe concentration at equilibrium in an aqueous phase (e.g., fermentationbroth). In one embodiment of the bi-phasic system described herein, theorganic phase is formed by the fatty acid derivative during theproduction process. However, in some examples, an organic phase can beprovided, such as by providing a layer of octane, to facilitate productseparation. When describing a two phase system, the partitioncoefficient, P, is usually discussed in terms of log P. A compound witha log P of 1 would partition 10:1 to the organic phase. A compound witha log P of −1 would partition 1:10 to the organic phase. By choosing anappropriate fermentation broth and organic phase, a fatty acidderivative with a high log P value will separate into the organic phaseeven at very low concentrations in the fermentation vessel.

Production host: A production host is a cell used to produce theproducts disclosed herein. As disclosed herein, the production host ismodified to express or over-express selected genes, or to haveattenuated expression of selected genes. Non-limiting examples ofproduction hosts include plant, animal, human, bacteria, yeast, orfilamentous fungi cells.

Promoters and enhancers: Transcriptional control signals in eukaryotescomprise “promoter” and “enhancer” elements. Promoters and enhancersconsist of short arrays of DNA sequences which interact specificallywith cellular proteins involved in transcription (Maniatis et al.,Science 236:1237, 1987). Promoter and enhancer elements have beenisolated from a variety of eukaryotic sources including genes in yeast,insect, mammalian and plant cells. Promoter and enhancer elements thathave been isolated from viruses. Analogous control elements, such aspromoters and enhancers, are also found in prokaryotes. The selection ofa particular promoter and enhancer depends on the cell type used toexpress the protein of interest. Some eukaryotic and prokaryoticpromoters and enhancers have a broad production host cell range whileothers are functional in a limited subset of production host cells (see,e.g., Voss et al., Trends Biochem. Sci., 11:287, 1986; and Maniatis etal., 1987 supra).

The terms “promoter element,” “promoter,” or “promoter sequence” referto a DNA sequence that functions as a switch which activates theexpression of a gene. If the gene is activated, it is said to betranscribed, or participating in transcription. Transcription involvesthe synthesis of mRNA from the gene. The promoter, therefore, serves asa transcriptional regulatory element and also provides a site forinitiation of transcription of the gene into mRNA.

Purified: The term “purified” refers to molecules that are removed fromtheir natural environment by, for example, isolation or separation.“Substantially purified” molecules are at least about 60% free,preferably at least about 75% free, and more preferably at least about90% free from other components with which they are naturally associated.As used herein, the term “purified” or “to purify” also refers to theremoval of contaminants from a sample. For example, the removal ofcontaminants can result in an increase in the percentage of fatty acidderivatives of interest in a sample. For example, after fatty acidderivatives are expressed in plant, bacterial, yeast, or mammalianproduction host cells, the fatty acid derivatives are purified by theremoval of production host cell proteins. After purification, thepercentage of fatty acid derivatives in the sample is increased.

The term purified does not require absolute purity; rather, it isintended as a relative term. Thus, for example, a purified fatty acidderivative preparation is one in which the product is more concentratedthan the product is in its environment within a cell. For example, apurified fatty ester is one that is substantially separated fromcellular components (e.g., nucleic acids, lipids, carbohydrates, andother peptides) that can accompany it. In another example, a purifiedfatty ester preparation is one in which the fatty ester is substantiallyfree from contaminants, such as those that might be present followingfermentation.

For example, a fatty ester is purified when at least about 50% by weightof a sample is composed of the fatty ester. In another example when atleast about 60%, 70%, 80%, 85%, 90%, 92%, 95%, 98%, or 99% or more byweight of a sample is composed of the fatty ester.

Recombinant: A recombinant nucleic acid molecule is one that has asequence that is not naturally occurring, has a sequence that is made byan artificial combination of two otherwise separated segments ofsequence, or both. This artificial combination can be achieved, forexample, by chemical synthesis or by the artificial manipulation ofisolated segments of nucleic acid molecules, such as genetic engineeringtechniques. Recombinant is also used to describe nucleic acid moleculesthat have been artificially manipulated, but contain the same regulatorysequences and coding regions that are found in the organism from whichthe nucleic acid was isolated. A recombinant protein is a proteinderived from a recombinant nucleic acid molecule.

A recombinant or transformed cell is one into which a recombinantnucleic acid molecule has been introduced, such as an acyl-CoA synthaseencoding nucleic acid molecule, for example by molecular biologytechniques. Transformation encompasses all techniques by which a nucleicacid molecule can be introduced into such a cell, including, but notlimited to, transfection with viral vectors, conjugation, transformationwith plasmid vectors, and introduction of naked DNA sequence byelectroporation, lipofection, and particle gun acceleration.

Sequence identity: The similarity between two nucleic acid sequences orbetween two amino acid sequences is expressed in terms of the level ofsequence identity shared between the sequences. Sequence identity istypically expressed in terms of percentage identity. The higher thepercentage identity, the more similar the two sequences. For thepurposes of this application, the terms “identity” and “similarity” areinterchangeable.

Methods for aligning sequences for comparison are well known in the art.Various programs and alignment algorithms are described in: Smith &Waterman, Adv. Appl. Math. 2:482, 1981; Needleman & Wunsch, J. Mol.Biol. 48:443, 1970; Pearson & Lipman, Proc. Natl. Acad. Sci. USA85:2444, 1988; Higgins & Sharp, Gene 73:237 244, 1988; Higgins & Sharp,CABIOS 5:151-153, 1989; Corpet et al., Nucleic Acids Research16:10881-10890, 1988; Huang et al., CABIOS 8:155-165, 1992; and Pearsonet al., Methods in Molecular Biology 24:307-331, 1994. Altschul et al.,J. Mol. Biol. 215:403-410, 1990, presents a detailed consideration ofsequence alignment methods and homology calculations.

The NCBI Basic Local Alignment Search Tool (BLAST™; Altschul et al., J.Mol. Biol. 215:403-410, 1990) is available from several sources,including the National Center for Biotechnology Information (NBCI,Bethesda, Md.), for use in connection with the sequence analysisprograms blastp, blastn, blastx, tblastn and tblastx. BLAST™ can beaccessed on the Internet at the NBCI website. As used herein, sequenceidentity is commonly determined with the BLAST™ software set to defaultparameters. For example, blastn (version 2.0) software can be used todetermine sequence identity between two nucleic acid sequences usingdefault parameters (e.g., expect=10, matrix=BLOSUM62, filter=DUST(Tatusov and Lipmann, in preparation as of Dec. 1, 1999; and Hancock andArmstrong, Comput. Appl. Biosci. 10:67-70, 1994), gap existence cost=11,per residue gap cost=1, and lambda ratio=0.85). For comparison of twopolypeptides, blastp (version 2.0) software can be used with defaultparameters (e.g., expect 10, filter=SEG (Wootton and Federhen, Computersin Chemistry 17:149-163, 1993), matrix=BLOSUM62, gap existence cost=11,per residue gap cost=1, lambda=0.85).

For comparisons of nucleic acid sequences, the “Blast 2 sequences”function of the BLAST™ (Blastn) program is employed using the defaultBLOSUM62 matrix set to default parameters (e.g., cost to open a gap[default=11]; cost to extend a gap [default=1]; expectation value (E)[default=10.0]; word size [default=11]; number of one-line descriptions(V) [default=100]; number of alignments to show (B) [default=100]).Nucleic acid sequences with even greater similarity to the referencesequences will show increasing percentage identities when assessed bythis method, such as at least about 45%, at least about 60%, at leastabout 70%, at least about 75%, at least about 80%, at least about 85%,at least about 90%, at least about 95%, or at least about 98%, or atleast about 99% sequence identity.

For comparisons of amino acid sequences of greater than about 30 aminoacids, the “Blast 2 sequences” function of the BLAST™ program isemployed using the default BLOSUM62 matrix set to default parameters(e.g., gap existence cost of 11, and a per residue gap cost of 1). Whenaligning short peptides (e.g., fewer than around 30 amino acids), thealignment should be performed using the Blast 2 sequences function,employing the PAM30 matrix set to default parameters (e.g., open gap 9,extension gap 1 penalties). Proteins with even greater similarity to thereference sequences will show increasing percentage identities whenassessed by this method, such as at least about 35%, at least about 45%,at least about 50%, at least about 60%, at least about 80%, at leastabout 85%, at least about 90%, at least about 95%, at least about 98%,or at least about 99% sequence identity to the sequences.

Surfactants: Substances capable of reducing the surface tension of aliquid in which they are dissolved. They are typically composed of awater-soluble head and a hydrocarbon chain or tail. The water solublehead is hydrophilic and can be either ionic or nonionic. The hydrocarbonchain is hydrophobic. Surfactants are used in a variety of products,including detergents and cleaners, and are also used as auxiliaries fortextiles, leather and paper, in chemical processes, in cosmetics andpharmaceuticals, in the food industry and in agriculture. In addition,they can be used to aid in the extraction and isolation of crude oilswhich are found hard to access environments or in water emulsions.

There are four types of surfactants characterized by varying uses.Anionic surfactants have detergent-like activity and are generally usedfor cleaning applications. Cationic surfactants contain long chainhydrocarbons and are often used to treat proteins and synthetic polymersor are components of fabric softeners and hair conditioners. Amphotericsurfactants also contain long chain hydrocarbons and are typically usedin shampoos. Non-ionic surfactants are generally used in cleaningproducts.

Synthase: A synthase is an enzyme which catalyzes a synthesis process.As used herein, the term synthase includes synthases and synthetases.

Transport protein: A protein that facilitates the movement of one ormore compounds in and/or out of an organism or organelle. In someembodiments, an exogenous DNA sequence encoding an ATP-Binding Cassette(ABC) transport protein will be functionally expressed by the productionhost so that the production host exports the fatty acid derivative intothe culture medium. ABC transport proteins are found in many organisms,such as Caenorhabditis elegans, Arabidopsis thalania, Alcaligeneseutrophus (later renamed Ralstonia eutropha), or Rhodococcuserythropolis. Non-limiting examples of ABC transport proteins includeCERS, AtMRP5, AmiS2 and AtPGP1. In a preferred embodiment, the ABCtransport protein is CERS (e.g., AY734542).

In other embodiments, the transport protein is an efflux proteinselected from: AcrAB, TolC, or AcrEF from E. coli or tll1618, tll1619,and tll0139 from Thermosynechococcus elongatus BP-1.

In further embodiments, the transport protein is a fatty acid transportprotein (FATP) selected from Drosophila melanogaster, Caenorhabditiselegans, Mycobacterium tuberculosis, or Saccharomyces cerevisiae or anyone of the mammalian FATPs well known in the art.

Under conditions that permit product production: Any fermentationconditions that allow a production host to produce a desired product,such as acyl-CoA or fatty acid derivatives such as fatty acids,hydrocarbons, fatty alcohols, waxes, or fatty esters. Fermentationconditions usually comprise many parameters. Exemplary conditionsinclude, but are not limited to, temperature ranges, levels of aeration,and media composition. Each of these conditions, individually and incombination, allows the production host to grow.

Exemplary mediums include broths or gels. Generally, the medium includesa carbon source, such as glucose, fructose, cellulose, or the like, thatcan be metabolized by the microorganism directly. In addition, enzymescan be used in the medium to facilitate the mobilization (e.g., thedepolymerization of starch or cellulose to fermentable sugars) andsubsequent metabolism of the carbon source.

To determine if the culture conditions permit product production, theproduction host can be cultured for about 4, 8, 12, 24, 36, or 48 hours.During culturing or after culturing, samples can be obtained andanalyzed to determine if the culture conditions permit productproduction. For example, the production hosts in the sample or themedium in which the production hosts were grown can be tested for thepresence of the desired product. When testing for the presence of aproduct, assays, such as, but not limited to, TLC, HPLC, GC/FID, GC/MS,LC/MS, MS, as well as those provided in the examples below, can be used.

Vector: A nucleic acid molecule as introduced into a cell, therebyproducing a transformed cell. A vector can include nucleic acidsequences that permit it to replicate in the cell, such as an origin ofreplication. A vector can also include one or more selectable markergenes or other genetic elements known in the art.

Wax: Wax is comprised of fatty esters. In a preferred embodiment, thefatty ester contains an A side and a B side comprised of medium to longcarbon chains.

In addition to fatty esters, a wax may comprise other components. Forexample, wax can also comprise hydrocarbons, sterol esters, aliphaticaldehydes, alcohols, ketones, beta-diketones, triacylglycerols, etc.

DETAILED DESCRIPTION

Many cells microorganisms can utilize fatty acids as energy sources and,therefore, contain β-oxidation pathways that metabolize fatty acids tomake energy. Surprisingly, it was found that over-expressing a peptidehaving acyl-CoA synthase activity (the first enzymatic activity found inthe β-oxidation pathway), and/or attenuating other genes in the betaoxidation pathway, could increase the amount of acyl-CoA produced, whilemaintaining the viability of the cell or microorganism. Similarly,over-expressing a peptide having acyl-CoA synthase activity incombination with over-expression of peptides that form fatty acidderivatives can improve fatty acid derivative production.

Fatty acid derivatives are useful as biofuels and specialty chemicals,which can be used to make additional products such as nutritionalsupplements, polymers, paraffin replacements, and personal careproducts. Furthermore, the teachings disclosed herein allow for theproduction of fatty acid derivatives with particular branch points,levels of saturation, and carbon chain length.

Non-limiting examples of microorganisms which can be used as productionhosts to produce fatty acid derivatives include bacteria, yeast, orfilamentous fungi. Further non-limiting examples of suitable productionhosts include plant, animal, or human cells.

Alcohols (short chain, long chain, branched, or unsaturated) can beproduced by the production hosts described herein. Such alcohols can beused as fuels directly or they can be used to create a fatty ester.Fatty esters, alone or in combination with other fatty acid derivativesdescribed herein, are useful as fuels.

Similarly, hydrocarbons produced from the production hosts describedherein can be used as biofuels. Such hydrocarbon-based fuels can bedesigned to contain branch points, defined degrees of saturation, andspecific carbon lengths. When used as biofuels alone or in combinationwith other fatty acid derivatives, the hydrocarbons can be combined withadditives or other traditional fuels (e.g., alcohols, diesel derivedfrom triglycerides, and petroleum-based fuels).

The centane number (CN), viscosity, melting point, and heat ofcombustion for various fatty esters have been characterized in Knothe,Fuel Processing Technology 86:1059-1070, 2005, which is hereinincorporated by reference in its entirety. A production host can beengineered to produce any of the fatty esters described in Knothe, usingthe teachings provided herein.

I. Production of Fatty Acid Derivatives and Modifications for IncreasingProduction

The production host used to produce acyl-CoA and/or fatty acidderivatives can be recombinantly modified to include nucleic acidsequences that over-express peptides. For example, the production hostcan be modified to increase the production of acyl-CoA and reduce thecatabolism of fatty acid derivatives and intermediates in the fatty acidbiosynthetic pathway, such as acyl-CoA, or to reduce feedback inhibitionat specific points in the fatty acid biosynthetic pathway. In additionto modifying the genes described herein, additional cellular resourcescan be diverted to over-produce fatty acids, for example, the lactate,succinate and/or acetate pathways can be attenuated, and acetyl-CoAcarboxylase (acc) can be over-expressed. The modifications to theproduction host described herein can be through genomic alterations,addition of recombinant expression systems, or combinations thereof.

The fatty acid biosynthetic pathways involved are illustrated in FIG. 2through FIG. 6. Subsections A-G below describe the steps in thesepathways. Different steps in the pathway are catalyzed by differentenzymes. Each step is a potential place for overexpression of the geneto produce more enzyme and thus drive the production of more fatty acidsand fatty acid derivatives. Genes encoding enzymes required for thepathway may also be recombinantly added to a production host lackingsuch enzymes. Finally, steps that would compete with the pathway leadingto production of fatty acids and fatty acid derivatives can beattenuated or blocked in order to increase the production of the desiredproducts.

A. Acetyl-CoA-Malonyl-CoA to Acyl-ACP

Fatty acid synthase (FAS) is a group of peptides that catalyze theinitiation and elongation of acyl chains (Marrakchi et al., BiochemicalSociety, 30:1050-1055, 2002). The acyl carrier protein (ACP) along withthe enzymes in the FAS pathway control the length, degree of saturation,and branching of the fatty acids produced. The steps in this pathway arecatalyzed by enzymes of the fatty acid biosynthesis (fab) and acetyl-CoAcarboxylase (acc) gene families Depending upon the desired product, oneor more of these genes can be attenuated or over-expressed (see FIG. 1for a detailed description of the enzymatic activity of each enzyme andits enzyme classification number).

1. Fatty Acid Biosynthetic Pathway: Acetyl-CoA or Malonyl-CoA toAcyl-ACP

The fatty acid biosynthetic pathway in the production host uses theprecursors acetyl-CoA and malonyl-CoA (FIG. 3). The steps in thispathway are catalyzed by enzymes of the fatty acid biosynthesis (fab)and acetyl-CoA carboxylase (acc) gene families. This pathway isdescribed in Heath et al., Prog. Lipid Res. 40(6):467-97 (2001), whichis incorporated herein by reference in its entirety.

Acetyl-CoA is carboxylated by acetyl-CoA carboxylase (Acc, amultisubunit enzyme encoded by four separate genes, accABCD), to formmalonyl-CoA. The malonate group is transferred to ACP by malonyl-CoA:ACPtransacylase (FabD) to form malonyl-ACP. A condensation reaction thenoccurs, where malonyl-ACP merges with acetyl-CoA, resulting inβ-ketoacyl-ACP. β-ketoacyl-ACP synthase III (FabH) initiates the FAScycle, while (3-ketoacyl-ACP synthase I (FabB) and β-ketoacyl-ACPsynthase II (FabF) are involved in subsequent cycles.

Next, a cycle of steps is repeated until a saturated fatty acid of theappropriate length is made. First, the β-ketoacyl-ACP is reduced byNADPH to form β-hydroxyacyl-ACP. This step is catalyzed byβ-ketoacyl-ACP reductase (FabG). β-hydroxyacyl-ACP is then dehydrated toform trans-2-enoyl-ACP. β-hydroxyacyl-ACP dehydratase/isomerase (FabA)or β-hydroxyacyl-ACP dehydratase (FabZ) catalyze this step.NADPH-dependent trans-2-enoyl-ACP reductase I, II, or III (FabI, FabK,and FabL, respectively) reduces trans-2-enoyl-ACP to form acyl-ACP.Subsequent cycles are started by the condensation of malonyl-ACP withacyl-ACP by β-ketoacyl-ACP synthase I or β-ketoacyl-ACP synthase II(FabB and FabF, respectively).

2. Modifications to the Fatty Acid Biosynthetic Pathway to IncreaseAcyl-ACP Production

Production host organisms may be engineered to overproduce acetyl-CoAand malonyl-CoA. Such production host organisms include plant, animal,or human cells. Microorganisms such as bacteria, yeast, or filamentousfungi can be used as production hosts. Non-limiting examples ofmicroorganisms that may be used as production hosts include E. coli,Saccharomyces cerevisiae, Candida lipolytica, E. coli, Arthrobacter AK19, Rhodotorula glutinins, Acinetobacter sp. strain M-1, Candidalipolytica, and other oleaginous microorganisms. Several differentmodifications can be made, either in combination or individually, to theproduction host to obtain increased acetyl-CoA/malonyl-CoA/fatty acidand fatty acid derivative production.

For example, to increase acetyl-CoA production, one or more of thefollowing genes could be expressed in a production host: pdh, panK,aceEF (encoding the E1p dehydrogenase component and the E2pdihydrolipoamide acyltransferase component of the pyruvate and2-oxoglutarate dehydrogenase complexes), fabH, fabD, fabG, acpP, fabF.In other examples, additional DNA sequence encoding fatty-acyl-CoAreductases and aldehyde decarbonylases could be expressed in theproduction host. It is well known in the art that a plasmid containingone or more of the aforementioned genes, all under the control of aconstitutive, or otherwise controllable promoter, can be constructed.Exemplary GenBank accession numbers for these genes are: pdh (BAB34380,AAC73227, AAC73226), panK (also known as coaA, AAC76952), aceEF(AAC73227, AAC73226), fabH (AAC74175), fabD (AAC74176), fabG (AAC74177),acpP (AAC74178), fabF (AAC74179).

Additionally, the expression levels of fadE, gpsA, ldhA, pflb, adhE,pta, poxB, ackA, and/or ackB can be reduced or knocked-out in theengineered microorganism by transformation with conditionallyreplicative or non-replicative plasmids containing null or deletionmutations of the corresponding genes, or by substituting promoter orenhancer sequences. Exemplary GenBank accession numbers for these genesare: fadE (AAC73325), gspA (AAC76632), ldhA (AAC74462), pflb (AAC73989),adhE (AAC74323), pta (AAC75357), poxB (AAC73958), ackA (AAC75356), andackB (BAB81430). The resulting engineered production hosts will haveincreased acetyl-CoA production levels when grown in an appropriateenvironment.

Moreover, malonyl-CoA overproduction can be affected by engineering theproduction host as described above with accABCD (e.g., accession numberAAC73296, EC 6.4.1.2) included in the plasmid synthesized de novo. Fattyacid overproduction can be achieved by further including a DNA sequenceencoding lipase (e.g., Accession numbers CAA89087, CAA98876) in theplasmid synthesized de novo.

As a result, in some examples, acetyl-CoA carboxylase is over-expressedto increase the intracellular concentration thereof by at least about2-fold, preferably at least about 5-fold, or more preferably at leastabout 10-fold, relative to native expression levels.

In addition, the plsB (e.g., Accession number AAC77011) D311E mutationcan be used to increase the amount of available acyl-CoA.

In addition, over-expression of a sfa gene (suppressor of FabA, e.g.,Accession number AAN79592) can be included in the production host toincrease production of monounsaturated fatty acids (Rock et al., J.Bacteriology 178:5382-5387, 1996).

B. Acyl-ACP to Fatty Acid

1. Fatty Acid Biosynthetic Pathway: Acyl-ACP to Fatty Acids

As described above, acetyl-CoA and malonyl-CoA are processed in severalsteps to form acyl-ACP chains. The enzyme sn-glycerol-3-phosphateacyltransferase (PlsB) catalyzes the transfer of an acyl group fromacyl-ACP or acyl-CoA to the sn-1 position of glycerol-3-phosphate. Thus,PlsB is a key regulatory enzyme in phospholipid synthesis, which is partof the fatty acid pathway. Inhibiting PlsB leads to an increase in thelevels of long chain acyl-ACP, which feedback will inhibit early stepsin the pathway (e.g., accABCD, fabH, and fabI). Uncoupling of thisregulation, for example by thioesterase overexpression, leads toincreased fatty acid production. The tes and fat gene families expressthioesterase. FabI is also inhibited in vitro by long-chain acyl-CoA.

2. Modifications to the Fatty Acid Biosynthetic Pathway to ProduceDesired Fatty Acids

To engineer a production host for the production of a homogeneouspopulation of fatty acid derivatives, one or more endogenous genes canbe attenuated or functionally deleted and, as a result, one or morethioesterases can be expressed. For example, C₁₀ fatty acid derivativescan be produced by attenuating thioesterase C₁₈ (e.g., accession numbersAAC73596 and P0ADA1), which uses C_(18:1)-ACP and expressingthioesterase C₁₀ (e.g., accession number Q39513), which uses C₁₀-ACP.This results in a relatively homogeneous population of fatty acidderivatives that have a carbon chain length of 10. In another example,C₁₄ fatty acid derivatives can be produced by attenuating endogenousthioesterases that produce non-C₁₄ fatty acids and expressing thethioesterase accession number Q39473 (which uses C₁₄-ACP). In yetanother example, C₁₂ fatty acid derivatives can be produced byexpressing thioesterases that use C₁₂-ACP (for example, accession numberQ41635) and attenuating thioesterases that produce non-C₁₂ fatty acids.Acetyl-CoA, malonyl-CoA, and fatty acid overproduction can be verifiedusing methods known in the art, for example by using radioactiveprecursors, HPLC, and GC-MS subsequent to cell lysis. Non-limitingexamples of thioesterases useful in the claimed methods and productionhosts are listed in Table 1.

TABLE 1 Thioesterases Preferential Accession product Number SourceOrganism Gene produced AAC73596 E. coli tesA without C_(18:1) leadersequence AAC73555 E. coli tesB Q41635, Umbellularia california fatBC_(12:0) AAA34215 Q39513; Cuphea hookeriana fatB2 C_(8:0)-C_(10:0)AAC49269 AAC49269; Cuphea hookeriana fatB3 C_(14:0)-C_(16:0) AAC72881Q39473, Cinnamonum camphorum fatB C_(14:0) AAC49151 CAA85388 Arabidopsisthaliana fatB [M141T]* C_(16:1) NP 189147; Arabidopsis thaliana fatAC_(18:1) NP 193041 CAC39106 Bradyrhiizobium fatA C_(18:1) japonicumAAC72883 Cuphea hookeriana fatA C_(18:1) AAL79361 Helianthus annus fatA1*Mayer et al., BMC Plant Biology 7: 1-11, 2007

C. Fatty Acid to Acyl-CoA

1. Conversion of Fatty Acids to Acyl-CoA

Acyl-CoA synthase (ACS) esterifies free fatty acids to acyl-CoA by atwo-step mechanism. The free fatty acid first is converted to anacyl-AMP intermediate (an adenylate) through the pyrophosphorolysis ofATP. The activated carbonyl carbon of the adenylate is then coupled tothe thiol group of CoA, releasing AMP and the acyl-CoA final product.See Shockey et al., Plant. Physiol. 129:1710-1722, 2002.

The E. coli ACS enzyme FadD and the fatty acid transport protein FadLare essential components of a fatty acid uptake system. FadL mediatestransport of fatty acids into the bacterial cell, and FadD mediatesformation of acyl-CoA esters. When no other carbon source is available,exogenous fatty acids are taken up by bacteria and converted to acyl-CoAesters, which bind to the transcription factor FadR and derepress theexpression of the fad genes that encode proteins responsible for fattyacid transport (FadL), activation (FadD), and β-oxidation (FadA, FadB,FadE, and FadH). When alternative sources of carbon are available,bacteria synthesize fatty acids as acyl-ACPs, which are used forphospholipid synthesis, but are not substrates for β-oxidation. Thus,acyl-CoA and acyl-ACP are both independent sources of fatty acids thatwill result in different end-products. See Caviglia et al., J. Biol.Chem. 279(12):1163-1169, 2004.

2. Modifications to Increase Conversion of Fatty Acids to Acyl-CoA

Production hosts can be engineered using known peptides to produce fattyacids of various lengths which can be converted to acyl-CoA. One methodof making fatty acid derivatives involves increasing the expression of,or expressing more active forms of, one or more acyl-CoA synthasepeptides (EC 6.2.1.-).

A list of acyl-CoA synthases that can be expressed to produce acyl-CoAand fatty acid derivatives is shown in Table 2. These Acyl-CoA synthaseswere examined to optimize any pathway that uses fatty-acyl-CoAs assubstrates. Using bioinformatics and synthetic genes, heterologous fadDgenes were expressed in production strains and evaluated for theircapacity to produce biodiesel and potentially biocrude.

TABLE 2 Acyl-CoA synthases % Identity % Similarity Gene to E. coli to E.coli Name/Locus Source NCBI ID FadD FadD fadD E. coli NP_416319 — — fadKE. coli YP_416216 45 27 fadD Acinetobacter sp. ADP1 YP_045024 51 70 fadDHaemophilus influenza NP_438551 64 78 RdKW20 BH3103 Bacillus haloduransNP_243969 40 58 C-125 yhfL Bacillus subtilis NP_388908 39 57 Pfl-4354Pseudomonas YP_350082 52 71 fluorescens Pfo-1 EAV15023 ComamonasZP_01520072 55 72 testosterone KF-1 fadD1 Pseudomonas NP_251989 54 72aeruginosa fadD2 Pseudomonas NP_251990 55 72 aeruginosa PAO1 fadDRhizobium etli CFN42 YP_533919 55 72 RPC_4074 Rhodopseudomonas YP_53391956 72 palustris Bis B18 fadD1 Rasltonia Solanacearum NP_520978 56 72 GMI1000 fadDD35 Mycobacterium NP_217021 28 46 tuberculosis H37Rv fadDD22Mycobacterium NP_217464 23 42 tuberculosis H37Rv PRK0059Stenotrophomonas ZP_01644857 59 75 Maltophilia R551-3

Based on their degree of similarity to E. coli FadD, the followinghomologous genes were selected to be synthesized and evaluated:

fadDD35 from M. tuberculosis HR7Rv [NP_217021].

yhfL from B. subtilis [NP_388908]. fadD1 from P. aeruginosa PAO1[NP_251989].

fadD homolog, Faa3p from Saccharomyces cerevisiae [NP_012257].

Additional fatty acid acyl-CoA synthases from eukaryotic organisms whichcan be used to produce acyl-CoA, as well as fatty acid derivatives,include those described in Shockey et al., Plant. Physiol. 129:1710-1722, 2002 (Arabidopsis), Caviglia et al., J. Biol. Chem. 279:1163-1169, 2004 (rat), and Knoll et al., J. Biol. Chem.269(23):16348-56, 1994 (yeast). Gene sequences encoding thesesynthetases are known in the art. See, e.g., Johnson et al., J. Biol.Chem. 269: 18037-18046, 1994; Shockey et al., Plant. Physiol. 129:1710-1722, 2002; Black et al., J. Biol Chem. 267: 25513-25520, 1992.These eukaryotic acyl-CoA synthases, despite their lack of high homologyto E. coli fadD sequences, can complement FadD activity in E. coli fadDknockouts.

D. Acyl-CoA to Fatty Alcohol

1. Conversion of Acyl-CoA to Fatty Alcohol

Acyl-CoA is reduced to a fatty aldehyde by NADH-dependent acyl-CoAreductase (e.g., Acr1). The fatty aldehyde is then reduced to a fattyalcohol by NADPH-dependent alcohol dehydrogenase (e.g., YqhD).Alternatively, fatty alcohol forming acyl-CoA reductase (FAR) catalyzesthe reduction of an acyl-CoA into a fatty alcohol and CoASH. FAR usesNADH or NADPH as a cofactor in this four-electron reduction. Althoughthe alcohol-generating FAR reactions proceed through an aldehydeintermediate, a free aldehyde is not released. Thus, the alcohol-formingFARs are distinct from those enzymes that carry out two-electronreductions of acyl-CoA and yield free fatty aldehyde as a product. (SeeCheng and Russell, J. Biol. Chem., 279(36):37789-37797, 2004; Metz etal., Plant Physiol., 122:635-644, 2000).

2. Modifications to Increase Conversion of Acyl-CoA to Fatty Alcohol

Production hosts can be engineered using known polypeptides to producefatty alcohols from acyl-CoA. One method of making fatty alcoholsinvolves increasing the expression of, or expressing more active formsof, fatty alcohol forming acyl-CoA reductases (encode by a gene such asacr1 from FAR, EC 1.2.1.50/1.1.1) or acyl-CoA reductases (EC 1.2.1.50)and alcohol dehydrogenase (EC 1.1.1.1). Exemplary GenBank AccessionNumbers are provided in FIG. 1.

Fatty alcohols can be described as hydrocarbon-based surfactants. Forsurfactant production, the production host is modified so that itproduces a surfactant from a renewable carbon source. Such a productionhost includes a first exogenous DNA sequence encoding a protein capableof converting a fatty acid to a fatty aldehyde and a second exogenousDNA sequence encoding a protein capable of converting a fatty aldehydeto an alcohol. In some examples, the first exogenous DNA sequenceencodes a fatty acid reductase. In one embodiment, the second exogenousDNA sequence encodes mammalian microsomal aldehyde reductase orlong-chain aldehyde dehydrogenase. In a further example, the first andsecond exogenous DNA sequences are from Arthrobacter AK 19, Rhodotorulaglutinins, Acinetobacter sp. strain M-1, or Candida lipolytica. In oneembodiment, the first and second heterologous DNA sequences are from amultienzyme complex from Acinetobacter sp. strain M-1 or Candidalipolytica.

Additional sources of heterologous DNA sequences encoding fatty acid tolong chain alcohol converting proteins that can be used in surfactantproduction include, but are not limited to, Mortierella alpina (ATCC32222), Cryptococcus curvatus, (also referred to as Apiotricumcurvatum), Alcanivorax jadensis (T9T=DSM 12718=ATCC 700854),Acinetobacter sp. HO1-N(ATCC 14987) and Rhodococcus opacus (PD630 DSMZ44193).

In one example, the fatty acid derivative is a saturated or unsaturatedsurfactant product having a carbon chain length of about 6 to about 36carbon atoms, about 8 to about 30 carbon atoms, about 10 to about 26carbon atoms, about 12 to about 20 carbon atoms, or about 12 to about 16carbon atoms. In another example, the surfactant product has a carbonchain length of about 10 to about 18 carbon atoms, or about 12 to about14 carbon atoms.

Appropriate production hosts for producing surfactants can be eithereukaryotic or prokaryotic microorganisms. Exemplary production hostsinclude Arthrobacter AK 19, Rhodotorula glutinins, Acinetobacter spstrain M-1, Arabidopsis thalania, Candida lipolytica, Saccharomycescerevisiae, and E. coli engineered to express acetyl-CoA carboxylase.Production hosts which demonstrate an innate ability to synthesize highlevels of surfactant precursors in the form of lipids and oils, such asRhodococcus opacus, Arthrobacter AK 19, and Rhodotorula glutinins E.coli engineered to express acetyl CoA carboxylase, and other oleaginousbacteria, yeast, and fungi can also be used.

E. Fatty Alcohols to Fatty Esters

Production hosts can be engineered using known polypeptides to producefatty esters of various lengths. One method of making fatty estersincludes increasing the expression of, or expressing more active formsof, one or more alcohol O-acetyltransferase peptides (EC 2.3.1.84).These peptides catalyze the acetylation of an alcohol by converting anacetyl-CoA and an alcohol to a CoA and an ester. In some examples, thealcohol O-acetyltransferase peptides can be expressed in conjunctionwith selected thioesterase peptides, FAS peptides, and fatty alcoholforming peptides, thus allowing the carbon chain length, saturation, anddegree of branching to be controlled. In some cases, the bkd operon canbe coexpressed to enable branched fatty acid precursors to be produced.

As used herein, alcohol O-acetyltransferase peptides include peptides inenzyme classification number EC 2.3.1.84, as well as any other peptidecapable of catalyzing the conversion of acetyl-CoA and an alcohol toform a CoA and an ester. Additionally, one of ordinary skill in the artwill appreciate that alcohol O-acetyltransferase peptides will catalyzeother reactions.

For example, some alcohol O-acetyltransferase peptides will accept othersubstrates in addition to fatty alcohols or acetyl-CoA thioester, suchas other alcohols and other acyl-CoA thioesters. Such non-specific ordivergent-specificity alcohol O-acetyltransferase peptides are,therefore, also included. Alcohol O-acetyltransferase peptide sequencesare publicly available. Exemplary GenBank Accession Numbers are providedin FIG. 1. Assays for characterizing the activity of particular alcoholO-acetyltransferase peptides are well known in the art.O-acyltransferases can be engineered to have new activities andspecificities for the donor acyl group or acceptor alcohol moiety.Engineered enzymes can be generated through well-documented rational andevolutionary approaches.

F. Acyl-CoA to Fatty Esters

1. Production of Fatty Esters

Fatty esters are synthesized by acyl-CoA:fatty alcohol acyltransferase(e.g., ester synthase), which conjugate a long chain fatty alcohol to afatty acyl-CoA via an ester linkage. Ester synthases and encoding genesare known from the jojoba plant and the bacterium Acinetobacter sp.strain ADP1 (formerly Acinetobacter calcoaceticus ADP1). The bacterialester synthase is a bifunctional enzyme, exhibiting ester synthaseactivity and the ability to form triacylglycerols from diacylglycerolsubstrates and fatty acyl-CoAs (acyl-CoA:diglycerol acyltransferase(DGAT) activity). The gene wax/dgat encodes both ester synthase andDGAT. See Cheng et al., J. Biol. Chem. 279(36):37798-37807, 2004;Kalscheuer and Steinbuchel, J. Biol. Chem. 278:8075-8082, 2003. Estersynthases may also be used to produce certain fatty esters which can beused as a fuel, such as biodiesel, as described herein.

2. Modifications to Produce Fatty Esters

The production of fatty esters, including waxes, from acyl-CoA andalcohols, can be engineered using known polypeptides. One method ofmaking fatty esters includes increasing the expression of, or expressingmore active forms of, one or more ester synthases (EC 2.3.1.20,2.3.1.75). Ester synthase peptide sequences are publicly available.Exemplary GenBank Accession Numbers are provided in FIG. 1. Methods toidentify ester synthase activity are provided in U.S. Pat. No.7,118,896, which is herein incorporated by reference in its entirety.

In particular examples, if the desired product is an ester-basedbiofuel, the production host is modified so that it produces an estergenerated from a renewable energy source. Such a production hostincludes an exongenous DNA sequence encoding an ester synthase that isexpressed so as to confer upon said production host the ability tosynthesize a saturated, unsaturated, or branched fatty ester from arenewable energy source. In some embodiments, the organism can alsoexpress DNA sequence encoding the following exemplary proteins: fattyacid elongases, acyl-CoA reductases, acyltransferases, ester synthases,fatty acyl transferases, diacylglycerol acyltransferases, acyl-coA waxalcohol acyltransferases. In an alternate embodiment, the organismexpresses a DNA sequence encoding a bifunctional estersynthase/acyl-CoA: diacylglycerol acyltransferase. For example, thebifunctional ester synthase/acyl-CoA:diacylglycerol acyltransferase canbe selected from the multienzyme complexes from Simmondsia chinensis,Acinetobacter sp. strain ADP1 (formerly Acinetobacter calcoaceticusADP1), Alcanivorax borkumensis, Pseudomonas aeruginosa, Fundibacterjadensis, Arabidopsis thaliana, or Alcaligenes eutrophus (later renamedRalstonia eutropha). In one embodiment, the fatty acid elongases,acyl-CoA reductases or wax synthases are from a multienzyme complex fromAlcaligenes eutrophus (later renamed Ralstonia eutropha) or otherorganisms known in the literature to produce esters, such as wax orfatty esters.

Additional sources of heterologous DNA sequence encoding ester synthesisproteins useful in fatty ester production include, but are not limitedto, Mortierella alpina (e.g., ATCC 32222), Cryptococcus curvatus (alsoreferred to as Apiotricum curvatum), Alcanivorax jadensis (for exampleT9T=DSM 12718=ATCC 700854), Acinetobacter sp. HO1-N, (e.g., ATCC 14987)and Rhodococcus opacus (e.g., PD630, DSMZ 44193).

Useful production hosts for producing fatty esters can be eithereukaryotic or prokaryotic microorganisms. Non-limiting examples ofproduction hosts for producing fatty esters include Saccharomycescerevisiae, Candida lipolytica, E. coli Arthrobacter AK 19, Rhodotorulaglutinins, Acinetobacter sp. strain M-1, Candida lipolytica, and otheroleaginous microorganisms.

In one example, the ester synthase from Acinetobacter sp. ADP1 at locusAAO17391 (described in Kalscheuer and Steinbuchel, J. Biol. Chem.278:8075-8082, 2003, herein incorporated by reference) is used. Inanother example, the ester synthase from Simmondsia chinensis at locusAAD38041 is used.

Optionally, an ester exporter such as a member of the FATP family can beused to facilitate the release of esters into the extracellularenvironment. A non-limiting example of an ester exporter that can beused is fatty acid (long chain) transport protein CG7400-PA, isoform A,from Drosophila melanogaster, at locus NP_524723.

G. Acyl-ACP, Acyl-CoA to Hydrocarbon

1. Hydrocarbons from Particular Microorganisms

A diversity of microorganisms are known to produce hydrocarbons, such asalkanes, olefins, and isoprenoids. Many of these hydrocarbons arederived from fatty acid biosynthesis. The production of thesehydrocarbons can be controlled by controlling the genes associated withfatty acid biosynthesis in the native production hosts.

For example, hydrocarbon biosynthesis in the algae Botryococcus brauniioccurs through the decarbonylation of fatty aldehydes. The fattyaldehydes are produced by the reduction of fatty acyl—thioesters byfatty acyl-CoA reductase. Thus, the structure of the final alkanes canbe controlled by engineering B. braunii to express specific genes, suchas thioesterases, which control the chain length of the fatty acidsbeing channeled into alkane biosynthesis. Expressing the enzymes thatresult in branched chain fatty acid biosynthesis in B. braunii willresult in the production of branched chain alkanes. Introduction ofgenes affecting the production of desaturation of fatty acids willresult in the production of olefins. Further combinations of these genescan provide further control over the final structure of the hydrocarbonsproduced.

To produce higher levels of the native or engineered hydrocarbons, thegenes involved in the biosynthesis of fatty acids and their precursorsor the degradation to other products can be expressed, over-expressed,or attenuated. Each of these approaches can be applied to the productionof alkanes in Vibrio fumissii M1 and other Vibrio fumissii strains,which produce alkanes through the reduction of fatty alcohols. Inaddition to Vibrio fumissii, other alkane producing organisms thatutilize the fatty acid pathway could be used.

Each of these approaches can also be applied to the production of theolefins produced by many strains of Micrococcus leuteus,Stenotrophomonas maltophilia, and related microorganisms. Thesemicroorganisms produce long chain olefins that are derived from the headto head condensation of fatty acid precursors. Controlling the structureand level of the fatty acid precursors using the methods describedherein will result in formation of olefins of different chain length,branching, and levels of saturation.

Cyanobacteria can also be used as production hosts for the production offatty acid derivatives such as fatty alcohols, fatty esters, andhydrocarbons. For example, Synechocystis sp. PCC6803 and Synechococcuselongatus PCC7942 can serve as production hosts and can be engineeredusing standard molecular biology techniques (Thiel, Genetic analysis ofcyanobacteria, in 1 THE MOLECULAR BIOLOGY OF CYANOBACTERIA, ADVANCES INPHOTOSYNTHESIS AND RESPIRATION 581-611 (Kluwer Academic Publishers1994); Koksharova & Wolk, Appl. Microbiol. Biotechnol., 58: 123-137,2002). Fatty acid biosynthesis genes can be easily identified andisolated in these organisms (see Table 18).

Furthermore, many cyanobacteria are natural producers of hydrocarbons,such as heptadecane, and therefore contain hydrocarbon biosynthesisgenes which can be deregulated and over-expressed in conjunction withmanipulating their fatty acid biosynthesis genes to increase hydrocarbonproduction.

Unlike other bacteria, some cyanobacteria (e.g., Synechocystis sp.PCC6803) contain polyunsaturated fatty acids in their lipids (Murata,Plant cell Physiol., 33: 933-941, 1992), and thus have the inherentcapability to produce polyunsaturated fatty acid derivatives. Mostimportantly, cyanobacteria are photosynthetic organisms that synthesizeall of their cellular carbon by harvesting sun light and fixing carbondioxide. Therefore, fatty acid derivatives produced in cyanobacteria aredirectly derived from CO₂.

2. Hydrocarbons from Reduction of Primary Alcohols

Hydrocarbons can also be produced using evolved oxidoreductases for thereduction of primary alcohols. Primary fatty alcohols are known to beused to produce alkanes in microorganisms, such as Vibrio fumissii M1(Park, J. Bacteriol., 187:1426-1429, 2005). One example of anoxidoreductase which can be used to produce hydrocarbons from fattyalcohols is NAD(P)H-dependent oxidoreductase. Synthetic NAD(P)Hdependent oxidoreductases can be produced through the use ofevolutionary engineering and can be expressed in production hosts toproduce fatty acid derivatives.

The process of “evolving” a fatty alcohol reductase to have the desiredactivity is well known (Kolkman and Stemmer, Nat. Biotechnol. 19:423-8,2001; Ness et al., Adv Protein Chem. 55:261-92, 2000; Minshull andStemmer, Curr. Opin. Chem. Biol. 3:284-90, 1999; Huisman and Gray, Curr.Opin. Biotechnol. 13:352-8, 2002; U.S. Patent Pub. No. 2006/0195947.

A library of NAD(P)H dependent oxidoreductases is generated by standardmethods, such as error prone PCR, site-specific random mutagenesis, sitespecific saturation mutagenesis, or site directed specific mutagenesis.Additionally, a library can be created through the “shuffling” ofnaturally occurring NAD(P)H dependent oxidoreductase encoding sequences.The library is expressed in a suitable production host, such as E. coli.Individual colonies expressing a different member of the oxidoreductaselibrary are then analyzed for expression of an oxidoreductase that cancatalyze the reduction of a fatty alcohol.

For example, each cell can be assayed as a whole cell bioconversion, acell extract, or a permeabilized cell. Enzymes purified from the cellcan be analyzed as well. Fatty alcohol reductases are identified byspectrophotometrically or fluorometrically monitoring the fattyalcohol-dependent oxidation of NAD(P)H. Production of alkanes ismonitored by GC-MS, TLC, or other methods.

An oxidoreductase identified in this manner is used to produce alkanes,alkenes, and related branched hydrocarbons. This is achieved either invitro or in vivo. The latter is achieved by expressing the evolved fattyalcohol reductase gene in an organism that produces fatty alcohols, suchas those described herein. The fatty alcohols act as substrates for thealcohol reductase, which produces alkanes. Other oxidoreductases canalso be engineered to catalyze this reaction, such as those that usemolecular hydrogen, glutathione, FADH, or other reductive coenzymes.

H. Release of Fatty Acid Derivatives—Transport Proteins

Transport proteins export fatty acid derivatives out of the productionhost. Many transport and efflux proteins serve to excrete a largevariety of compounds, and can naturally be modified to be selective forparticular types of fatty acid derivatives. Non-limiting examples ofsuitable transport proteins are ATP-Binding Cassette (ABC) transportproteins, efflux proteins, and fatty acid transporter proteins (FATP).Additional non-limiting examples of suitable transport proteins includethe ABC transport proteins from organisms such as Caenorhabditiselegans, Arabidopsis thalania, Alkaligenes eutrophus, Rhodococcuserythropolis. Exemplary ABC transport proteins which could be used areCERS, AtMRP5, AmiS2, or AtPGP1. In a preferred embodiment, the ABCtransport proteins is CERS (e.g., AY734542)). See also transportproteins identified in FIG. 1. Vectors containing genes that expresssuitable transport proteins can be inserted into the protein productionhost to increase the release of fatty acid derivatives.

Production hosts can also be chosen for their endogenous ability torelease fatty acid derivatives. The efficiency of product production andrelease into the fermentation broth can be expressed as a ratio ofintracellular product to extracellular product. In some examples, theratio can be about 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, or 1:5.

II. Selection of Carbon Chain Characteristics of Fatty Acid Derivatives

Fatty acid derivatives with particular branch points, levels ofsaturation, carbon chain length, and ester characteristics can beproduced as desired. Microorganisms that naturally produce particularderivatives can be chosen. Alternatively, genes that express enzymesthat will produce particular fatty acid derivatives can be inserted intothe production host microorganism. FIG. 1 provides non-limiting examplesof enzymes that can be used alone or in combination to make fatty acidderivatives with desired characteristics.

In some examples, the expression of exongenous FAS genes originatingfrom different species or engineered variants can be introduced into theproduction host to result in the biosynthesis of fatty acids that arestructurally different (in length, branching, degree of unsaturation,etc.) from those of the native production host. These heterologous geneproducts can also be chosen or engineered to be unaffected by thenatural regulatory mechanisms in the production host cell, and thereforeallow for control of the production of the desired commercial product.For example, the FAS enzymes from Bacillus subtilis, Saccharomycescerevisiae, Streptomyces spp., Ralstonia, Rhodococcus, Corynebacteria,Brevibacteria, Mycobacteria, oleaginous yeast, and the like can beexpressed in the production host. The expression of such exongenousenzymes will alter the structure of the fatty acid produced.

When a production host is engineered to produce a fatty acid with aspecific level of unsaturation, branching, or carbon chain length, theresulting engineered fatty acid can be used in the production of fattyacid derivatives. Fatty acid derivatives generated from such productionhosts can display the characteristics of the engineered fatty acid.

For example, a production host can be engineered to make branched, shortchain fatty acids, which may then be used by the production host toproduce branched, short chain fatty alcohols. Similarly, a hydrocarboncan be produced by engineering a production host to produce a fatty acidhaving a defined level of branching, unsaturation, and/or carbon chainlength, thus, producing a homogeneous hydrocarbon population. Additionalsteps can be employed to improve the homogeneity of the resultingproduct. For example, when an unsaturated alcohol, fatty ester, orhydrocarbon is desired, the production host organism can be engineeredto produce low levels of saturated fatty acids and in addition can bemodified to express an additional desaturase and thus lessen theproduction of saturated product.

A. Branched and Cyclic Moieties

1. Engineering Branched and Cyclic Fatty Acid Derivatives

Fatty acids are a key intermediate in the production of fatty acidderivatives. Fatty acid derivatives can be produced that contain branchpoints, cyclic moieties, and combinations thereof, by using branched orcyclic fatty acids to make the fatty acid derivatives.

For example, E. coli naturally produces straight chain fatty acids(sFAs). To engineer E. coli to produce branched chain fatty acids(brFAs), several genes that provide branched precursors (e.g., bkdoperon) can be introduced into the production host and expressed toallow initiation of fatty acid biosynthesis from branched precursors(e.g., fabH). The bkd, ilv, icm, and fab gene families may be expressedor over-expressed to produce branched chain fatty acid derivatives.Similarly, to produce cyclic fatty acids, genes that provide cyclicprecursors can be introduced into the production host and expressed toallow initiation of fatty acid biosynthesis from cyclic precursors. Theans, chc, and plm gene families may be expressed or over-expressed toproduce cyclic fatty acids. FIG. 1 recites non-limiting examples ofgenes in these gene families that may be used in the present methods andproduction hosts.

Additionally, the production host can be engineered to express genesencoding proteins for the elongation of brFAs (e.g., ACP, FabF, etc.)and/or to delete or attenuate the corresponding E. coli genes thatnormally lead to sFAs. In this regard, endogenous genes that wouldcompete with the introduced genes (e.g., fabH, fabF) are deleted orattenuated.

The branched acyl-CoA (e.g., 2-methyl-butyryl-CoA, isovaleryl-CoA,isobutyryl-CoA, etc.) are the precursors of brFA. In most microorganismscontaining brFA, the brFA are synthesized in two steps from branchedamino acids (e.g., isoleucine, leucine, and valine) (Kadena, Microbiol.Rev. 55:288, 1991). A production host can be engineered to express orover-express one or more of the enzymes involved in these two steps toproduce brFAs, or to over-produce brFAs. For example, the productionhost may have an endogenous enzyme that can accomplish one step leadingto brFA, therefore only genes encoding enzymes involved in the secondstep need to be introduced recombinantly.

2. Formation of Branched Fatty Acids and Branched Fatty Acid Derivatives

The first step in forming brFAs is the production of the correspondingα-keto acids by a branched-chain amino acid aminotransferase. Productionhosts may endogenously include genes encoding such enzymes or such genesmay be recombinantly introduced. E. coli, for example, endogenouslyexpresses such an enzyme, IlvE (EC 2.6.1.42; GenBank accessionYP_026247). In some production hosts, a heterologous branched-chainamino acid aminotransferase may not be expressed. However, E. coli IlvEor any other branched-chain amino acid aminotransferase (e.g., IlvE fromLactococcus lactis (GenBank accession AAF34406), IlvE from Pseudomonasputida (GenBank accession NP_745648), or IlvE from Streptomycescoelicolor (GenBank accession NP_629657)), if not endogenous, can beintroduced. If the aminotransferase reaction is rate limiting in brFAbiosynthesis in the chosen production host organism, then theaminotransferase can be over-expressed.

The second step is the oxidative decarboxylation of the α-ketoacids tothe corresponding branched-chain acyl-CoA. This reaction can becatalyzed by a branched-chain α-keto acid dehydrogenase complex (bkd; EC1.2.4.4.) (Denoya et al., J. Bacteriol. 177:3504, 1995), which consistsof E1α/β (decarboxylase), E2 (dihydrolipoyl transacylase) and E3(dihydrolipoyl dehydrogenase) subunits. These branched-chain α-keto aciddehydrogenase complexes are similar to pyruvate and α-ketoglutaratedehydrogenase complexes. Every microorganism that possesses brFAs and/orgrows on branched-chain amino acids can be used as a source to isolatebkd genes for expression in production hosts such as, for example, E.coli. Furthermore, E. coli has the E3 component as part of its pyruvatedehydrogenase complex (lpd, EC 1.8.1.4, GenBank accession NP_414658),thus it can be sufficient to only express the E1α/β and E2 bkd genes.Table 3 recites non-limiting examples of bkd genes from severalmicroorganisms that can be recombinantly introduced and expressed in aproduction host to provide branched-chain acyl-CoA precursors.Microorganisms having such bkd genes can also be used as productionhosts.

TABLE 3 Bkd genes from selected microorganisms GenBank Organism GeneAccession # Streptomyces coelicolor bkdA1 (E1α) NP_628006 bkdB1 (E1β)NP_628005 bkdC1 (E2) NP_638004 Streptomyces coelicolor bkdA2 (E1α)NP_733618 bkdB2 (E1β) NP_628019 bkdC2 (E2) NP_628018 Streptomycesavermitilis bkdA (E1a) BAC72074 bkdB (E1b) BAC72075 bkdC (E2) BAC72076Streptomyces avermitilis bkdF (E1α) BAC72088 bkdG (E1β) BAC72089 bkdH(E2) BAC72090 Bacillus subtilis bkdAA (E1α) NP_390288 bkdAB (E1β)NP_390288 bkdB (E2) NP_390288 Pseudomonas putida bkdA1 (E1α) AAA65614bkdA2 (E1β) AAA65615 bkdC (E2) AAA65617

In another example, isobutyryl-CoA can be made in a production host, forexample in E. coli, through the coexpression of a crotonyl-CoA reductase(Ccr, EC 1.6.5.5, 1.1.1.1) and isobutyryl-CoA mutase (large subunitIcmA, EC 5.4.99.2; small subunit IcmB, EC 5.4.99.2) (Han and Reynolds,J. Bacteriol. 179:5157, 1997). Crotonyl-CoA is an intermediate in fattyacid biosynthesis in E. coli and other microorganisms. Non-limitingexamples of ccr and icm genes from selected microorganisms are given inTable 4.

TABLE 4 Ccr and icm genes from selected microorganisms GenBank OrganismGene Accession # Streptomyces Ccr NP_630556 coelicolor icmA NP_629554icmB NP_630904 Streptomyces ccr AAD53915 cinnamonensis icmA AAC08713icmB AJ246005

In addition to expression of the bkd genes, the initiation of brFAbiosynthesis utilizes β-ketoacyl-acyl-carrier-protein synthase III(FabH, EC 2.3.1.41) with specificity for branched chain acyl-CoAs (Li etal., J. Bacteriol. 187:3795-3799, 2005). Non-limiting examples of suchFabH enzymes are listed in Table 5. fabH genes that are involved infatty acid biosynthesis of any brFA-containing microorganism can beexpressed in a production host. The Bkd and FabH enzymes from productionhosts that do not naturally make brFA may not support brFA production,therefore Bkd and FabH can be expressed recombinantly. Vectorscontaining the bkd and fabH genes can be inserted into such a productionhost. Similarly, the endogenous level of Bkd and FabH production may notbe sufficient to produce brFA, therefore, they can be over-expressed.Additionally, other components of fatty acid biosynthesis pathway can beexpressed or over-expressed, such as acyl carrier proteins (ACPs) andβ-ketoacyl-acyl-carrier-protein synthase II (fabF, EC 2.3.1.41)(non-limiting examples of candidates are listed in Table 5). In additionto expressing these genes, some genes in the endogenous fatty acidbiosynthesis pathway may be attenuated in the production host. Genesencoding enzymes that would compete for substrate with the enzymes ofthe pathway that result in brFA production may be attenuated to increasebrFA production. For example, in E. coli the most likely candidates tointerfere with brFA biosynthesis are fabH (GenBank accession #NP_415609) and/or fabF genes (GenBank accession # NP_415613).

TABLE 5 FabH, ACP and fabF genes from selected microorganisms with brFAsGenBank Organism Gene Accession # Streptomyces coelicolor fabH1NP_626634 ACP NP_626635 fabF NP_626636 Streptomyces avermitilis fabH3NP_823466 fabC3 (ACP) NP_823467 fabF NP_823468 Bacillus subtilis fabH_ANP_389015 fabH_B NP_388898 ACP NP_389474 fabF NP_389016 StenotrophomonasSmalDRAFT_0818 (FabH) ZP_01643059 maltophilia SmalDRAFT_0821 (ACP)ZP_01643063 SmalDRAFT_0822 (FabF) ZP_01643064 Legionella pneumophilaFabH YP_123672 ACP YP_123675 fabF YP_123676

As mentioned above, branched chain alcohols can be produced through thecombination of expressing genes that support brFA synthesis and alcoholsynthesis. For example, when an alcohol reductase, such as Acr1 fromAcinetobacter baylyi ADP1, is coexpressed with a bkd operon, E. coli cansynthesize isopentanol, isobutanol or 2-methyl butanol. Similarly, whenAcr1 is coexpressed with ccr/icm genes, E. coli can synthesizeisobutanol.

3. Formation of Cyclic Fatty Acids and Cyclic Fatty Acid Derivatives

To convert a production host such as E. coli into an organism capable ofsynthesizing ω-cyclic fatty acids (cyFA), a gene that provides thecyclic precursor cyclohexylcarbonyl-CoA (CHC-CoA) (Cropp et al., NatureBiotech. 18:980-983, 2000) is introduced and expressed in the productionhost. A similar conversion is possible for other production hosts, forexample, bacteria, yeast and filamentous fungi.

Non-limiting examples of genes that provide CHC-CoA in E. coli include:ansJ, ansK, ansL, chcA and ansM from the ansatrienin gene cluster ofStreptomyces collinus (Chen et al., Eur. J. Biochem. 261: 98-107, 1999)or plmJ, plmK, plmL, chcA and plmM from the phoslactomycin B genecluster of Streptomyces sp. HK803 (Palaniappan et al., J. Biol. Chem.278:35552-35557, 2003) together with the chcB gene (Patton et al.,Biochem. 39:7595-7604, 2000) from S. collinus, S. avermitilis or S.coelicolor (see Table 6 for GenBank accession numbers). The genes listedabove in Table 5 can then be expressed to allow initiation andelongation of ω-cyclic fatty acids. Alternatively, the homologous genescan be isolated from microorganisms that make cyFA and expressed in E.coli.

TABLE 6 Genes for the synthesis of CHC-CoA GenBank Organism GeneAccession # Streptomyces collinus ansJK U72144* ansL chcA ansM chcBAF268489 Streptomyces sp. HK803 pmlJK AAQ84158 pmlL AAQ84159 chcAAAQ84160 pmlM AAQ84161 Streptomyces coelicolor chcB/caiD NP_629292Streptomyces avermitilis chcB/caiD NP_629292 *Only chcA is annotated inGenBank entry U72144, ansJKLM are according to Chen et al. (Eur. J.Biochem. 261: 98-107, 1999).

The genes listed in Table 5 (fabH, ACP and fabF) are sufficient to allowinitiation and elongation of ω-cyclic fatty acids because they can havebroad substrate specificity. If the coexpression of any of these geneswith the ansJKLM/chcAB or pmlJKLM/chcAB genes from Table 5 does notyield cyFA, then fabH, ACP and/or fabF homologs from microorganisms thatmake cyFAs can be isolated (e.g., by using degenerate PCR primers orheterologous DNA sequence probes) and coexpressed. Table 7 listsnon-limiting examples of microorganisms that contain ω-cyclic fattyacids.

TABLE 7 Non-limiting examples of microorganisms that contain ω-cyclicfatty acids Organism Reference Curtobacterium pusillum ATCC19096Alicyclobacillus acidoterrestris ATCC49025 Alicyclobacillusacidocaldarius ATCC27009 Alicyclobacillus cycloheptanicus* Moore, J.Org. Chem. 62: pp. 2173, 1997. *Uses cycloheptylcarbonyl-CoA and notcyclohexylcarbonyl-CoA as precursor for cyFA biosynthesis.

B. Saturation

Fatty acids are a key intermediate in the production of fatty acidderivatives. The degree of saturation in fatty acid derivatives can becontrolled by regulating the degree of saturation of the fatty acidintermediates. The sfa, gns, and fab families of genes can be expressedor over-expressed to control the saturation of fatty acids. FIG. 1recites non-limiting examples of genes in these gene families that maybe used in the present methods and production hosts.

Production hosts can be engineered to produce unsaturated fatty acids byengineering the production host to over-express fabB, or by growing theproduction host at low temperatures (e.g., less than 37° C.). FabB haspreference to cis-δ³decenoyl-ACP and results in unsaturated fatty acidproduction in E. coli. Over-expression of fabB results in the productionof a significant percentage of unsaturated fatty acids (de Mendoza etal., J. Biol. Chem., 258:2098-101, 1983). fabB may be inserted into andexpressed in production hosts not naturally having the gene. Theseunsaturated fatty acids can then be used as intermediates in productionhosts that are engineered to produce fatty acid derivatives, such asfatty alcohols, fatty esters, waxes, olefins, alkanes, and the like.

Alternatively, the repressor of fatty acid biosynthesis, for example,fabR (GenBank accession NP_418398), can be deleted, which will alsoresult in increased unsaturated fatty acid production in E. coli (Zhanget al., J. Biol. Chem. 277:15558, 2002). Similar deletions may be madein other production hosts. Further increase in unsaturated fatty acidsmay be achieved, for example, by over-expression of fabM (trans-2,cis-3-decenoyl-ACP isomerase, GenBank accession DAA05501) and controlledexpression of fabK (trans-2-enoyl-ACP reductase II, GenBank accessionNP_357969) from Streptococcus pneumoniae (Marrakchi et al., J. Biol.Chem. 277: 44809, 2002), while deleting E. coli fabI (trans-2-enoyl-ACPreductase, GenBank accession NP_415804). Additionally, to increase thepercentage of unsaturated fatty esters, the production host can alsoover-express fabB (encoding β-ketoacyl-ACP synthase I, Accessions:BAA16180, EC:2.3.1.41), sfa (encoding a suppressor of fabA, Accession:AAC44390), and gnsA and gnsB (both encoding secG null mutantsuppressors, (i.e., cold shock proteins), Accession:ABD18647.1,AAC74076.1). In some examples, the endogenous fabF gene can beattenuated, thus increasing the percentage of palmitoleate (C_(16:1))produced.

C. Chain Length and Ester Characteristics

1. Chain Length and Production of Odd-Numbered Chains

The methods described herein permit production of fatty esters and fattyacid derivatives of varied lengths. Chain length is controlled bythioesterase, which is produced by expression of the tes and fat genefamilies By expressing specific thioesterases, fatty acids and fattyacid derivatives having a desired carbon chain length can be produced.Non-limiting examples of suitable thioesterases are listed in FIG. 1. Agene encoding a particular thioesterase may be introduced into aproduction host so that a fatty acid or fatty acid derivative of aparticular carbon chain length is produced. Expression of endogenousthioesterases should then be suppressed.

In one embodiment, the fatty acid derivative contain a carbon chain ofabout 4 to 36 carbon atoms, about 6 to 32 carbon atoms, about 10 to 30carbon atoms, about 10 to 18 carbon atoms, about 24 to 32 carbon atoms,about 26 to 30 carbon atoms, about 26 to 32 carbon atoms, about 5 to 10carbon atoms, about 10 to 16 carbon atoms, or about 12 to 18 carbonatoms. In an alternate embodiment, the fatty acid derivative contain acarbon chain less than about 20 carbon atoms, less than about 18 carbonatoms, or less than about 16 carbon atoms. In another embodiment, thefatty ester product is a saturated or unsaturated fatty ester producthaving a carbon atom content between 24 and 46 carbon atoms. In oneembodiment, the fatty ester product has a carbon atom content between 24and 32 carbon atoms. In another embodiment, the fatty ester product hasa carbon content of 14 and 20 carbons. In another embodiment, the fattyester is the methyl ester of C_(18:1). In another embodiment, the fattyester is the ethyl ester of C_(16:1). In another embodiment, the fattyester is the methyl ester of C_(16:1). In yet another embodiment, thefatty ester is octadecyl ester of octanol.

Some microorganisms preferentially produce even- or odd-numbered carbonchain fatty acids and fatty acid derivatives. For example, E. colinormally produce even-numbered carbon chain fatty acids and fatty acidethyl esters (FAEE). Surprisingly, the methods disclosed herein may beused to alter that production. For example, E. coli can be made toproduce odd-numbered carbon chain fatty acids and FAEE.

2. Ester Characteristics

An ester includes what may be designated an “A” side and a “B” side. TheB side may be contributed by a fatty acid produced from de novosynthesis in the production host organism. In some embodiments where theproduction host is additionally engineered to make alcohols, includingfatty alcohols, the A side is also produced by the production hostorganism. In yet other embodiments, the A side can be provided in themedium. By selecting the desired thioesterase genes, the B side (and theA side when fatty alcohols are being made) can be designed to be havecertain carbon chain characteristics. These characteristics includepoints of branching, unsaturation, and desired carbon chain lengths.

When particular thioesterase genes are selected, the A and B side willhave similar carbon chain characteristics when they are both contributedby the production host using fatty acid biosynthetic pathwayintermediates. For example, at least about 50%, 60%, 70%, or 80% of thefatty esters produced will have A sides and B sides that vary by about2, 4, 6, 8, 10, 12, or 14 carbons in length. The A side and the B sidecan also display similar branching and saturation levels.

In addition to producing fatty alcohols for contribution to the A side,the production host can produce other short chain alcohols such asethanol, propanol, isopropanol, isobutanol, and butanol forincorporation on the A side using techniques well known in the art. Forexample, butanol can be made by the production host organism. To createbutanol producing cells, the LS9001 strain, for example, can be furtherengineered to express atoB (acetyl-CoA acetyltransferase) fromEscherichia coli K12, β-hydroxybutyryl-CoA dehydrogenase fromButyrivibrio fibrisolvens, crotonase from Clostridium beijerinckii,butyryl CoA dehydrogenase from Clostridium beijerinckii, CoA-acylatingaldehyde dehydrogenase (ALDH) from Cladosporium flavum, and adhEencoding an aldehyde-alchol dehydrogenase of Clostridium acetobutylicumin the pBAD24 expression vector under the prpBCDE promoter system. Otherproduction host organisms may be similarly modified to produce butanolor other short chain alcohols. For example, ethanol can be produced in aproduction host using the methods taught by Kalscheuer et al.,Microbiology 152:2529-2536, 2006, which is herein incorporated byreference.

III. Genetic Engineering of Production Strain to Increase Fatty AcidDerivative Production

Heterologous DNA sequences involved in a biosynthetic pathway for theproduction of fatty acid derivatives can be introduced stably ortransiently into a production host cell using techniques well known inthe art (non-limiting examples include electroporation, calciumphosphate precipitation, DEAE-dextran mediated transfection,liposome-mediated transfection, conjugation, transduction, and genomicintegration). For stable transformation, a DNA sequence can furtherinclude a selectable marker, including non-limiting examples such asantibiotic resistance and genes that complement auxotrophicdeficiencies.

Various embodiments of this disclosure utilize an expression vector thatincludes a heterologous DNA sequence encoding a protein involved in ametabolic or biosynthetic pathway. Suitable expression vectors include,but are not limited to, viral vectors (such as baculovirus vectors),phage vectors (such as bacteriophage vectors), plasmids, phagemids,cosmids, fosmids, bacterial artificial chromosomes, viral vectors (e.g.,viral vectors based on vaccinia virus, poliovirus, adenovirus,adeno-associated virus, SV40, herpes simplex virus, and the like),P1-based artificial chromosomes, yeast plasmids, yeast artificialchromosomes, and any other vectors for specific production hosts ofinterest (such as E. coli, Pseudomonas pisum, and Saccharomycescerevisiae).

Useful expression vectors can include one or more selectable markergenes to provide a phenotypic trait for selection of transformedproduction host cells. The selectable marker gene encodes a proteinnecessary for the survival or growth of transformed production hostcells grown in a selective culture medium. Production host cells nottransformed with the vector containing the selectable marker gene willnot survive in the culture medium. Typical selection genes encodeproteins that (a) confer resistance to antibiotics or other toxins(e.g., ampicillin, neomycin, methotrexate, or tetracycline); (b)complement auxotrophic deficiencies; or (c) supply critical nutrientsnot available from complex media (e.g., the gene encoding D-alanineracemate for Bacilli). In alternative embodiments, the selectable markergene is one that encodes dihydrofolate reductase or confers neomycinresistance (for use in eukaryotic cell culture), or one that conferstetracycline or ampicillin resistance (for use in a prokaryoticproduction host cell, such as E. coli).

In the expression vector, the DNA sequence encoding the gene in thebiosynthetic pathway is operably linked to an appropriate expressioncontrol sequence, (promoters, enhancers, and the like) to directsynthesis of the encoded gene product. Such promoters can be derivedfrom microbial or viral sources, including CMV and SV40. Depending onthe production host/vector system utilized, any number of suitabletranscription and translation control elements can be used in theexpression vector, including constitutive and inducible promoters,transcription enhancer elements, transcription terminators, etc. (see,e.g., Bitter et al., Methods in Enzymology, 153:516-544, 1987).

Suitable promoters for use in prokaryotic production host cells include,but are not limited to, promoters capable of recognizing the T4, T3, Sp6and T7 polymerases, the P_(R) and P_(L) promoters of bacteriophagelambda, the trp, recA, heat shock, and lacZ promoters of E. coli, thealpha-amylase and the sigma-specific promoters of B. subtilis, thepromoters of the bacteriophages of Bacillus, Streptomyces promoters, theint promoter of bacteriophage lambda, the bla promoter of thebeta-lactamase gene of pBR322, and the CAT promoter of thechloramphenicol acetyl transferase gene. Prokaryotic promoters arereviewed by Glick, J. Ind. Microbiol. 1:277, 1987; Watson et al.,MOLECULAR BIOLOGY OF THE GENE, 4th Ed. (1987), Benjamin Cummins (1987);and Sambrook et al., MOLECULAR CLONING: A LABORATORY MANUAL, 2nd Ed.(Cold Spring Harbor Laboratory Press 1989). Non-limiting examples ofsuitable eukaryotic promoters for use within a eukaryotic productionhost are viral in origin and include the promoter of the mousemetallothionein I gene (Hamer et al., J. Mol. Appl. Gen. 1:273, 1982);the TK promoter of herpes virus (McKnight, Cell 31:355, 1982); the SV40early promoter (Benoist et al., Nature (London) 290:304, 1981); thecytomegalovirus promoter (Foecking et al., Gene 45:101, 1980); the yeastgal4 gene promoter (Johnston et al., PNAS (USA) 79:6971, 1982; Silver etal., PNAS (USA) 81:5951, 1984); and the IgG promoter (Orlandi et al.,PNAS (USA) 86:3833, 1989).

The production host can be genetically modified with a heterologous DNAsequence encoding a biosynthetic pathway gene product that is operablylinked to an inducible promoter. Inducible promoters are well known inthe art. Non-limiting examples of suitable inducible promoters includepromoters that are affected by proteins, metabolites, or chemicals.These include, but are not limited to: a bovine leukemia virus promoter,a metallothionein promoter, a dexamethasone-inducible MMTV promoter, anSV40 promoter, an MRP polIII promoter, a tetracycline-inducible CMVpromoter (such as the human immediate-early CMV promoter) as well asthose from the trp and lac operons.

In some examples, a production host is genetically modified with aheterologous DNA sequence encoding a biosynthetic pathway gene productthat is operably linked to a constitutive promoter. Suitableconstitutive promoters are known in the art and include constitutiveadenovirus major late promoter, a constitutive MPSV promoter, or aconstitutive CMV promoter.

In some examples, a modified production host is one that is geneticallymodified with an exongenous DNA sequence encoding a single proteininvolved in a biosynthesis pathway. In other embodiments, a modifiedproduction host is one that is genetically modified with exongenous DNAsequences encoding two or more proteins involved in a biosynthesispathway, for example, the first and second enzymes in a biosyntheticpathway.

Where the production host is genetically modified to express two or moreproteins involved in a biosynthetic pathway, those DNA sequences caneach be contained in a single or in separate expression vectors. Whenthose DNA sequences are contained in a single expression vector, in someembodiments, the nucleotide sequences will be operably linked to acommon control element where the common control element controlsexpression of all of the biosynthetic pathway protein-encoding DNAsequences in the single expression vector (e.g., a promoter).

When a modified production host is genetically modified withheterologous DNA sequences encoding two or more proteins involved in abiosynthesis pathway, one of the DNA sequences can be operably linked toan inducible promoter, and one or more of the DNA sequences can beoperably linked to a constitutive promoter.

In some embodiments, the intracellular concentration (e.g., theconcentration of the intermediate in the genetically modified productionhost) of the biosynthetic pathway intermediate can be increased tofurther boost the yield of the final product. The intracellularconcentration of the intermediate can be increased in a number of ways,including, but not limited to, increasing the concentration in theculture medium of a substrate for a biosynthetic pathway; increasing thecatalytic activity of an enzyme that is active in the biosyntheticpathway; increasing the intracellular amount of a substrate (e.g., aprimary substrate) for an enzyme that is active in the biosyntheticpathway; and the like.

In some examples, the fatty acid derivative or intermediate is producedin the cytoplasm of the production host. The cytoplasmic concentrationcan be increased in a number of ways, including, but not limited to,binding of the fatty acid to coenzyme A to form an acyl-CoA thioester.Additionally, the concentration of acyl-CoA can be increased byincreasing the biosynthesis of CoA in the cell, such as byover-expressing genes associated with pantothenate biosynthesis (e.g.,panD) or knocking out the genes associated with glutathione biosynthesis(e.g., glutathione synthase).

Regulatory sequences, coding sequences, and combinations thereof, can beintroduced or altered in the chromosome of the production host. In someexamples, the integration of the desired recombinant sequence into theproduction host genomic sequence does not require the use of aselectable marker such as an antibiotic. In some examples, the genomicalterations include changing the control sequence of the target genes byreplacing the native promoter(s) with a promoter that is insensitive toregulation. There are numerous approaches for doing this. For example,Valle and Flores, Methods Mol. Biol. 267:113-122, 2006, describes aPCR-based method to over-express chromosomal genes in E. coli. Anotherapproach is based on the use of single-strand oligonucleotides to createspecific mutations directly in the chromosome, using the technologydeveloped by Court et al., Proc. Nat. Acad. Sci. 100:15748-15753, 2003.This technology is based on the use of the over-expression of the Betaprotein from the bacteriophage lambda to enhance genetic recombination.The advantages of this approach are that synthetic oligonucleotides 70bases long (or more) can be used to create point mutations, insertions,and deletions, thus eliminating any cloning steps. Furthermore, thesystem is sufficiently efficient that no markers are necessary toisolate the desired mutations.

With this approach the regulatory region of a gene can be changed tocreate a stronger promoter and/or eliminate the binding site of arepressor. In such a manner, a desired gene can be overexpressed in theproduction host organism.

IV. Fermentation

A. Maximizing Production Efficiency

The production and isolation of fatty acid derivatives can be enhancedby employing specific fermentation techniques. One method for maximizingproduction while reducing costs is increasing the percentage of thecarbon source that is converted to hydrocarbon products.

During normal cellular lifecycles carbon is used in cellular functionsincluding producing lipids, saccharides, proteins, organic acids, andnucleic acids. Reducing the amount of carbon necessary forgrowth-related activities can increase the efficiency of carbon sourceconversion to output. This can be achieved by first growingmicroorganisms to a desired density, such as a density achieved at thepeak of the log phase of growth. At such a point, replication checkpointgenes can be harnessed to stop the growth of cells. Specifically, quorumsensing mechanisms (reviewed in Camilli and Bassler Science 311:1113,2006; Venturi FEMS Microbio. Rev. 30:274-291, 2006; and Reading andSperandio FEMS Microbiol. Lett. 254:1-11, 2006, which references areincorporated by reference herein) can be used to activate genes such asp.53, p21, or other checkpoint genes.

Genes that can be activated to stop cell replication and growth in E.coli include umuDC genes, the over-expression of which stops theprogression from stationary phase to exponential growth (Murli et al.,J. of Bact. 182:1127, 2000). UmuC is a DNA polymerase that can carry outtranslesion synthesis over non-coding lesions—the mechanistic basis ofmost UV and chemical mutagenesis. The umuDC gene products are used forthe process of translesion synthesis and also serve as a DNA sequencedamage checkpoint. The umuDC gene products include UmuC, UmuD, umuD′,UmuD′₂C, UmuD′ ₂ and UmuD₂. Simultaneously, the product-producing genescould be activated, thus minimizing the need for replication andmaintenance pathways to be used while the fatty acid derivative is beingmade. Production host microorganisms can also be engineered to expressumuC and umuD from E. coli in pBAD24 under the prpBCDE promoter systemthrough de novo synthesis of this gene with the appropriate end-productproduction genes.

The percentage of input carbons converted to fatty esters or hydrocarbonproducts is a cost driver. The more efficient the process is (i.e., thehigher the percentage of input carbons converted to fatty esters orhydrocarbon products), the less expensive the process will be. Foroxygen-containing carbon sources (e.g., glucose and other carbohydratebased sources), the oxygen must be released in the form of carbondioxide. For every 2 oxygen atoms released, a carbon atom is alsoreleased leading to a maximal theoretical metabolic efficiency of ˜34%(w/w) (for fatty acid derived products). This figure, however, changesfor other hydrocarbon products and carbon sources. Typical efficienciesin the literature are approximately <5%. Production hosts engineered toproduce hydrocarbon products can have greater than 1, 3, 5, 10, 15, 20,25, and 30% efficiency. In one example, production hosts will exhibit anefficiency of about 10% to about 25%. In other examples, such productionhosts will exhibit an efficiency of about 25% to about 30%. In otherexamples, such production hosts will exhibit >30% efficiency.

The production host can be additionally engineered to expressrecombinant cellulosomes, such as those described in PCT applicationnumber PCT/US2007/003736, incorporated herein by reference in itsentirety, which could allow the production host to use cellulosicmaterial as a carbon source. For example, the production host can beadditionally engineered to express invertases (EC 3.2.1.26) so thatsucrose can be used as a carbon source.

Similarly, the production host can be engineered using the teachingsdescribed in U.S. Pat. Nos. 5,000,000; 5,028,539; 5,424,202; 5,482,846;and U.S. Pat. No. 5,602,030 to Ingram et al., all incorporated herein byreference in their entirety, so that the production host can assimilatecarbon efficiently and use cellulosic materials as carbon sources.

In one example, the fermentation chamber will enclose a fermentationthat is undergoing a continuous reduction. In this instance, a stablereductive environment would be created. The electron balance would bemaintained by the release of carbon dioxide (in gaseous form). Effortsto augment the NAD/H and NADP/H balance can also facilitate instabilizing the electron balance.

The availability of intracellular NADPH can also be enhanced byengineering the production host to express an NADH:NADPHtranshydrogenase. The expression of one or more NADH:NADPHtranshydrogenase converts the NADH produced in glycolysis to NADPH whichenhances the production of fatty acid derivatives.

B. Small-Scale Hydrocarbon Production

For small scale hydrocarbon product production, E. coli BL21(DE3) cellsharboring pBAD24 (with ampicillin resistance and the end-productsynthesis pathway) as well as pUMVC1 (with kanamycin resistance and theacetyl CoA/malonyl CoA over-expression system) are incubated overnightin 2 L flasks at 37° C. shaken at >200 rpm in 500 mL LB mediumsupplemented with 75 μg/mL ampicillin and 50 μg/ml kanamycin untilcultures reach an OD₆₀₀ of >0.8. Upon achieving an OD₆₀₀ of >0.8, cellsare supplemented with 25 mM sodium proprionate (pH 8.0) to activate theengineered gene systems for production, and to stop cellularproliferation by activating UmuC and UmuD proteins. Induction isperformed for 6 hours at 30° C. After incubation, the media is examinedfor hydrocarbon product using GC-MS.

C. Large-Scale Hydrocarbon Production

For large scale product production, the engineered production hosts aregrown in batches of 10 L, 100 L, or larger; fermented; and induced toexpress desired products based on the specific genes encoded in theappropriate plasmids.

For example, E. coli BL21(DE3) cells harboring pBAD24 (with ampicillinresistance and the end-product synthesis pathway) as well as pUMVC1(with kanamycin resistance and the acetyl-CoA/malonyl-CoAover-expression system) are incubated from a 500 mL seed culture for 10L fermentations (5 L for 100 L fermentations) in LB media (glycerolfree) with 50 μg/mL kanamycin and 75 μg/mL ampicillin at 37° C., shakenat >200 rpm, until cultures reach an OD₆₀₀ of >0.8 (typically 16 hours).Media is continuously supplemented to maintain 25 mM sodium proprionate(pH 8.0) to activate the engineered gene systems for production, and tostop cellular proliferation by activating umuC and umuD proteins. Mediais continuously supplemented with glucose to maintain a concentration 25g/100 mL.

After the first hour of induction, aliquots of no more than 10% of thetotal cell volume are removed each hour and allowed to sit withoutaggitation to allow the hydrocarbon product to rise to the surface andundergo a spontaneous phase separation. The hydrocarbon component isthen collected and the aqueous phase returned to the reaction chamber.The reaction chamber is operated continuously. When the OD₆₀₀ dropsbelow 0.6, the cells are replaced with a new batch grown from a seedculture.

For wax ester production, the wax esters are isolated, washed briefly in1 M HCl to split the ester bond, and returned to pH 7 with extensivewashing with distilled water.

V. Post-Production Processing

The fatty acid derivatives produced during fermentation can be separatedfrom the fermentation media. Any technique known for separating fattyacid derivatives from aqueous media can be used. One exemplaryseparation process provided herein is a two phase (bi-phasic) separationprocess. This process involves fermenting the genetically engineeredproduction hosts under conditions sufficient to produce a fatty acidderivative, allowing the derivative to collect in an organic phase, andseparating the organic phase from the aqueous fermentation broth. Thismethod can be practiced in both a batch and continuous fermentationsetting.

Bi-phasic separation uses the relative immisiciblity of fatty acidderivatives to facilitate separation Immiscible refers to the relativeinability of a compound to dissolve in water and is defined by thecompounds partition coefficient. One or ordinary skill in the art willappreciate that by choosing a fermentation broth and organic phase suchthat the fatty acid derivative being produced has a high log P value,the fatty acid derivative will separate into the organic phase, even atvery low concentrations in the fermentation vessel.

The fatty acid derivatives produced by the methods described herein willbe relatively immiscible in the fermentation broth, as well as in thecytoplasm. Therefore, the fatty acid derivative will collect in anorganic phase either intracellularly or extracellularly. The collectionof the products in the organic phase will lessen the impact of the fattyacid derivative on cellular function, and will allow the production hostto produce more product.

The fatty alcohols, fatty esters, waxes, and hydrocarbons produced asdescribed herein allow for the production of homogeneous compoundswherein at least about 60%, 70%, 80%, 90%, or 95% of the fatty alcohols,fatty esters, and waxes produced will have carbon chain lengths thatvary by less than about 6, less than about 4 carbons, or less than about2 carbons. These compounds can also be produced so that they have arelatively uniform degree of saturation, for example at least about 60%,70%, 80%, 90%, or 95% of the fatty alcohols, fatty esters, hydrocarbonsand waxes will be monounsaturated, diunsaturated, or triunsaturated.These compounds can be used directly as fuels, personal care additives,or nutritional supplements. These compounds can also be used asfeedstock for subsequent reactions for example transesterification,hydrogenation, catalytic cracking (via hydrogenation, pyrolisis, orboth), or epoxidation reactions to make other products.

The fatty alcohols, fatty esters, waxes, and hydrocarbons produced asdescribed herein contain low levels of unwanted or undesired elements,including, but not limited to, heavy metals. In some embodiments, thefatty alcohols, fatty esters, waxes, and hydrocarbons produced asdescribed herein will contain less than about 50 ppm arsenic; less thanabout 300 ppm calcium; less than about 200 ppm chlorine; less than about50 ppm cobalt; less than about 50 ppm copper; less than about 300 ppmiron; less than about 2% by weight water; less than about 50 ppm lead;less than about 50 ppm manganese; less than about 0.2 ppm mercury; lessthan about 50 ppm molybdenum; less than about 1% by weight nitrogen;less than about 200 ppm potassium; less than about 300 ppm sodium; lessthan about 3% by weight sulfur; less than 50 ppm zinc; or less than 700ppm phosphorus.

In some embodiments, the fatty alcohols, fatty esters, waxes, andhydrocarbons produced as described herein will contain between about 50%and about 90% carbon; between about 5% and about 25% hydrogen; orbetween about 5% and about 25% oxygen. In other embodiments, the fattyalcohols, fatty esters, waxes, and hydrocarbons produced as describedherein will contain between about 65% and about 85% carbon; betweenabout 10% and about 15% hydrogen; or between about 10% and about 20%oxygen.

VI. Fuel Compositions

The fatty acid derivatives described herein can be used as fuel. One ofordinary skill in the art will appreciate that, depending upon theintended purpose of the fuel, different fatty acid derivatives can beproduced and used. For example, a branched fatty acid derivative may bedesirable for automobile fuel that is intended to be used in coldclimates.

Using the methods described herein, fuels comprising relativelyhomogeneous fatty acid derivatives that have desired fuel qualities canbe produced. Such fatty acid derivative-based fuels can be characterizedby carbon fingerprinting, and their lack of impurities when compared topetroleum derived fuels or biodiesel derived from triglyceride. Thefatty acid derivative-based fuels can also be combined with other fuelsor fuel additives to produce fuels having desired properties.

The production hosts and methods disclosed herein can be used to producefree fatty acids and fatty esters. In some embodiments, the percentageof free fatty acids in the product produced by the production host is atleast about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 15%, 20%, or 25%.In some embodiments, the percentage of fatty esters in the productproduced by the production host is at least about 50%, 55%, 60%, 65%,70%, 75%, 80%, 85%, or 90%. In some embodiments, the ratio of fattyesters to free fatty acids in the product produced by the productionhost is about 10:1, 9:1, 8:1, 7:1, 5:1, 2:1, or 1:1. In otherembodiments, the fatty ester produced by the production host is ethyldodecanoate, ethyl tridecanoate, ethyl tetradecanoate, ethylpentadecanoate, ethyl cis-9-hexadecenoate, ethyl hexadecanoate, ethylheptadecanoate, ethyl cis-11-octadecenoate, ethyl octadecanoate, orcombinations thereof. In other embodiments, the free fatty acid producedby the production host is dodecanoic acid, tetradecanoic acid,pentadecanoic acid, cis-9-hexadecenoic acid, hexadecanoic acid,cis-11-octadecenoic acid, or combinations thereof.

A. Carbon Fingerprinting

Biologically produced fatty acid derivatives represent a new source offuels, such as alcohols, diesel, and gasoline. Some biofuels made usingfatty acid derivatives have not been produced from renewable sources andare new compositions of matter. These new fuels can be distinguishedfrom fuels derived form petrochemical carbon on the basis of dualcarbon-isotopic fingerprinting. Additionally, the specific source ofbiosourced carbon (e.g., glucose vs. glycerol) can be determined by dualcarbon-isotopic fingerprinting (see U.S. Pat. No. 7,169,588, which isherein incorporated by reference in its entirety, in particular, seecol. 4, line 31, to col. 6, line 8).

The fatty acid derivatives and the associated biofuels, chemicals, andmixtures may be completely distinguished from their petrochemicalderived counterparts on the basis of ¹⁴C (f_(M)) and dualcarbon-isotopic fingerprinting.

The fatty acid derivatives described herein have utility in theproduction of biofuels and chemicals. The new fatty acidderivative-based products provided by the instant invention additionallymay be distinguished on the basis of dual carbon-isotopic fingerprintingfrom those materials derived solely from petrochemical sources. Theability to distinguish these products is beneficial in tracking thesematerials in commerce. For example, fuels or chemicals comprising both“new” and “old” carbon isotope profiles may be distinguished from fuelsand chemicals made only of “old” materials. Thus, the instant materialsmay be followed in commerce or identified in commerce as a biofuel onthe basis of their unique profile. In addition, other competingmaterials can be identified as being biologically derived or derivedfrom a petrochemical source.

In some examples, a biofuel composition is made that includes a fattyacid derivative having δ¹³C of from about −10.9 to about −15.4, whereinthe fatty acid derivative accounts for at least about 85% of biosourcedmaterial (i.e., derived from a renewable resource such as cellulosicmaterials and sugars) in the composition. In other examples, the biofuelcomposition includes a fatty acid derivative having the formula:

X—(CH(R))_(n)CH₃

-   -   wherein X represents CH₃, —CH₂OR¹; —C(O)OR²; or —C(O)NR³R⁴;    -   R is, for each n, independently absent, H or a lower aliphatic;    -   n is an integer from about 8 to about 34, preferably from about        10 to about 24; and    -   R¹, R², R³ and R⁴ independently are selected from H or a lower        alkyl.

Typically, when R is lower aliphatic, R represents a branched,unbranched or cyclic lower alkyl or lower alkenyl moiety. Exemplary Rgroups include, without limitation, methyl, isopropyl, isobutyl,sec-butyl, cyclopentenyl, and the like. The fatty acid derivative isadditionally characterized as having a δ¹³C of from about −10.9 to about−15.4, and the fatty acid derivative accounts for at least about 85% ofbiosourced material in the composition. In some examples the fatty acidderivative in the biofuel composition is characterized by having afraction of modern carbon (f_(M) ⁴C) of at least about 1.003, 1.010, or1.5.

B. Impurities

The fatty acid derivatives described herein are useful for makingbiofuels. These fatty acid derivatives are made directly from fattyacids and not from the chemical processing of triglycerides.Accordingly, fuels comprising the disclosed fatty acid derivatives willcontain fewer impurities than are normally associated with biofuelsderived from triglycerides, such as fuels derived from vegetable oilsand fats.

The crude fatty acid derivative biofuels described herein (prior tomixing the fatty acid derivative with other fuels such aspetroleum-based fuels) will contain less transesterification catalystthan petrochemical diesel or biodiesel. For example, the fatty acidderivative can contain less than about 2%, 1.5%, 1.0%, 0.5%, 0.3%, 0.1%,0.05%, or 0% of a transesterification catalyst or an impurity resultingfrom a transesterification catalyst.

Non-limiting examples of transesterification catalysts include hydroxidecatalysts, such as NaOH, KOH, and LiOH; and acidic catalysts, such asmineral acid catalysts and Lewis acid catalysts. Non-limiting examplesof catalysts and impurities resulting from transesterification catalystsinclude tin, lead, mercury, cadmium, zinc, titanium, zirconium, hafnium,boron, aluminum, phosphorus, arsenic, antimony, bismuth, calcium,magnesium, strontium, uranium, potassium, sodium, lithium, andcombinations thereof.

Similarly, the crude fatty acid derivative biofuels described herein(prior to mixing the fatty acid derivative with other fuels such aspetrochemical diesel or biodiesel) will contain less glycerol (orglycerin) than biofuels made from triglycerides. For example, the fattyacid derivative can contain less than about 2%, 1.5%, 1.0%, 0.5%, 0.3%,0.1%, 0.05%, or 0% by weight of glycerol.

The crude biofuel derived from fatty acid derivatives will also containless free alcohol (i.e., alcohol that is used to create the ester) thanbiodiesel made from triglycerides. This is due in part to the efficiencyof utilization of the alcohol by the production host. For example, thefatty acid derivative will contain less than about 2%, 1.5%, 1.0%, 0.5%,0.3%, 0.1%, 0.05%, or 0% by weight of free alcohol.

Biofuel derived from the disclosed fatty acid derivatives can beadditionally characterized by its low concentration of sulfur comparedto petroleum derived diesel. For example, biofuel derived from fattyacid derivatives can have less than about 2%, 1.5%, 1.0%, 0.5%, 0.3%,0.1%, 0.05%, or 0% by weight of sulfur.

C. Additives

Fuel additives are used to enhance the performance of a fuel or engine.For example, fuel additives can be used to alter the freezing/gellingpoint, cloud point, lubricity, viscosity, oxidative stability, ignitionquality, octane level, and flash point. In the United States, all fueladditives must be registered with Environmental Protection Agency. Thenames of fuel additives and the companies that sell the fuel additivesare publicly available by contacting the EPA or by viewing the agency'swebsite. One of ordinary skill in the art will appreciate that the fattyacid derivatives described herein can be mixed with one or more fueladditives to impart a desired quality.

The fatty acid derivatives described herein can be mixed with otherfuels such as biodiesel derived from triglycerides, various alcoholssuch as ethanol and butanol, and petroleum-derived products such asgasoline or diesel.

In some examples, a fatty acid derivative with a low gel point, such asC_(16:1) ethyl ester or C_(18:1) ethyl ester, is produced. This low gelpoint fatty acid derivative can be mixed with biodiesel made fromtriglycerides to reduce gel point of the resulting fuel when compared tothe biodiesel made from triglycerides. Similarly, a fatty acidderivative, such as C_(16:1) ethyl ester or C_(18:1) ethyl ester, can bemixed with petroleum-derived diesel to provide a mixture that is atleast about, and often greater than, 5% by weight of biodiesel. In someexamples, the mixture includes at least about 10%, 15%, 20%, 30%, 40%,50%, 60% by weight of the fatty acid derivative.

For example, a biofuel composition can be made that includes at leastabout 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, 85%, 90% or 95% of afatty acid derivative that includes a carbon chain that is 8:0, 10:0,12:0, 14:0, 14:1, 16:0, 16:1, 18:0, 18:1, 18:2, 18:3, 20:0, 20:1, 20:2,20:3, 22:0, 22:1 or 22:3. Such biofuel compositions can additionallyinclude at least one additive selected from a cloud point loweringadditive that can lower the cloud point to less than about 5° C., or 0°C.; a surfactant; a microemulsion; at least about 5%, 10%, 15%, 20%,30%, 40%, 50%, 60%, 70% or 80%, 85%, 90%, or 95% diesel fuel fromtriglycerides; petroleum-derived gasoline; or diesel fuel frompetroleum.

EXAMPLES

The examples that follow illustrate the engineering of production hoststo produce specific fatty acid derivatives. The biosynthetic pathwayinvolved in the production of fatty acid derivatives are illustrated inthe figures.

For example, FIG. 3 is a diagram of the FAS pathway showing the enzymesdirectly involved in the synthesis of acyl-ACP. To increase theproduction of fatty acid derivatives, such as waxes, fatty esters, fattyalcohols, and hydrocarbons one or more of the enzymes in FIG. 3 can beover expressed or mutated to reduce feedback inhibition to increase theamount of acyl-ACP produced. Additionally, enzymes that metabolize theintermediates to make non-fatty acid based products (side reactions) canbe functionally deleted or attenuated to increase the flux of carbonthrough the fatty acid biosynthetic pathway. In the examples below, manyproduction hosts are described that have been modified to increase fattyacid production.

FIG. 4, FIG. 5, and FIG. 6 show biosynthetic pathways that can beengineered to make fatty alcohols and fatty esters, respectively. Asillustrated in FIG. 5, the conversion of each substrate (e.g.,acetyl-CoA, malonyl-CoA, acyl-ACP, fatty acid, and acyl-CoA) to eachproduct (e.g., acetyl-CoA, malonyl-CoA, acyl-ACP, fatty acid, andacyl-CoA) can be accomplished using several different polypeptides thatare members of the enzyme classes indicated.

The examples below describe microorganisms that have been engineered orcan be engineered to produce specific fatty alcohols, waxes, fattyesters, and hydrocarbons.

Example 1. Production Host Construction

An exemplary production host is LS9001. LS9001 was produced by modifyingC41(DE3) from Over-express.com (Saint Beausine, France) to knock-out thefadE gene (acyl-CoA dehydrogenase).

Briefly, the fadE knock-out strain of E. coli was made using primersYafV_NotI and Ivry_O1 to amplify about 830 bp upstream of fadE andprimers Lpcaf_ol and LpcaR_Bam to amplify about 960 bp downstream offadE. Overlap PCR was used to create a construct for in-frame deletionof the complete fadE gene. The fadE deletion construct was cloned intothe temperature-sensitive plasmid pKOV3, which contained a sacB gene forcounterselection, and a chromosomal deletion of fadE was made accordingto the method of Link et al., J. Bact. 179:6228-6237, 1997. Theresulting strain was not capable of degrading fatty acids and fattyacyl-CoAs. This knock-out strain is herein designated as ΔfadE.

Additional modifications that were included in a production host includeintroducing a plasmid carrying the four genes which are responsible foracetyl-CoA carboxylase activity in E. coli (accA, accB, accC, and accD,Accessions: NP_414727, NP_417721, NP_417722, NP_416819, EC 6.4.1.2). TheaccABCD genes were cloned in two steps as bicistronic operons into theNcoO/HindIII and NdeI/AvrII sites of pACYCDuet-1 (Novagen, Madison,Wis.), and the resulting plasmid was termed pAS004.126.

Additional modifications that were included in a production host includethe following: over-expression of aceEF (encoding the E1p dehydrogasecomponent and the E2p dihydrolipoamide acyltransferase component of thepyruvate and 2-oxoglutarate dehydrogenase complexes); andfabH/fabD/fabG/acpP/fabF (encoding FAS) from E. coli, Nitrosomonaseuropaea (ATCC 19718), Bacillus subtilis, Saccharomyces cerevisiae,Streptomyces spp, Ralstonia, Rhodococcus, Corynebacteria, Brevibacteria,Mycobacteria, and oleaginous yeast. Similarly, production hosts wereengineered to express accABCD (encoding acetyl co-A carboxylase) fromPisum savitum. However, when the production host is also producingbutanol it is less desirable to express the Pisum savitum homolog.

In some production hosts, genes were knocked out or attenuated using themethod of Link, et al., J. Bacteria 179:6228-6237, 1997. Genes that wereknocked out or attenuated include gpsA (encoding biosyntheticsn-glycerol 3-phosphate dehydrogenase, accession NP_418065, EC:1.1.1.94); ldhA (encoding lactate dehydrogenase, accession NP_415898,EC: 1.1.1.28); pflb (encoding formate acetyltransferase 1, accessions:P09373, EC: 2.3.1.54); adhE (encoding alcohol dehydrogenase, accessions:CAA47743, EC: 1.1.1.1, 1.2.1.10); pta (encoding phosphotransacetylase,accessions: NP_416800, EC: 2.3.1.8); poxB (encoding pyruvate oxidase,accessions: NP_415392, EC: 1.2.2.2); ackA (encoding acetate kinase,accessions: NP_416799, EC: 2.7.2.1) and combinations thereof.

Similarly, the PlsB[D311E] mutation was introduced into LS9001 toattenuate plsB using the method described in Example 1 for the fadEdeletion. This mutation decreased the amount of carbon diverted tophospholipid production (see FIG. 1). An allele encoding PlsB[D311E] wasmade by replacing the GAC codon for aspartate 311 with a GAA codon forglutamate. The altered allele was made by gene synthesis and thechromosomal plsB wildtype allele was exchanged for the mutantplsB[D311E] allele using the method of Link et al. (see above).

For the commercial production of fatty acid derivatives viafermentation, the production host internal regulatory pathways wereoptimized to produce more of the desired products. In many instances,this regulation was diminished by over-expressing certain enzymes. Someexamples are shown in Table 8.

TABLE 8 Additional genes that can be optimized for fatty acid derivativeproduction Example of E. coli EC gene(s) (or other Enzymatic ActivityNumber microorganism) Pantetheine-phosphate adenylyltransferase 2.7.7.3coaD dephospho-CoA kinase 2.7.1.24 coaE Biotin-[acetyl-CoA-carboxylase]ligase 6.3.4.15 birA Carbonic anhydrase 4.2.1.1 cynT, can(yadF)apo-[acyl carrier protein] None acpP holo-[acyl-carrier-protein]synthase 2.7.8.7 acpS, acpT Pyruvate dehydogenase complex 1.2.4.1 aceF2.3.1.12 aceE 1.8.1.4 lpd NAD Kinase 2.7.1.23 nadK (yfjB)Pyruvate-ferredoxin oxidoreductase 1.2.7.1 porA (Desulfovobrio vulgarisDP4)

Example 2. Production Host Modifications

The following plasmids were constructed for the expression of variousproteins that are used in the synthesis of fatty acid derivatives. Theconstructs were made using standard molecular biology methods. All thecloned genes were put under the control of IPTG-inducible promoters(e.g., T7, tac, or lac promoters).

The tesA gene (thioesterase A gene accession NP_415027 without leadersequence (Cho and Cronan, J. Biol. Chem., 270:4216-9, 1995, EC: 3.1.1.5,3.1.2.-)) of E. coli was cloned into NdeI/AvrII digested pETDuet-1(pETDuet-1 described herein is available from Novagen, Madison, Wis.).Genes encoding for FatB-type plant thioesterases (TEs) from Umbellulariacalifornica, Cuphea hookeriana, and Cinnamonum camphorum (accessions:UcFatB1=AAA34215, ChFatB2=AAC49269, ChFatB3=AAC72881, CcFatB=AAC49151)were individually cloned into three different vectors: (i) NdeI/AvrIIdigested pETDuet-1; (ii) XhoI/HindIII digested pBluescript KS+(Stratagene, La Jolla, Calif., to create N-terminal lacZ::TE fusionproteins); and (iii) XbaI/HindIII digested pMAL-c2X (New England Lab,Ipswich, Mass.) (to create n-terminal malE::TE fusions). The fadD gene(encoding acyl-CoA synthase) from E. coli was cloned into a NcoI/HindIIIdigested pCDFDuet-1 derivative, which contained the acr1 gene (acyl-CoAreductase) from Acinetobacter baylyi ADP1 within its NdeI/AvrII sites.Table 9 provides a summary of the plasmids generated to make severalexemplary production strains. One of ordinary skill in the art willappreciate that different plasmids and genomic modifications can be usedto achieve similar strains.

TABLE 9 Summary of plasmids used in production hosts Source OrganismAccession No., Plasmid Gene Product EC number pETDuet-1-tesA E. coliAccessions: TesA NP_415027, EC: 3.1.1.5, 3.1.2.— pETDuet-1-TEucUmbellularia Q41635 californica pBluescript-TEuc UcFatB1 pMAL-c2X-TEucAAA34215 pETDuet-1-TEch Cuphea hookeriana ABB71581 pBluescript-TEchChFatB2 AAC49269 pMAL-c2X-TEch ChFatB3 AAC72881 pETDuet-1-TEccCinnamonum camphorum pBluescript-TEcc CcFabB AAC49151 TEcipETDuet-1-atFatA3 Arabidopsis NP_189147 thaliana pETDuet-1-HaFatA1Helianthus annuus AAL769361 pCDFDuet-1-fadD-acr1 E. coli fadD:Accessions NP_416319, EC 6.2.1.3 acr1: Accessions YP_047869pETDuet-1-tesA E. coli Accessions: TesA NP_415027, EC: 3.1.1.5, 3.1.2.—pETDuet-1-TEuc Umbellularia Q41635 californica pBluescript-TEuc UcFatB1AAA34215 pMAL-c2X-TEuc pETDuet-1-TEch Cuphea hookeriana ABB71581pBluescript-TEch ChFatB2 AAC49269 pMAL-c2X-TEch ChFatB3 AAC72881pETDuet-1-TEcc Cinnamonum camphorum pBluescript-TEcc CcFatB AAC49151TEci pCDFDuet-1-fadD-acr1 E. coli fadD: Accessions NP_416319, EC 6.2.1.3acr1: Accessions YP_047869

The chosen expression plasmids contain compatible replicons andantibiotic resistance markers to produce a four-plasmid expressionsystem. Therefore, LS9001 can be co-transformed with: (i) any of theTE-expressing plasmids; (ii) the FadD-expressing plasmid, which alsoexpresses Acr1; and (iii) ester synthase expression plasmid. Wheninduced with IPTG, the resulting strain will produce increasedconcentrations of fatty alcohols from carbon sources such as glucose.

Example 3. Production of Fatty Alcohol in the Recombinant E. coli Strain

Fatty alcohols were produced by expressing a thioesterase gene and anacyl-CoA reductase gene exogenously in a production host. Morespecifically, plasmids pCDFDuet-1-fadD-acr1 (acyl-CoA reductase) andpETDuet-1-′tesA (thioesterase) were transformed into E. coli strainLS9001 (described in Example 1) and corresponding transformants wereselected in LB plates supplemented with 100 mg/L of spectinomycin and 50mg/L of carbenicillin. Four transformants of LS9001/pCDFDuet-1-fadD-acr1were independently inoculated into 3 mL of M9 medium supplemented with50 mg/L of carbenicillin and 100 mg/L of spectinomycin. The samplescontaining the transformants were grown in at 25° C. in a shaker (250rpm) until they reached 0.5 OD₆₀₀. Next, 1.5 mL of each sample wastransferred into a 250 mL flask containing 30 mL of the M9 mediumdescribed above. The resulting culture was grown at 25° C. in a shakeruntil the culture reached between 0.5-1.0 OD₆₀₀. IPTG was then added toa final concentration of 1 mM. Cell growth continued for 40 hours.

The cells were then spun down at 4000 rpm. The cell pellets weresuspended in 1.0 mL of methanol. 3 mL of ethyl acetate was then mixedwith the suspended cells. 3 mL of H₂O was then added to the mixture.Next, the mixture was sonicated for 20 minutes. The resulting sample wascentrifuged at 4000 rpm for 5 minutes. Then the organic phase (the upperphase), which contained fatty alcohol, was subjected to GC/MS analysis.The total alcohol (including tetradecanol, hexadecanol, hexadecenol andoctadecenol) yield was about 1-10 mg/L. When an E. coli strain carryingonly empty vectors was cultured in the same way, fatty alcohols yieldsof only 0.2-0.5 mg/L were measured in the ethyl acetate extract.

Example 4. Production of Fatty Acids (FA) and Fatty Acid Ethyl Esters(FAEE) Containing Odd-Numbered Carbon Chains without Heavy Metals

1. Production of Biodiesel Sample #23-30

Biodiesel sample #23-30 (“sample #23-30”) was produced by the bioreactorcultivation of an E. coli strain (C41 DE3 ΔfadE ΔfabR ′TesA fadD adp1ws)engineered to produce fatty esters. A two-stage inoculum protocol wasutilized for expansion of the culture. The first stage consisted of theinoculation of 50 mL LB media (supplemented with 100 μg/L carbenicillinand 100 μg/L spectinomycin) in a 250 mL baffled shake flask with a 1 mLfrozen stock vial of the E. coli ester production strain. This seedflask was incubated at 37° C. for seven hours (final OD₆₀₀=4.5 AU, pH6.7), after which 3 mL of the primary culture was transferred to each ofthree 2 L baffled flasks containing 350 mL buffered F1 minimal medium,also containing 100 μg/L carbenicillin and 100 μg/L spectinomycin. Theshake flask buffer used was Bis-Tris propane at a final concentration of200 mM (pH 7.2). These secondary seed flasks were incubated at 37° C.for eighteen hours (final OD₆₀₀=12 AU, pH 5.5) and the contents used toinoculate three 14 L bioreactors with a starting volume of 6.5 liters ofbuffered F1 minimal medium following inoculation. These bioreactors alsocontained 100 μg/L carbenicillin and 100 g/L spectinomycin.

These 14 L bioreactors were initially cultivated at 37° C., and thedissolved oxygen level was maintained at 30% of saturation, using theagitation and oxygen enrichment cascade loops. The pH of the cultivationwas maintained at 7.2, using 1 M H₂SO₄ and anhydrous ammonia gas. Anutrient feed consisting primarily of 43% (w/v) glucose was initiatedwhen the original 5 g/L charge in the basal medium was exhausted. Theglucose solution feed rate was then manually tuned for the duration ofthe run to keep the residual glucose at a low (but non-zero) value forthe duration of the fermentation. Cultures were induced with 1 mM IPTG(final concentration) when the optical density of the culture reached avalue of 30 AU. At this induction point, the bioreactor cultivationtemperature was reduced to 30° C., and approximately 15 mL/L (on a 6.5to 7 liter volume basis) of ethanol was added to the culture andmonitored by HPLC throughout. Additional ethanol was added periodicallyto the bioreactors to maintain the residual concentration at around 20mL/L. The bioreactors were harvested after approximately 60 hours ofcultivation, with approximately 10 L of the broth harvested from each ofthe three bioreactors.

These harvest broths were combined and extracted with an equivalentvolume of ethyl acetate with stirring at room temperature for two hours.The broth extract was then centrifuged (3500 rpm, 30 minutes) toseparate the liquid layers, followed by the removal of the organic layerfor further processing. The ethyl acetate was almost completely removed(<0.3% residual, by GC/FID) from this organic layer by rotaryevaporation (Büchi, R-200), leaving approximately 90 mL of a dark, oilyliquid. This liquid was referred to as sample #23-30.

2. Quantification of FA and FAEE in Sample #23-30

GC-MS was performed using an Agilent 5975B MSD system equipped with a 30m×0.25 mm (0.10 μm film) DB-5 column. The column temperature was 3 minisothermal at 100° C. The column was programmed to rise from 100° C. to320° C. at a rate of 20° C./min. When the final temperature was reached,the column remained isothermal for 5 minutes at 320° C. The injectionvolume was 1 μL. The carrier gas, helium, was released at 1.3 mL/min.The mass spectrometer was equipped with an electron impact ionizationsource. The ionization source temperature was set at 300° C. FAEEstandards (e.g., ethyl dodecanoate, ethyl tetradecanoate, ethylcis-9-hexadecenoate, ethyl hexadecanoate, ethyl octadecanoate,all >99%); fatty acid methyl ester (FAME) standards (e.g., methyldodecanoate, methyl tetradecanoate, methyl pentadecanoate, methylcis-9-hexadecenoate, methyl hexadecanoate, methyl cis-11-octadecenoate,all >99%); trimethylsilyl diazomethane (TMSD, 2 M in hexane);hydrochloric acid (37%); methanol (>99.9%); and ethyl acetate (>99.9%)were purchased from Sigma-Aldrich and used without further purification.

Sample #23-30 was derivatized by adding 50 μL trimethylsilyldiazomethane(TMSD), 8 μL HCl, and 36 μL methanol to 1 mL of sample (1 mg/mL in ethylacetate). The mixture was incubated at room temperature for 1 hour.

Prior to quantitation, the FAEE and FAME in sample #23-30 wereidentified using two methods. First, the GC retention time of eachcompound was compared to the retention time of a known standard. Second,identification of each compound was confirmed by matching the compound'smass spectrum to a standard's mass spectrum in the mass spectra library.

When a standard for a FAEE or FAME was available, the quantification ofthe FAEE or FAME was determined by generating a calibration curve(concentration vs. instrument response). A linear relationship betweenthe instrument response and the analyte concentration was then obtained.The concentration of the compound in the sample was determined by takingits instrument response and referring to the calibration curve.

When a standard for an FAEE was not available, an average instrumentresponse was used to determine the compound's concentrations. The slopeand the intercept for all existing calibration curves were averaged.From these averages, a linear relationship between concentration andinstrument response was determined. The concentration of unknowncompounds was then determined by referencing its instrument response tothe linear relationship between instrument response and concentrationusing Equation 1.

concentration=(instrument response−average interception)/averageslope  Equation 1:

After identifying and quantifying the FAME, the concentration of theassociated free fatty acids was determined based upon the concentrationof FAME and the molecular weight ratio of FA to FAME. Finally, theconcentration of FAEE and FA in mg/L was converted into percentage inthe biodiesel sample (w/w %).

The concentrations of FAEE and FA in sample #23-30 are listed in Table10. The total concentration of FAEEs and FAs was 80.7%. The rest of theunknown compounds may be analyzed by LC/MS/MS method. Ethylpentadecanoate, ethyl cis-9-hexadecenoate, ethyl hexadecanoate and ethylcis-11-octadecenoate were the major component of sample #23-30.

TABLE 10 Percentage of FAEE and FA in sample #23-30 Name Structure MWPercentage, % Ethyl dodecanoate

228.2 1.82 ± 0.03 Ethyl tridecanoate

242.2 0.16 ± 0.01 Ethyl tetradecanoate

256.2 12.88 ± 0.16  Ethyl pentadecanoate

270.3 0.62 ± 0.02 Ethyl cis-9- hexadecenoate

282.3 24.12 ± 0.20  Ethyl hexadecanoate

284.3 9.04 ± 0.11 Ethyl heptadecanoate

298.3 0.11 ± 0.01 Ethyl cis-11- octadecenoate

310.3 23.09 ± 0.33  Ethyl octadecanoate

312.3 0.19 ± 0.03 Dodecanoic acid

200.2 0.94 ± 0.02 Tetradecanoic acid

228.2 2.63 ± 0.03 Pentadecanoic acid

242.2 0.10 ± 0.01 cis-9-hexadecenoic acid

254.2 1.97 ± 0.01 Hexadecanoic acid

256.2 1.01 ± 0.01 cis-11- octadecenoic acid

282.3 2.00 ± 0.02 *Percentage is w/w %.

Surprisingly, sample #23-30 contained odd-numbered FA and FAEE. Furtheranalysis, such as LC/MS/MS, may be performed to confirm that theseodd-numbered carbon chain fatty acids were produced by E. coli and didnot come from the E. coli's own lipids.

3. Quantitative Elemental Analysis of Sample #23-30

Heavy metals are known to poison the catalysts used in catalyticcracking. To measure the levels of heavy metals in sample #23-30, sample#23-30 was sent to Galbraith Laboratories, Inc. for quantitativeelemental analysis of arsenic, calcium, carbon, chlorine, cobalt,copper, hydrogen, iron, Karl Fisher water, lead, manganese, magnesium,mercury, molybdenum, nitrogen, potassium, sodium, sulfur, zinc, oxygen,and phosphorus. Preparatory and analytical methods are described below.Results are shown in Table 11. All amounts in Table 11 were below thelevel of quantitation (LOQ) except for carbon (73.38%), chlorine (91ppm), hydrogen (12.1%), Karl Fisher water (0.998%), mercury (0.057 ppm),oxygen (14.53%), and phosphorus (343 ppm). Therefore, sample #23-30 didnot contain high levels of the heavy metals that were measured.

Method G-52, Rev 6: Microwave Digestion of Samples for Metals Analysis

An appropriate amount of sample was weighed into a microwave vessel tothe nearest 0.001 g. The appropriate reagents were then added to themicrowave vessel. If a visible reaction was observed the reaction wasallowed to cease before capping the vessel. The vessel was then sealedand placed in the microwave according to the manufacture's directions.The temperature of each vessel reached a minimum of 180±10° C. in 5minutes. It remained at a minimum of 180±10° C. for 10 minutes. At theend of the microwave program the vessels were allowed to cool for aminimum of 5 minutes before removal. The vessels were then uncapped andtransferred to volumetric flasks for analysis by the proper technique.

Method G-55, Rev 3: Parr Oxygen Bomb Combustion for the Determination ofHalogens

Samples were weighed into a combustion cup, and Mineral oil was added asa combustion aid. For chlorine (Cl) and bromine (Br) measurements, 1%hydrogen peroxide solution was added into the bomb. For sulfur (S)measurements, 0.01 N sodium hydroxide solution was added. The sample andcup were sealed into a Parr oxygen combustion bomb along with a suitableabsorbing solution. The bomb was purged with oxygen, then pressurized to25-30 atm of oxygen pressure, and ignited. Afterwards, the contents ofthe bomb were well mixed and transferred to a beaker for subsequentanalysis.

Method G-30B, Rev 7: Wet Ash Digestion of Inorganic and OrganicCompounds for Metals Analysis

The sample was charred using H₂SO₄. If analyzing for metals that forminsoluble sulfates, HClO₄ and HNO₃ were used to char the organicmaterial. After charring the sample, HNO₃ was added and the sample wasrefluxed to solubilize the metals present. If the solution becamecloudy, HCl was added to aid complete digestion. HF could be used ifsilicon was present in the sample but only if silicon was not an analyteof interest. All HF used was restricted to Teflon vessels. The cleardigestate was quantitatively transferred to a Class A volumetric flaskand brought to final volume. The sample was then analyzed.

Method ME-4A Rev 2: Determination of Anions Suppressed by IonChromatography

Instrument Dionex Model DX500 Chromatograph Dionex IonPac AS9-SC 4 × 250mm Column Eluent 2.4 mM 1.8 mM NaHCO₃ Na₂CO₃ Preparation Aqueous samplesmay be analyzed as is. Water- soluble samples are typically transferredby weight to a known volume. Other solid materials that are notwater-soluble may be extracted to determine extractable quantities ofvarious anions or combusted to determine total quantities of an elementsuch as Cl or Br. Calibration Standards to bracket sample concentration.0.2 mg/L-4.0 mg/L Sample Intro Auto injection (Hitachi Model AS7200)Determination Conductivity detection/linear regression QuantitationTypically 0.2 mg/L in solution. Limit Interferences Anions with similarretention times; overlapping peaks from major constituent anions.

Method S-300 Rev 7: Determination of Water by Coulometric Titration(Karl Fischer)

This method combined coulometry with the Karl Fischer titration. Thesample was mixed with an amine-methanol mixture containing predominantlyiodide ion (I−) and sulfur dioxide. The iodine produced at the anodethrough the electrolysis was allowed to react with water. In such cases,iodine was produced in direct proportion to the quantity of electricityaccording to Faraday's Law. Also, because 1 mole of waterstoichiometrically reacts with 1 mole of iodine, 1 mg of water wasequivalent to 10.71 coulombs of electricity. Utilizing this principle,the Moisture Meter determined the amount of water directly from thenumber of coulombs required for the electrolysis. This procedureincluded both direct introduction and a vaporizer pre-treatmenttechnique.

Preparation Weigh to obtain 100 μg to 3 mg H2O; Protect samples fromatmospheric moisture during weighing and transfer. Instrument MitsubishiMoisture Meter MCl Model CA-06 (Inst. #569) Mitsubishi MoistureVaporizer, Model CA/VA-06 (Inst. #568) Control Sodium tartratemonohydrate (15.66%); Frequency: every 10 samples, one each day minimum,95-105% recovery Sample Intro A. Entry port, Direct transfer; capillary,syringe, or scoop B. Furnace, tin capsules (Water Vaporizer VA-06);Temperature varies, 200° C. is default value used for standards. Mostsamples analyzed at 160° C. Other temperatures upon request.Determination Coulometric titration of Karl Fischer reagent viaautomatic titrator Quantitation 100 μg H₂O Limit RSD RE INSTR# Precision& 1.35% −0.54% 569 Accuracy Sodium 1.34% −2.13% 568 Tartrate MonohydrateEquations (2I⁻ − 2e⁻ → I₂); (I₂ + SO₂ + 3C₅H₅N + H₂O → 2C₅H₅NHI +C₅H₅NSO₃) μg H₂O/spl wt (g) = ppm H₂O μgH₂O × 0.1/spl wt (mg) = % H₂)Interferences (direct transfer only) free alkali; oxidizing, reducingagent; mercaptans

Method E16-2, Rev 9 (Trace E16-2A): Sulfur Determination Using the LECOSC-432DR

The SC-432DR Sulfur Analyzer is a non-dispersive infrared, digitallycontrolled instrument designed to measure sulfur content in a variety oforganic and inorganic materials. The sample was combusted at 1350+50° C.in an atmosphere of pure oxygen. The sulfur was oxidized to sulfurdioxide and quantitated by infrared absorption. The SC-432DR wasequipped with two detectors, a high-range and a low-range infrared cell.

Instrument LECO SC-432DR Sulfur Analyzer Sample Intro Weigh sample tonearest 0.01 mg. Weigh samples directly into sample boat tared onelectronic balance. Weight automatically transferred to SC432 database.Cover sample with LECO Com-Cat combustion accelerator as called for bysample type. Calibration Three conditioners of 5-10 mg cystine. Sevencalibration standards of 30-175 mg NIST SRM 8415 Whole Egg Powder(0.512% S). Internal calibration using a quadratic regressed curve.Control NIST SRM 1549 Milk Powder (0.351%); others to match sample type.Frequency: one for every ten samples. Determination Combustion in O₂atmosphere at 1350° C. Determination of resulting SO₂ by infrareddetector. Quantitation Limit 0.08 mg S Calculations Internal RSD (%)Mean Recovery (%) Precision & 2.60 97.97 Accuracy (milk powder)

Method ME-2, Rev 14: Carbon, Hydrogen, and Nitrogen Determination

This instrument burns sample in pure oxygen at 950° C. under staticconditions to produce combustion products of CO₂, H₂O, and N₂. ThePE-240 automatically analyzes these products in a self-integrating,steady state thermal conductivity analyzer. Tungstic anhydride may beadded to aid combustion. An extended combustion time (e.g., burn hardmode) may be employed for difficult to combust samples.

Instrument PerkinElmer 240 Elemental Analyzer (Instrument # 409, 410)Sample intro Weigh 1.0-2.5 mg into Al capsule; crimp (see GLI ProcedureG-6) for liquids; washed with solvent prior to weighing upon requestDecomposition Combustion at ≧950° C., reduction at ≧675° C. = CO₂, H₂O,N₂ Calibration Cyclohexanone-2,4-dinitropheylhydrazone (1-2.5 mg)Control s-1409, 2-1410: Cyclohexanone-2,4-dinitropheylhydrazone (51.79%C, 5.07% H, 20.14% N) Determination CO₂, H₂O, N₂ by thermal conductivityanalyzer Quantitation 0.5% C, 0.5% H, 0.5% N Instrument #409 Instrument#410 Precision & accuracy C H N C H N RSD % 0.28 1026 0.39 0.35 1.120.41 Mean recovery (%) 99.94 101.25 99.86 100.13 100.40 100.04Interferences Metals and some halogens cause incomplete combustion.Combustion aids and/or an extended combustion time can be used toalleviate this problem. Calculations Instrument calculates & prints w/wresults for % C, % H, and % N. For samples crimped in an aluminumcapsule, the % N is corrected with a factor; (μV/μg sample/K) × 100 = %Element, where K = calibration = μV/μg of C, or H, or N

Method ME-70, Rev 4: Inductively Coupled Plasma Atomic EmissionSpectrometry

This method describes multi-elemental determinations by ICP-AES usingsimultaneous optical systems and axial or radial viewing of the plasma.The instrument measures characteristic emission spectra by opticalspectrometry. Samples are nebulized and the resulting aerosol istransported to the plasma torch. Element-specific emission spectra areproduced by radio-frequency inductively coupled plasma. The spectra aredispersed by a grating spectrometer, and the intensities of the emissionlines are monitored by photosensitive devices. Background correction isrequired for trace element determination. Background must be measuredadjacent to analyte lines on samples during analysis. The positionselected for the background-intensity measurement, on either or bothsides of the analytical line, will be determined by the complexity ofthe spectrum adjacent to the analyte line. In one mode of analysis, theposition used should be as free as possible from spectral interferenceand should reflect the same change in background intensity as occurs atthe analyte wavelength measured. Background correction is not requiredin cases of line broadening where a background correction measurementwould actually degrade the analytical result.

Instrument ICP-OES Optima 5300, 3300DV and 4300DV, or equivalentDecomposition Prior to analysis, samples must be acidified or digestedusing appropriate Sample Preparation Methods. Calibration 0.01 ppm-60ppm plus matrix specific calibrations Sample Intro Peristaltic pump,cross flow nebulizer, gemcone nebulizer, scott ryton spray chamber andquartz cylonic spray chamber Determination Atomic emission by radiofrequency inductively coupled plasma of element-specific emissionspectra through a grating spectrometer monitored by photosensitivedevices. Quantitation Element and calibration specific ranging fromLimit 0.01-2 ppm Precision & ±10% RSD Accuracy Interferences Spectral,chemical, physical, memory Calculations wt % = (fc × v/10 × D)/spl ppm =(fc × v × D)/SPL Where fc = final concentration in μg/mL; v = samplevolume in mL; D = dilution factor; spl = sample mass in mg; SPL = samplemass in g

Method E80-2, Rev 4: Determination of Mecury (Automated Cold VaporTechnique)

This procedure is based on EPA SW846 Method 7471A. Cold Vapor AtomicAbsorption is based on the general theory of atomic absorption, whichholds that free atoms of the analyte absorb energy from a lamp sourcethat is proportional to the concentration of analyte. By using a lampcontaining the metal to be measured, the exact wavelength needed forabsorption is produced and interferences are greatly reduced. Cold VaporAtomic Absorption uses this principle, and the mercury atoms areliberated by reducing mercury ions with Tin (II) Chloride (SnCl₂).Nitrogen gas carries the atoms through an optical cell, with the Hg lampon one end and the detector on the other end. Because the cold vapormethod is employed, instead of a flame method, undigested organiccompounds are an interference concern, because of their wide band ofabsorption wavelengths.

Instrument PerkinElmer FIMS 400 Automated Mercury Analyzer or equivalentDecomposition Variable, usually microwave digestion or permanganate hotwater bath digestion Calibration 0.1−5.0 μg/L Sample Autosampler,peristaltic pump Introduction Determination Primary wavelength 253.7 nm,using a solid state detector Detection Varies with preparation methodand sample matrix Limit Precision & For microwave For MnO₄ ⁻ Accuracydigestion: digestion: RE −2.47% 4.90% RSD   7.48% 5.20% InterferencesUndigested organic compounds Calculations${{ppb}\mspace{14mu} {Hg}} = \frac{\begin{matrix}{{µg}\text{/}L\mspace{14mu} {in}\mspace{14mu} {solution}\; \times {volume}\mspace{14mu} ({mL}) \times} \\{{dilution}\mspace{14mu} {factor}}\end{matrix}}{{sample}\mspace{14mu} {weight}\mspace{14mu} (g)}$

TABLE 11 Quantitative elemental analysis of sample #23-30 PreparationAnalytical Element Method Method Result Arsenic G-52 ME-70 <25 ppmCalcium G-30B ME-70 <119 ppm Carbon N/A ME-2 73.38% Chlorine G-55 ME-4A91 ppm Cobalt G-30B ME-70 <23 ppm Copper G-30B ME-70 <23 ppm HydrogenN/A ME-2  12.1% Iron G-30B ME-70 <136 ppm Karl Fisher water N/A S-3000.998% Lead G-52 ME-70 <25 ppm Manganese G-30B ME-70 <23 ppm MagnesiumG-30B ME-70 <23 ppm Mercury G-52 E80-2 0.057 ppm Molybdenum G-30B ME-70<23 ppm Nitrogen N/A ME-2  <0.5% Potassium G-30B ME-70 <103 ppm SodiumG-30B ME-70 <140 ppm Sulfur N/A E16-2A <0.140%   Zinc G-30B ME-70 <23ppm Oxygen N/A Subtraction* 14.53% Phosphorus G-30B ME-70 343 ppmResults presented as “<” are below LOQ. *Oxygen content was determinedby subtracting the observed results for all other elements from 100%.

Example 5. Production and Release of Fatty Alcohol from Production Host

Acr1 (acyl-CoA reductase) was expressed in E. coli grown on glucose asthe sole carbon and energy source. The E. coli produced small amounts offatty alcohols such as dodecanol (C_(12:0)—OH), tetradecanol(C_(14:0)—OH) and hexadecanol (C_(16:0)—OH). In other samples, FadD(acyl-CoA synthase) was expressed together with acr1 in E. coli. Afive-fold increase in fatty alcohol production was observed.

In other samples, acr1, fadD, and accABCD (acetyl-CoA carboxylase)(plasmid carrying accABCD constructed as described in Example 1) wereexpressed along with various individual thioesterases (TEs) in wild-typeE. coli C41(DE3) and an E. coli C41 (DE3 ΔfadE, a strain lackingacyl-CoA dehydrogenase). This resulted in additional increases in fattyalcohol production and modulation of the profiles of fatty alcohols (seeFIG. 7). For example, over-expression of E. coli tesA (pETDuet-1-′tesA)in this system achieved approximately a 60-fold increase in C_(12:0)—OH,C_(14:0)—OH and C_(16:0)—OH, with C_(14:0)—OH being the major fattyalcohol. A very similar result was obtained when the ChFatB3 enzyme(FatB3 from Cuphea hookeriana in pMAL-c2X-TEcu) was expressed. When theUcFatB1 enzyme (FatB1 from Umbellularia californicain in pMAL-c2X-TEuc)was expressed, fatty alcohol production increased approximately 20-foldand C_(12:0)—OH was the predominant fatty alcohol.

Expression of ChFatB3 and UcFatB1 also led to the production ofsignificant amounts of the unsaturated fatty alcohols C_(16:1)—OH andC_(14:1)—OH, respectively. The presence of fatty alcohols was also foundin the supernatant of samples generated from the expression of tesA(FIG. 8). At 37° C., approximately equal amounts of fatty alcohols werefound in the supernatant and in the cell pellet. Whereas at 25° C.,approximately 25% of the fatty alcohols were found in the supernatant.

Example 6. Production of Fatty Alcohol Using a Variety of Acyl-CoAReductases

This example describes fatty alcohol production using a variety ofacyl-CoA reductases. Fatty alcohols can be the final product.Alternatively, the production host cells can additionallyexpress/over-express ester synthases to produce fatty esters.

Each of four genes encoding fatty acyl-CoA reductases (Table 12) fromvarious sources were codon-optimized for E. coli expression andsynthesized by Codon Devices, Inc. (Cambridge, Mass.). Each of thesynthesized genes was cloned as a NdeI-AvrII fragment intopCDFDuet-1-fadD (described in Example 3). Each of the plasmids carryingthese acyl-CoA reductase genes with the E. coli fadD gene wastransformed into E. coli strain C41 (DE) strain, which was purchasedfrom Over-expression.com.

The recombinant strains were grown in 3 mL of LB broth (supplementedwith 100 mg/L of spectinomycin) at 37° C. overnight. 0.3 mL of theovernight culture was transferred to 30 mL of fresh M9 medium (with 100mg/L of spectinomycin) and grown at 25° C. When the cultures reachedOD₆₀₀ of 0.5, IPTG was added to obtain a final concentration of 1 mM.Each culture was fed 0.1% of one of three fatty acids dissolved in H₂Oat pH 7.0. The three fatty acids fed were sodium dodecanoate, sodiummyristate, or sodium palmitate. A culture without the addition of fattyacid was also included as a control. After induction the cultures weregrown at the same temperature for an additional 40 hours at 25° C.

The quantification of fatty alcohol yield at the end of fermentation wasperformed using GC-MS as described above in Example 3 and Example 4. Theresulting fatty alcohol produced from the corresponding fatty acid isshown in Table 13. The results showed that three acyl-CoAreductases—Acr1, AcrM and BmFAR—could convert all three fatty acids intocorresponding fatty alcohols. The results also showed that hFAR andJjFAR had activity when myristate and palmitate were the substrates.However, there was little to no activity when dodecanoate was thesubstrate. mFAR1 and mFAR2 only showed low activity with myristate andshowed no activity with the other two fatty acids.

TABLE 12 Acyl-CoA reductases Acyl-coA Protein ID accession reductasenumber Protein sources mFAR1 AAH07178 Mus musculus mFAR2 AAH55759 Musmusculus JjFAR AAD38039 Simmondsia chinensis BmFAR BAC79425 Bombyx moriAcr1 AAC45217 Acinetobacter baylyi ADP1 AcrM BAB85476 Acinetobacter sp.M1 hFAR AAT42129 Homo sapiens

TABLE 13 Fatty alcohol production Acyl- Peak Area^(c) CoA No fatty acidE. coli Reductase Dodecanoate/ Myristate/ Palmitate/ feeding^(a)/C41(DE3) genes dodecanol^(b) tetradecanol^(b) hexadecanol^(b)hexadecanol mFAR1 7,400 85,700 8,465 70,900 mFAR2 2,900 14,100 32,50025,800 JjFAR 5,200 8,500 53,112 33,800 BmFAR 35,800 409,000 407,00048,770 acr1 202,000 495,000 1,123,700 58,515 acrM 42,500 189,000 112,44836,854 hFAR1 5,050 59,500 109,400 94,400 vector control 4,000 1,48332,700 27,500 media control 10,700 1,500 25,700 25,000 Note: ^(a)Onlyhexadecanol was quantified in this case. ^(b)Fatty acid fed/fattyalcohol produced. ^(c)The area peak of fatty alcohol produced.

Example 7. Medium Chain Fatty Esters

Alcohol acetyl transferases (AATs, EC 2.3.1.84), which is responsiblefor acyl acetate production in various plants, can be used to producemedium chain length fatty esters, such as octyl octanoate, decyloctanoate, decyl decanoate, and the like. Fatty esters, synthesized frommedium chain alcohol (such as C₆ and C₈) and medium chain acyl-CoA (orfatty acids, such as C₆ and C₈) have a relatively low melting point. Forexample, hexyl hexanoate has a melting point of −55° C. and octyloctanoate has a melting point of −18° C. to −17° C. The low meltingpoints of these compounds make them good candidates for use as biofuels.

Example 8. Medium Chain Fatty Esters

In this example, an SAAT gene encoding a thioesterase was co-expressedin a production host E. coli C41(DE3, ΔfadE) with fadD from E. coli andacr1 (alcohol reductase from A. baylyi ADP1). Octanoic acid was providedin the fermentation broth. This resulted in the production of octyloctanoate. Similarly, when the ester synthase gene from A. baylyi ADP1was expressed in the production host instead of the SAAT gene, octyloctanoate was produced.

A recombinant SAAT gene was synthesized by DNA 2.0 (Menlo Park, Calif.94025). The synthesized DNA sequence was based on the published genesequence (accession number AF193789), but modified to eliminate the NcoIsite. The synthesized SAAT gene (as a BamHI-HindIII fragment) was clonedin pRSET B (Invitrogen, Calsbad, Calif.), linearized with BamHI andHindIII. The resulting plasmid, pHZ1.63A was cotransformed into an E.coli production host with pAS004.114B, which carries a fadD gene from E.coli and acr1 gene from A. baylyi ADP1. The transformants were grown in3 mL of M9 medium with 2% glucose. After IPTG induction and the additionof 0.02% octanoic acid, the culture was continued at 25° C. for 40hours. 3 mL of acetyl acetate was then added to the whole culture andmixed several times with a mixer. The acetyl acetate phase was analyzedby GC/MS.

Surprisingly, no acyl acetate was observed in the acetyl acetateextract. However, octyl octanoate was observed. However, the controlstrain without the SAAT gene (C41(DE3, ΔfadE)/pRSET B+pAS004.114B) didnot produce octyl octanoate. Furthermore, the strain (C41(DE3,ΔfadE)/pHZ1.43 B+pAS004.114B) in which the ester synthase gene from A.baylyi ADP1 was carried by pHZ1.43 produced octyl octanoate (see FIG.9A-D).

The finding that SAAT activity produces octyl octanoate makes itpossible to produce medium chain fatty esters, such as octyl octanoateand octyl decanoate, which have low melting point and are goodcandidates for use as biofuels to replace triglyceride based biodiesel.

Example 9. Production of Fatty Esters in E. coli Strain LS9001

Fatty esters were produced by engineering an E. coli production host toexpress a fatty alcohol forming acyl-CoA reductase, thioesterase, and anester synthase. Thus, the production host produced both the A and the Bside of the ester and the structure of both sides was influenced by theexpression of the thioesterase gene.

Ester synthase from A. baylyi ADP1 (termed WSadp1, accessions AA017391,EC 2.3.175) was amplified with the following primers using genomic DNAsequence from A. baylyi ADP1 as the template: (1) WSadp1_NdeI,5′-TCATATGCGCCCATTACATCCG-3′ (SEQ ID NO: 17) and (2) WSadp1_Avr,5′-TCCTAGGAGGGCTAATTTAGCCCTTTAGTT-3′ (SEQ ID NO: 18).

The PCR product was digested with NdeI and AvrII and cloned intopCOALDeut-1 to give pHZ 1.43. The plasmid carrying WSadp1 was thenco-transformed into E. coli strain LS9001 with both pETDuet-1′tesA andpCDFDuet-1-fadD-acr1 and transformants were selected in LB platessupplemented with 50 mg/L of kanamycin, 50 mg/L of carbenicillin and 100mg/L of spectinomycin.

Three transformants were inoculated in 3 mL of LBKCS (LB brothsupplement with 50 mg/L kanamycin, 50 mg/L carbenicillin, 100 mg/Lspectinomycin, and 10 g/L glucose) and incubated at 37° C. in a shaker(250 rpm). When the cultures reached 0.5 OD₆₀₀, 1.5 mL of each culturewas transferred into 250 mL flasks containing 50 mL LBKCS. The flaskswere then incubated in a shaker (250 rpm) at 37° C. until the culturereached 0.5-1.0 OD₆₀₀. IPTG was then added to a final concentration of 1mM. The induced cultures were incubated at 37° C. in a shaker (250 rpm)for another 40-48 hours.

The culture was then placed into 50 mL conical tubes and the cells werespun down at 3500×g for 10 minutes. The cell pellet was then mixed with5 mL of ethyl acetate. The ethyl acetate extract was analyzed withGC/MS. The yield of fatty esters (including C₁₆C₁₆, C_(14:1)C₁₆,C_(18:1)C_(18:1), C₂C₁₄, C₂C₁₆, C₂C_(16:1), C₁₆C_(16:1) and C₂C_(18i))was about 10 mg/L. When an E. coli strain only carrying empty vectorswas cultured in the same way, only 0.2 mg/L of fatty esters was found inthe ethyl acetate extract.

Example 10. Production and Release of Fatty-Ethyl Ester from ProductionHost

The LS9001 strain was transformed with plasmids carrying an estersynthase gene from A. baylyi (plasmid pHZ1.43), a thioesterase gene fromCuphea hookeriana (plasmid pMAL-c2X-TEcu) and a fadD gene from E. coli(plasmid pCDFDuet-1-fadD).

This recombinant strain was grown at 25° C. in 3 mL M9 medium with 50mg/L kanamycin, 100 mg/L carbenicillin, and 100 mg/L of spectinomycin.After IPTG induction, the media was adjusted to a final concentration of1% ethanol and 2% glucose.

The culture was allowed to grow for 40 hours after IPTG induction. Thecells were separated from the spent medium by centrifugation at 3500×gfor 10 minutes). The cell pellet was re-suspended with 3 mL of M9medium. The cell suspension and the spent medium were then extractedwith 1 volume of ethyl acetate. The resulting ethyl acetate phases fromthe cells suspension and the supernatant were subjected to GC-MSanalysis.

The C₁₆ ethyl ester was the most prominent ester species (as expectedfor this thioesterase, see Table 1), and 20% of the fatty ester producedwas released from the cell (see FIG. 10). A control E. coli strainC41(DE3, ΔfadE) containing pCOLADuet-1 (empty vector for the estersynthase gene), pMAL-c2X-TEuc (containing fatB from U. california) andpCDFDuet-1-fadD (fadD gene from E. coli) failed to produce detectableamounts of fatty ethyl esters. The fatty esters were quantified usingcommercial palmitic acid ethyl ester as the reference.

Fatty esters were also made using the methods described herein exceptthat methanol or isopropanol was added to the fermentation broth. Theexpected fatty esters were produced.

Example 11. The Influence of Various Thioesterases on the Composition ofFatty-Ethyl Esters Produced in Recombinant E. coli Strains

The thioesterases FatB3 (C. hookeriana), TesA (E. coli), and FatB (U.california) were expressed simultaneously with ester synthase (A.baylyi). A plasmid, pHZ1.61, was constructed by replacing the NotI-AvrIIfragment (carrying the acr1 gene) with the NotI-AvrII fragment frompHZ1.43 so that fadD and the ADP1 ester synthase were in one plasmid andboth coding sequences were under the control of separate T7 promoter.The construction of pHZ1.61 made it possible to use a two plasmid systeminstead of the three plasmid system as described in Example 8. pHZ1.61was then co-transformed into E. coli C41(DE3, ΔfadE) with one of thevarious plasmids carrying the different thioesterase genes stated above.

The total fatty acid ethyl esters (in both the supernatant andintracellular fatty acid ethyl fluid) produced by these transformantswere evaluated using the technique described herein. The yields and thecomposition of fatty acid ethyl esters are summarized in Table 14.

TABLE 14 Yields (mg/L) and composition of fatty acid ethyl esters byrecombinant E. coli C41(DE3, ΔfadE)/pHZ1.61 and plasmids carryingvarious thioesterase genes. Thioesterases C₂C₁₀ C₂C_(12:1) C₂C₁₂C₂C_(14:1) C₂C₁₄ C₂C_(16:1) C₂C₁₆ C₂C_(18:1) Total ‘TesA 0.0 0.0 6.5 0.017.5 6.9 21.6 18.1 70.5 ChFatB3 0.0 0.0 0.0 0.0 10.8 12.5 11.7 13.8 48.8ucFatB 6.4 8.5 25.3 14.7 0.0 4.5 3.7 6.7 69.8 pMAL 0.0 0.0 0.0 0.0 5.60.0 12.8 7.6 26.0 Note: ‘TesA, pETDuet-1-’ tesA; chFatB3, pMAL-c2X-TEcu;ucFatB, pMAL-c2X-TEuc; pMAL, pMAL-c2X, the empty vector for thioesterasegenes used in the study.

Example 12. Use of Various Ester Synthases to Produce Biofuel

Four genes encoding ester synthases were synthesized based oncorresponding DNA sequences reported on NCBI GenBank with minormodifications. These modifications include the removal of internal NcoI,NdeI, HindIII and AvrII sites present without introducing changes to thecorresponding amino acid sequence. The four genes of interest weresynthesized with an NdeI site on the 5′ end and an AvrII at the 3′ end.The sequences were then cloned into the NdeI and AvrII site ofpCOLADuet-1 (Novagene) to produce pHZ1.97-376, pHZ1.97-377,pHZ1.97-atfA1 and pHZ1.97-atfA2. The plasmids carrying each of the fourgenes of interest along with the respective GenBank accession numbersand the GenPeptide accessions numbers are listed in Table 15 below.

TABLE 15 Ester synthases DNA sequence GenPeptide Plasmids LS9 IDoriginal sources GenBank # accession # pHZ1.97-376 FES376(376)Marinobacter CP000514.1 ABM17275 aquaeolei VT8 pHZ1.97-377 FES377(377)Marinobacter CP000514.1 ABM20141 aquaeolei VT8 pHZ1.97-atfA1FESA1(AtfA1) Alcanivorax NC_008260.1 YP_694462 borkumensis SK2pHZ1.97-atfA2 FESA2(AtfA2) Alcanivorax NC_008260.1 YP_693524 borkumensisSK2

Each of the four plasmids was transformed into E. coli C41 (DE3,ΔfadEΔfabR)/pETDuet-1-tesA+pCDFDuet-1-fadD. Three transformants fromeach transformation were picked for fermentation to test their abilityto synthesize fatty acid ethyl esters. The fermentation was performed asdescribed in Example 9, but with two different temperatures, either at25° C. or 37° C. Strain C41 (DE3,ΔfadEΔfabR)/pETDuet-1-tesA+pCDFDuet-1-fadD+pHZ1.43 (expressing ADP1ester synthase) was used as a positive control and C41 (DE3,ΔfadEΔfabR)/pETDuet-1-tesA+pCDFDuet-1-fadD as a negative control.

The expression of each of the four ester synthase genes in the E. colistrain with attenuated fadE and fabR activity and over-expressing ′tesAand fadD enabled each strain to produce around 250 mg/L of FAEE at 25°C. This is the same amount produced by the positive control thatexpressed ADP1. In contrast, the negative control strain produced lessthan 50 mg/L FAEE in the same condition (FIG. 11) at 25° C. The fattyacyl composition of FAEE produced from these four ester synthases issimilar to that from ADP1 ester synthases (FIG. 12).

Results from fermentations performed at 37° C. indicated that strainscarrying pHZ1.97_aftA2 and strains carrying pHZ1.97_376 produced moreFAEE than the positive control carrying pHZ1.43 (FIG. 13). The strainscarrying pHZ1.97_aftA2 and the strains carrying pHZ1.97_376 alsoproduced large amount of free fatty acid. Whereas the strain carryingpHZ.143 did not accumulate free fatty acid (FIG. 14). The results showedthat these four ester synthases are capable of accepting ethanol and abroad range of acyl-CoA as substrates.

Example 13. Use of Eukaryotic Ester Synthase to Produce Biofuel

This example describes the cloning and expression of an ester synthasefrom Saccharomyces cerevisiae. Plasmids were generated using standardmolecular biology techniques.

TABLE 16 Plasmids with eeb1 Given Name Vector Backbone ConstructionpGL10.59 pCOLADuet-1 eeb1* gene inserted between BamHI (Novagen) andHindIII sites (KanR) pGL10.104 pMAL c2x eeb1* gene inserted betweenBamHI (NEB) and HindIII sites (AmpR) pMAL-c2X- pMAL c2x See Table 8above TEuc (NEB) pCDFDuet-1- pCDFDuet-1 See Table 8 above acr1 (Novagen)*The Saccharomyces cerevisiae gene eeb1 (GenBank accession numberYPL095C) was PCR-amplifed from S. cerevisiae genomic DNA sequence usingprimers introducing 5′ BamHI and 3′ HindIII sites.

An E. coli C41 (DE3 ΔfadE) production host was used to express thevarious plasmids. The E. coli cells were grown on M9 minimal media (6g/L Na₂HPO₄, 3 g/L KH₂PO₄, 0.5 g/L NaCl, 1 g/L NH₄Cl, 1 mg/L thiamine(vit. B1), 1 mM MgSO₄, 0.1 mM CaCl₂, 0.4% (w/v) or 2% (w/v) glucose, asindicated). All fatty acid stock solutions were prepared by dissolvingthe fatty acid sodium or potassium salt in distilled deinoized water atpH 7.0. Octanoic acid stock was purchased from Sigma, St. Louis, Mo.

Fermentations were performed using the C41 (DE3 ΔfadE) strain containingplasmids pCDFDuet-1-acr1, pMAL-c2X-TEuc (ucFatB), and pGL10.59 (eeb1).The control strain was C41 (DE3 ΔfadE) strain carrying pCDFDuet-1-acr1,pMAL-c2X-TEuc, and the empty pCOLADuet-1 vector. Three colonies fromeach transformation were used to inoculate M9+0.4% glucose startercultures supplemented with carbenicillin (100 μg/mL), spectinomycin (100μg/mL), and kanamycin (50 μg/mL). The cultures were allowed to grow at37° C. overnight. Production cultures were established by making a 1:100dilution of starter culture to inoculate 3 mL M9 media+0.4% glucose. Theproduction cultures were allowed to grow at 37° C. until OD₆₀₀=0.6before being induced with 1 mM IPTG, fed 1% ethanol, and cultured for anadditional 40 hours at 25° C. Whole cell cultures were extracted with anequal volume of ethyl acetate by vortexing vigorously for 30 seconds.The organic phase was taken and run on the GC/MS using the methodalkane_1_splitless_ctc.m for FAEE detection, which is described above inExample 4, part 2, “Quantification of FA and FAEE in sample #23-30.”

No FAEE peaks could be detected in any of the samples. In order todetermine whether Eeb1 was being properly expressed, IPTG-induced anduninduced cultures were analyzed by SDS-PAGE. No bands corresponding tothe size of Eeb1 (˜52 kDa) could be detected. This suggests that forthis particular plasmid system, Eeb1 is not well-expressed.

Additional expression experiments were preformed using a differentexpression vector. The gene was cloned into the vector pMALc2x, whichexpresses the target protein as a maltose binding protein (MBP) fusion.SDS-PAGE analysis of whole-cell lysates revealed that cultures inducedwith 1 mM IPTG yielded an appropriately-sized band corresponding to theEeb1-MBP fusion (˜92 kDa). The band was not present in uninduced cells.

Eeb1 enzymatic activity was assessed using the C41 (DE3 ΔfadE) E. colistrain carrying plasmids pCDFDuet-1-acr1 and pGL10.104 (eeb1). A C41(DE3 ΔfadE) with pCDFDuet-1-acr1 and pMALc2x served as the controlstrain. Three colonies were picked from each transformation and used toinoculate M9+0.4% glucose overnight starter cultures supplemented withcarbenicillin (100 μg/mL) and spectinomycin (100 μg/mL). A 1:100dilution of the starter cultures was used to inoculate 10 mL M9+0.4%glucose production cultures. The production cultures were allowed togrow at 37° C. until OD₆₀₀=0.4-0.5 before inducing with 1 mM IPTG,feeding 1% ethanol, and feeding octanoic acid (0.01% or 0.02% finalvolume) or decanoic acid (0.02% final volume). Fermentations wereallowed to continue for 24 hours at 25° C. Extractions were carried outby adding 1/10 volume of 12 M HCl and an equal volume of ethyl acetateto the culture and vortexing for 30 seconds. Samples were analyzed byGC/MS as described above.

GC/MS data revealed a peak corresponding to the octanoic acid ethylester could be detected for cells expressing Eeb1 and fed octanoic acidand ethanol. The vector control strain also showed a C₂C₈ peak, albeit asmaller peak than that of the Eeb1 expressing cells.

Cells fed 0.02% decanoic acid did not grow well, therefore the followingstudies were conducted using 0.01% or 0.005% decanoic acid. To test theability of Eeb1 to utilize alcohols other than ethanol in the synthesisof fatty acid esters, fermentations were carried out using the samestrain: C41 (DE3 ΔfadE) with pCDFDuet-1-acr1 and pGL10.104. Cells werecultured as previously described. At induction, the cells were fed 0.02%octanoic acid along with either 1% methanol, ethanol, propanol, orisopropanol. Cells were also fed 0.01% or 0.005% decanoic acid and 1%ethanol. Fermentations were continued post-induction for 24 hours at 25°C. For GC/MS, cultures were spun down to separate the pellet and thesupernatant. The pellet was resuspended in an equal volume of freshM9+0.4% glucose media. Both the resuspended pellet and supernatantsamples were extracted as described above and analyzed by GC/MS.

All of the supernatant samples contained large amounts of fatty acid andno fatty acid esters were detected. Similarly, the vector control pelletsamples contained no peaks. However, cells fed C10 fatty acid showedpeaks identified as decanoic acid.

The pellet samples derived from the cells expressing Eeb1 and fed C₈fatty acid and propanol or ethanol showed small peaks corresponding tothe propyl or ethyl esters. No peaks were detected for the cells fedmethanol or isopropanol. Cultures fed 0.01% or 0.005% C10 fatty acid andethanol also produced the C₂C₁₀ FAEE, which was present in the pelletsamples.

The results indicated that Eeb1 was capable of synthesizing FAEEs usingoctanoic or decanoic acids and was also able to use methanol to generatethe octanoic methyl ester. However, these compounds are highly volatileand GC/MS data may not accurately reflect the true titers. To moreaccurately measure product formation a hexadecane overlay was used tofacilitate the capture of these more volatile FAEE.

Eeb1 activity using various fatty acid substrates was assessed usingstrain C41 (DE3 ΔfadE) with pCDFDuet-1-acr1 and pGL10.104 while feedingdifferent chain-length fatty acids. Cells were cultured as before, butwere induced at OD₆₀₀=0.8-0.9 so as to promote better cell growthpost-induction. At this point, cells were fed 1% ethanol and 0.02% C8fatty acid or 0.01% of the following fatty acids: C10, C12, C14, andC16. Cultures fed C₈ or C₁₀ fatty acids were overlaid with 20% totalvolume hexadecane. Fermentations were carried out for an additional 24hours at 25° C. For product analysis, whole cultures (without separatingthe supernatant from the pellet) were extracted as before, with 1/10volume of HCl and a volume of ethyl acetate equal to the culture.Hexadecane samples were injected directly into the GC/MS using theprogram hex_1_splitless_ctc.m, which is described above in Example 4,part 2, “Quantification of FA and FAEE in sample #23-30.”

None of the vector controls showed any FAEE peaks. For the C₈- andC₁₀-fed cells, large C₂C₈ and C₂C₁₀ peaks could be detected in thehexadecane samples, but not in the ethyl acetate samples. Thisdemonstrated that hexadecane was able to successfully trap the volatileFAEEs. For the rest of the ethyl acetate samples, small peaks could bedetected for C₂C₁₂ and C₂C₁₄ FAEEs, but none for C₂C₁₆. Thus, Eeb1generated ethyl esters using fatty acids with chain lengths from C₈ toC₁₄. Eeb1 favored C₈ and C₁₀ over the longer-chain fatty acids.

Example 14. Genomic Integration of Recombinant Sequences to Make a HostStrain that Over-Expresses E. coli fabA and/or fabB Genes

It is known that the product of the fabR gene acts as a repressor of theexpression of the fabA and fabB genes. It is also known that FadR worksas an activator of the same genes. The FabR and predicted consensusbinding sequences were previously published by Zhang et al., J. Biol.Chem. 277: 15558-15565, 2002. The consensus binding sequences and theirlocation as they relate to the fabA and fabB genes from E. coli is shownin FIG. 15.

A fabR knock-out strain of E. coli was created. Primers TrmA_R-_NotI andFabR_FOP were used to amplify approximately 1000 bp upstream of fabR,and primers SthA_F_Bam and FabR_ROP were used to amplify approximately1000 bp downstream of fabR (see Table D). Overlap PCR was applied tocreate a construct for in-frame deletion of the complete fabR gene. ThefabR deletion construct was cloned into the temperature-sensitiveplasmid pKOV3, which contained SacB for counterselection, and achromosomal deletion of fabR was made according to the method of Churchand coworkers (Link et al., J. Bact. 179:6228-6237, 1997).

TABLE 17 fabR knock-out primers Primer Name Primer Sequence (5′ to 3′)TrmA_R_Not ATAGTTTAGCGGCCGCAAATCGAGCTGGATCAGGATTA (SEQ ID NO: 19)FabR_FOP AGGATTCAGACATCGTGATGTAATGAAACAAGCAAATC AAGATAGA (SEQ ID NO: 20)SthA_F_Bam CGCGGATCCGAATCACTACGCCACTGTTCC (SEQ ID NO: 21) FabR_ROPTTGATTTGCTTGTTTCATTACATCACGATGTCTGAATC CTTG (SEQ ID NO: 22)

Example 15. Production Host Construction

Table 18 identifies the homologues of many of the genes described hereinwhich are known to be expressed in microorganisms that producebiodiesels, fatty alcohols, and hydrocarbons. To increase fatty acidproduction and, therefore, hydrocarbon production in production hostssuch as those identified in Table 18, heterologous genes can beexpressed, such as those from E. coli. One of ordinary skill in the artwill also appreciate that genes that are endogenous to the micoorganismsprovided in Table 18 can also be expressed, over-expressed, orattenuated using the methods described herein. Moreover, genes that aredescribed in Table 18 can be expressed, over-expressed, or attenuated inproduction hosts that endogenously produce hydrocarbons to allow for theproduction of specific hydrocarbons with defined carbon chain length,saturation points, and branch points.

TABLE 18 Hydrocarbon production hosts Accession No./ Organism Seq GeneName ID/Loci EC No. Desulfovibrio accA YP_388034 6.4.1.2 desulfuricansG20 Desulfovibrio accC YP_388573/ 6.3.4.14, desulfuricans G22 YP_3880336.4.1.2 Desulfovibrio accD YP_388034 6.4.1.2 desulfuricans G23Desulfovibrio fabH YP_388920 2.3.1.180 desulfuricans G28 DesulfovibriofabD YP_388786 2.3.1.39 desulfuricans G29 Desulfovibrio fabG YP_3889211.1.1.100 desulfuricans G30 Desulfovibrio acpP YP_388922/ 3.1.26.3,desulfuricans G31 YP_389150 1.6.5.3, 1.6.99.3 Desulfovibrio fabFYP_388923 2.3.1.179 desulfuricans G32 Desulfovibrio gpsA YP_3896671.1.1.94 desulfuricans G33 Desulfovibrio ldhA YP_388173/ 1.1.1.27,desulfuricans G34 YP_390177 1.1.1.28 Erwinia accA 942060-943016 6.4.1.2(micrococcus) amylovora Erwinia accB 3440869-3441336 6.4.1.2(micrococcus) amylovora Erwinia accC 3441351-3442697 6.3.4.14,(micrococcus) 6.4.1.2 amylovora Erwinia accD 2517571-2516696 6.4.1.2(micrococcus) amylovora Erwinia fadE 1003232-1000791 1.3.99.—(micrococcus) amylovora Erwinia plsB(D311E) 333843-331423 2.3.1.15(micrococcus) amylovora Erwinia aceE 840558-843218 1.2.4.1 (micrococcus)amylovora Erwinia aceF 843248-844828 2.3.1.12 (micrococcus) amylovoraErwinia fabH 1579839-1580789 2.3.1.180 (micrococcus) amylovora ErwiniafabD 1580826-1581749 2.3.1.39 (micrococcus) amylovora Erwinia fabGCAA74944 1.1.1.100 (micrococcus) amylovora Erwinia acpP 1582658-15828913.1.26.3, (micrococcus) 1.6.5.3, amylovora 1.6.99.3 Erwinia fabF1582983-1584221 2.3.1.179 (micrococcus) amylovora Erwinia gpsA124800-125810 1.1.1.94 (micrococcus) amylovora Erwinia ldhA1956806-1957789 1.1.1.27, (micrococcus) 1.1.1.28 amylovora KineococcusaccA ZP_00618306 6.4.1.2 radiotolerans SRS30216 Kineococcus accBZP_00618387 6.4.1.2 radiotolerans SRS30216 Kineococcus accC ZP_00618040/6.3.4.14, radiotolerans ZP_00618387 6.4.1.2 SRS30216 Kineococcus accDZP_00618306 6.4.1.2 radiotolerans SRS30216 Kineococcus fadE ZP_006177731.3.99.— radiotolerans SRS30216 Kineococcus plsB(D311E) ZP_006172792.3.1.15 radiotolerans SRS30216 Kineococcus aceE ZP_00617600 1.2.4.1radiotolerans SRS30216 Kineococcus aceF ZP_00619307 2.3.1.12radiotolerans SRS30216 Kineococcus fabH ZP_00618003 2.3.1.180radiotolerans SRS30216 Kineococcus fabD ZP_00617602 2.3.1.39radiotolerans SRS30216 Kineococcus fabG ZP_00615651 1.1.1.100radiotolerans SRS30216 Kineococcus acpP ZP_00617604 3.1.26.3,radiotolerans 1.6.5.3, SRS30216 1.6.99.3 Kineococcus fabF ZP_006176052.3.1.179 radiotolerans SRS30216 Kineococcus gpsA ZP_00618825 1.1.1.94radiotolerans SRS30216 Kineococcus ldhA ZP_00618879 1.1.1.28radiotolerans SRS30216 Rhodospirillum accA YP_425310 6.4.1.2 rubrumRhodospirillum accB YP_427521 6.4.1.2 rubrum Rhodospirillum accCYP_427522/ 6.3.4.14, rubrum YP_425144/ 6.4.1.2 YP_427028/ YP_426209/YP_427404 Rhodospirillum accD YP_428511 6.4.1.2 rubrum RhodospirillumfadE YP_427035 1.3.99.— rubrum Rhodospirillum aceE YP_427492 1.2.4.1rubrum Rhodospirillum aceF YP_426966 2.3.1.12 rubrum Rhodospirillum fabHYP_426754 2.3.1.180 rubrum Rhodospirillum fabD YP_425507 2.3.1.39 rubrumRhodospirillum fabG YP_425508/ 1.1.1.100 rubrum YP_425365 RhodospirillumacpP YP_425509 3.1.26.3, rubrum 1.6.5.3, 1.6.99.3 Rhodospirillum fabFYP_425510/ 2.3.1.179 rubrum YP_425510/ YP_425285 Rhodospirillum gpsAYP_428652 1.1.1.94 rubrum 1.1.1.27 Rhodospirillum ldhA YP_426902/1.1.1.28 rubrum YP_428871 Vibrio furnissii accA  1, 16 6.4.1.2 Vibriofurnissii accB  2, 17 6.4.1.2 Vibrio furnissii accC  3, 18 6.3.4.14,6.4.1.2 Vibrio furnissii accD  4, 19 6.4.1.2 Vibrio furnissii fadE  5,20 1.3.99.— Vibrio furnissii plsB(D311E)  6, 21 2.3.1.15 Vibriofurnissii aceE  7, 22 1.2.4.1 Vibrio furnissii aceF  8, 23 2.3.1.12Vibrio furnissii fabH  9, 24 2.3.1.180 Vibrio furnissii fabD 10, 252.3.1.39 Vibrio furnissii fabG 11, 26 1.1.1.100 Vibrio furnissii acpP12, 27 3.1.26.3, 1.6.5.3, 1.6.99.3 Vibrio furnissii fabF 13, 282.3.1.179 Vibrio furnissii gpsA 14, 29 1.1.1.94 Vibrio furnissii ldhA15, 30 1.1.1.27, 1.1.1.28 Stenotrophomonas accA ZP_01643799 6.4.1.2maltophilia R551-3 Stenotrophomonas accB ZP_01644036 6.4.1.2 maltophiliaR551-3 Stenotrophomonas accC ZP_01644037 6.3.4.14, maltophilia 6.4.1.2R551-3 Stenotrophomonas accD ZP_01644801 6.4.1.2 maltophilia R551-3Stenotrophomonas fadE ZP_01645823 1.3.99.— maltophilia R551-3Stenotrophomonas plsB(D311E) ZP_01644152 2.3.1.15 maltophilia R551-3Stenotrophomonas aceE ZP_01644724 1.2.4.1 maltophilia R551-3Stenotrophomonas aceF ZP_01645795 2.3.1.12 maltophilia R551-3Stenotrophomonas fabH ZP_01643247 2.3.1.180 maltophilia R551-3Stenotrophomonas fabD ZP_01643535 2.3.1.39 maltophilia R551-3Stenotrophomonas fabG ZP_01643062 1.1.1.100 maltophilia R551-3Stenotrophomonas acpP ZP_01643063 3.1.26.3 maltophilia 1.6.5.3, R551-31.6.99.3 Stenotrophomonas fabF ZP_01643064 2.3.1.179 maltophilia R551-3Stenotrophomonas gpsA ZP_01643216 1.1.1.94 maltophilia R551-3Stenotrophomonas ldhA ZP_01645395 1.1.1.28 maltophilia R551-3Synechocystis sp. accA NP_442942 6.4.1.2 PCC6803 Synechocystis sp. accBNP_442182 6.4.1.2 PCC6803 Synechocystis sp. accC NP_442228 6.3.4.14,PCC6803 6.4.1.2 Synechocystis sp. accD NP_442022 6.4.1.2 PCC6803Synechocystis sp. fabD NP_440589 2.3.1.39 PCC6803 Synechocystis sp. fabHNP_441338 2.3.1.180 PCC6803 Synechocystis sp. fabF NP_440631 2.3.1.179PCC6803 Synechocystis sp. fabG NP_440934 1.1.1.100, PCC6803 3.1.26.3Synechocystis sp. fabZ NP_441227 4.2.1.60 PCC6803 Synechocystis sp. fablNP_440356 1.3.1.9 PCC6803 Synechocystis sp. acp NP_440632 PCC6803Synechocystis sp. fadD NP_440344 6.2.1.3 PCC6803 Synechococcus accAYP_400612 6.4.1.2 elongates PCC7942 Synechococcus accB YP_401581 6.4.1.2elongates PCC7942 Synechococcus accC YP_400396 6.3.4.14, elongates6.4.1.2 PCC7942 Synechococcus accD YP_400973 6.4.1.2 elongates PCC7942Synechococcus fabD YP_400473 2.3.1.39 elongates PCC7942 SynechococcusfabH YP_400472 2.3.1.180 elongates PCC7942 Synechococcus fabF YP_3995562.3.1.179 elongates PCC7942 Synechococcus fabG YP_399703 1.1.1.100,elongates 3.1.26.3 PCC7942 Synechococcus fabZ YP_399947 4.2.1.60elongates PCC7942 Synechococcus fabl YP_399145 1.3.1.9 elongates PCC7942Synechococcus acp YP_399555 elongates PCC7942 Synechococcus fadDYP_399935 6.2.1.3 elongates PCC7942

For Table 18, Accession Numbers are from GenBank, Release 159.0 as ofApr. 15, 2007, EC Numbers are from KEGG, Release 42.0 as of April 2007(plus daily updates up to and including 05/09/07), results for Erwiniaamylovora strain Ea273 are taken from the Sanger sequencing center,completed shotgun sequence as of 5/9/07, positions for Erwinia representlocations on the Sanger psuedo-chromosome, sequences from Vibrio fumisiiM1 are from the LS9 VFM1 pseudochromosome, v2 build, as of 9/28/06, andinclude the entire gene, and may also include flanking sequence.

Example 16. Additional Exemplary Production Strains

Table 19 provides additional exemplary production strains. Two examplebiosynthetic pathways are described for producing fatty acids, fattyalcohols, and wax esters. For example, Table 19 provides Examples 1 and2 that produce fatty acids. The production host strain used to producefatty acids in Example 1 is a production host cell that is engineered tohave the synthetic enzymatic activities indicated by the “x” marks inthe rows which identify the genes (see “x” identifying acetyl-CoAcarboxylase, thio-esterase, and acyl-CoA synthase activity). Productionhost cells can be selected from bacteria, yeast, and fungi. These genescan also be transformed into a production host cell that is modified tocontain one or more of the genetic manipulations described in FIG. 1. Asprovided in Table 19, additional production hosts can be created usingthe indicated exogenous genes.

TABLE 19 Combination of genes useful for making genetically engineeredproduction strains Fatty acids Fatty alcohols wax/fatty esters Sourcesof Exmpl. Exmpl. Exmpl. Exmpl. Exmpl. Exmpl. Peptide genes Genes 1 2 1 21 2 acetyl-CoA E. coli accABCD X X X X X X carboxylase thio- E. colitesA X X X X esterase Cinnamomum ccFatB camphora Umbellularia umFatB X Xcalifornica Cuphea chFatB2 hookeriana Cuphea chFatB3 hookeriana CupheachFatA hookerian Arabidopsis AtFatA1 thaliana Arabidopsis AtFatB1thaliana [M141T] acyl-CoA E. coli fadD X X X X X X synthase acyl-CoABombyx mori bFAR reductase Acinetobacter acr 1 X X baylyi ADP1Simmondsia jjFAR X X chinensis Triticum TTA1 aestivum Mus mFAR1 musculusMUS mFAR2 musculus Acinetpbacter acr M1 sp. M1 Homo hFAR sapiens EsterFundibacter WST9 synthase/ jadensis DSM alcohol 12178 acyl-Acinetobacter WSHN X transferase sp. HO1-N Acinetobacter WSadp1 X baylylADP1 Mus mWS musculus Homo hWS sapiens Fragaria × SAAT ananassa Malus ×MpAAT domestica Simmondsia JjWS chinensis (AAD38041) DecarbonylaseArabidopsis cer1 thaliana Oryzasativa cer1 Transport Acinetobacterunknown X X protein sp. HO1-N Arabidopsis Cer5 thaliana

Example 17. Use of Additional Acyl-CoA Synthases to Over ProduceAcyl-CoA

Homologues to E. coli fadD can be expressed in E. coli by synthesizingcodon-optimized genes of the desired sequence from M. tuberculosis HR7Rv(NP_217021, FadDD35), B. subtilis (NP_388908, YhfL), Saccharomycescerevisiae (NP_012257, Faa3p) and P. aeruginosa PAO1 (NP_251989). Thesynthetic genes can be designed to include NcoI and HindII compatableoverhangs. The acyl-CoA synthases can be then cloned into NcoI/HindIIIdigested pTrcHis2 vector (Invitrogen Corp., Carlsbad, Calif.) asdescribed above and expressed in E. coli strain MG1655 ΔfadE. Afterexpression in E. coli, acyl-CoA production will be increased.

Fatty acid derivatives such as FAEE can also be produced byco-tranformation of the E. coli strain MG1655 ΔfadE with variousacyl-CoA synthases in the pTrcHis2 vector with a compatible plasmidderived from pCL1920, which contains the ester synthase from A. baylyior the thioesterase gene from Cuphea hookeriana. The resultingproduction host will produce FAEE when cultured in media containingethanol as described above.

Example 18. Use of Additional Acyl-CoA Synthases to Overproduce Acyl-CoA

The DNA sequences or protein sequences of numerous E. coli FadD homologsare known. However, the biochemical properties of only a few have beendescribed. See, e.g., Knoll et al., J. Biol. Chem. 269(23):16348-56,1994; Shockey et al., Plant Physiol. 132: 1065-1076, 2003. Furthermore,their capacity to be expressed in an active form at significant levelsfor commercial purposes is unknown. To explore the possibility of usingheterologous acyl-CoA synthases for esters production, several acyl-CoAsynthases genes were cloned and expressed as follows. Although thisexample describes transforming the production host with separateplasmids for the thioesterase, ester synthase, and acyl-CoA synthasegenes, these genes may alternatively be incorporated together in oneplasmid to transform the production host.

1) Construction of pOP-80 Plasmid

To over-express the genes, a low copy plasmid based on the commercialvector pCL1920 (Lerner & Inouye, (1990) NAR 18: 4631) carrying a strongtranscriptional promoter was constructed by digesting pCL1920 with therestriction enzymes AfIII and SfoI (New England BioLabs Inc. Ipswich,Mass.). Three DNA sequence fragments were produced by this digestion.The 3737 bp fragment was gel-purified using a gel-purification kit(Qiagen, Inc. Valencia, Calif.). In parallel, a DNA sequence fragmentcontaining the trc-promoter and lacI region from the commercial plasmidpTrcHis2 (Invitrogen, Carlsbad, Calif.) was amplified by PCR usingprimers LF302 (5′-atatgacgtcGGCATCCGCTTACAGACA-3′) (SEQ ID NO: 23) andLF303 (5′-aattcttaagTCAGGAGAGCGTTCACCGACAA-3′) (SEQ ID NO: 24). Thesetwo primers also introduced recognition sites for the ZraI and AfIIIenzymes, respectively, at the end of the PCR products. Afteramplification, the PCR products were purified using a PCR-purificationkit (Qiagen, Inc. Valencia, Calif.) and digested with ZraI and AfIIIfollowing the recommendations of the supplier (New England BioLabs Inc.,Ipswich, Mass.). After digestion, the PCR product was gel-purified andligated with the 3737 bp DNA sequence fragment derived from pCL1920.After transformation with the ligation mixture in TOP10 chemicallycompetent cells (Invitrogen, Carlsbad, Calif.), transformants wereselected on Luria agar plates containing 100 μg/mL spectinomycin. Manycolonies were visible after overnight incubation at 37° C. Plasmidspresent in these colonies were purified, analyzed with restrictionenzymes, and then sequenced. One plasmid produced in this way wasretained, named pOP-80, and used for further expression experiments. Amap of pOP-80 is shown in FIG. 17.

The DNA sequence of relevant regions of plasmid pOP-80 was corroborated.It was found that in the junctions were the 2 fragments were ligated,3-4 bases at each end were missing, this was probably caused by anexonuclease activity contaminating one of the restriction enzymes. It islikely that these small deletions did not affect any relevant plasmidfunction. The resulting plasmid was used for all expression experimentsdescribed in this example. The full sequence of the plasmid is disclosedas SEQ ID NO: 1 (FIG. 18).

2) Cloning of fadD35 from Mycobacterium tuberculosis HR7Rv

An E. coli codon-optimized gene was synthesized by DNA 2.0 Inc. (MenloPark, Calif.), using the protein sequence of the fadD35 gene depositedat NCBI with the accession code NP_217021. The synthetic gene containeda unique NcoI site at the 5′-end and a unique EcoRI site at the 3′-end.The synthetic gene was provided by DNA 2.0 Inc. cloned in plasmidpJ201:16084. The fad35 gene was released from this plasmid by digestingwith NcoI and EcoRI. The sequence of this fragment is shown in SEQ IDNO: 1. The resulting DNA sequence fragment (SEQ ID NO: 2, FIG. 19) wasligated with pOP-80, which was previously digested with NcoI and EcoRI.The ligation mixture was transformed into TOP10 chemically competentcells (Invitrogen, Carlsbad, Calif.), which were then plated on Luriaagar plates containing 100 μg/mL spectinomycin and incubated at 37° C.overnight. Colonies that appeared the next day were screened, and astrain containing the correct plasmid was identified. The plasmid wasnamed pDS9.

3) Cloning of fadD1 from Pseudomonas aeruginosa PAO1

An E. coli codon-optimized gene was synthesized by DNA 2.0 Inc. (MenloPark, Calif.) using the protein sequence of the fadD1 gene deposited atNCBI with the accession code NP_251989. The synthetic gene contained aunique B spHI site at the 5′-end and a unique EcoRI site at the 3′-end.The synthetic gene was provided by DNA 2.0, Inc. and cloned in plasmidpJ201:16083. The fadD1 gene was released from this plasmid by digestingwith BspHI and EcoRI. The sequence of this fragment is shown in SEQ IDNO: 3 (FIG. 20). The resulting DNA sequence fragment was ligated withpOP-80, which was previously digested with NcoI and EcoRI. The ligationmixture was transformed into TOP10 chemically competent cells(Invitrogen, Carlsbad, Calif.), which were then plated on Luria agarplates containing 100 μg/mL spectinomycin and incubated at 37° C.overnight. Colonies that appeared the next day were screened. A straincontaining the correct plasmid was identified. The plasmid was namedpDS8.

4) Cloning of yhfL from Bacillus subtilis

The yhfL gene was amplified by PCR using Bacillus subtilis 1168chromosomal DNA sequence as a template, and two primers designed basedon the DNA sequence deposited at NCBI with the accession code NC_000964.The sequence of the 2 primers was:

BsyhfLBspHIF: (SEQ ID NO: 4, FIG. 21) 5′-CATCATGAATCTTGTTTC-3′BsyhfLEcoR:  (SEQ ID NO: 5, FIG. 22) 5′-CGGAATTCTTATTGGGGCAAAATATC-3′

These two primers introduced a BspHI recognition site at the 5′-end andan EcoRI recognition site at the 3′-end. The PCR product was cloneddirectly into pCR-Blunt II-TOPO vector using the Zero Blunt TOPO PCRcloning kit (Invitrogen, Carlsbad, Calif.). A plasmid carrying the yhfLgene was named pDS1. To subclone yhfL, plasmid pDS1 was digested withBspHI and EcoRI. The resulting DNA sequence fragment (SEQ ID NO: 6, FIG.23) was gel-purified and cloned into pOP-80, which was previouslydigested with NcoI and EcoRI. The plasmid carrying the B. subtilis yhfLgene cloned into pOP-80 was named pDS4

5) Cloning of faa3p from Saccharomyces cerevisiae (NP_012257)

The faa3p gene was amplified by PCR using commercial Saccharomycescerevisiae chromosomal DNA sequence ATCC 204508D (American Type CultureCollection, Manassas, Va.) as a template, and two primers that weredesigned based on the DNA sequence deposited at NCBI with the accessioncode NC_001141. The sequence of the two primers was:

Scfaa3pPciF:  (SEQ ID NO: 7, FIG. 24) 5′-CGACATGTCCGAACAACAC-3′Scfaa3pPciI:  (SEQ ID NO: 8, FIG. 25) 5′-GCAAGCTTCTAAGAATTTTCTTTG-3′

These two primers introduced a PciI recognition site at the 5′-end andan HindIII recognition site at the 3′-end.

The PCR product was cloned directly into pCR-Blunt II-TOPO vector usingthe Zero Blunt TOPO PCR cloning kit (Invitrogen, Carlsbad, Calif.). Aplasmid carrying the faa3p gene was named pDS2. To subclone faa3p,plasmid pDS2 was digested with PciI and HindIII. The DNA sequencefragment (SEQ ID NO: 9, FIG. 26) was gel-purified and cloned intopOP-80, which was previously digested with NcoI and HindIII. The plasmidcarrying the S. cerevisiae faa3p gene cloned into pOP-80 was named pDS5.

6) Cloning of ZP_01644857 from Stenotrophomonas maltophilia R551-3

The structural gene sequence for the protein ZP_01644857 is available atNCBI as part of the locus NZ_AAVZ01000044. The gene was amplified by PCRusing Stenotrophomonas maltophilia R551-3 chromosomal DNA sequence astemplate, and two primers designed based on the deposited DNA sequence.The sequence of the two primers was:

Smprk59BspF: (SEQ ID NO: 10, FIG. 27) 5′-AGTCATGAGTCTGGATCG-3′Smprk59HindR:  (SEQ ID NO: 11, FIG. 28) 5′-GGAAGCTTACGGGGCGGGCG-3′

These two primers introduced a BspHI recognition site at the 5′-end andan HindIII recognition site at the 3′-end.

The PCR product was cloned directly into pCR-Blunt II-TOPO vector usingthe Zero Blunt TOPO PCR cloning kit (Invitrogen, Carlsbad, Calif.). Aplasmid carrying the gene encoding the protein ZP_01644857 was namedpDS3. To facilitate further subcloning of the gene, an internal BspHIsite was removed by site directed mutagenesis using the primerPrkBsp-(5′-GCGAACGGCCTGGTCTTTATGAAGTTCGGTGG-3′) (SEQ ID NO: 12, FIG. 29)and the QuikChange Multi Site-Directed mutagenesis kit (Stratagene, LaJolla, Calif.). After the proper mutation was corroborated by DNAsequencing, the resulting plasmid was digested with BspHI and HindIII,and was named pDS6. The DNA sequence fragment (SEQ ID NO: 13, FIG. 30)was gel-purified and cloned into pOP-80 previously digested with NcoIand HindIII. The plasmid carrying the gene encoding the proteinZP_01644857 cloned into pOP-80 was named pDS7. The protein sequence ofZP_01644857 is disclosed in SEQ ID NO: 14 (FIG. 31).

7) Construction of Strains to Produce Fatty Esters.

An E. coli BL21(DE3) strain was first transformed with plasmidpETDuet-1-tesA (described in Example 2) carrying the E. coli tesA gene,and plasmid pHZ1.97 (described in Example 12) carrying the atfA2 estersynthetase gene, respectively. Both genes were under the T7 promoterinducible by IPTG. Two independent transformants carrying both plasmidswere transformed with each of the recombinant plasmids carrying theheterologous fadD genes, and selected on Luria agar plates containing100 μg/mL carbenicillin, 50 μg/mL kanamycin, and 100 μg/mLspectinomycin. Three independent colonies carrying the three plasmidswere tested for fatty-ester production.

8) Analysis of Fatty Esters Produced Using ZP_01644857 fromStenotrophomonas maltophilia R551-3

To evaluate the use of the protein ZP_01644857 from Stenotrophomonasmaltophilia R551-3 in a production host to produce fatty esters, an E.coli BL21(DE3) strain was transformed with plasmid pETDuet-1-tesA(described in Example 2) carrying the E. coli tesA gene, plasmid pHZ1.97(described in Example 12) carrying the atfA2 ester synthetase gene, andplasmid pDS7 carrying the gene encoding the protein ZP_01644857(described above in this example). This production host was fermented toproduce fatty esters as described in Example 13. As a control, a secondE. coli strain BL21(DE3)ΔfadE, containing plasmids pETDuet-1-tesA,pHZ1.97, and pCL1920 was used as a production host to produce fattyesters.

Table 20 below shows the fatty ester yields from these production hosts.

TABLE 20 Fatty ester yields from a production host that producedZP_01644857 C₂C_(12:1) C₂C_(12:0) C₂C_(14:1) C₂C_(14:0) C₂C_(16:1)C₂C_(16:0) C₂C_(18:1) C₂C_(18:0) Total Ester type: mg/L mg/L mg/L mg/Lmg/L mg/L mg/L mg/L mg/L^(c) Control^(a) 0.0 0.0 0.0 1.78 9.80 5.65 33.70.00 50.93 fadD 1.49 3.57 3.68 33.22 52.77 43.09 91.11 10.08 239.01ZP_01644857^(b) ^(a)Control: strain BL21(DE3) D fadE, containingplasmids pETDuet-1-tesA, pHZ1.97 and pCL1920. ^(b)Strain BL21(DE3) DfadE, containing plasmids pETDuet-1-tesA, pHZ1.97 and pDS7. ^(c)Thesevalues represent the average of 3 cultures.

Example 19. Down-Regulation of Beta-Oxidation

This example describes the creation of an E. coli strain MG1655 ΔfadEΔydiO.

Fatty acid degradation can be eliminated or attenuated by attenuatingany of the β-oxidation enzymatic reactions described above (see FIG. 3).For example, the E. coli strain MG1655 ΔfadE can be further engineeredby using primers to amplify up-stream of ydiO and additional primers toamplify downstream of ydiO. Overlap PCR can then be used to create aconstruct for in-frame deletion of the complete ydiO gene. The ydiOdeletion construct is then cloned into the temperature sensitive plasmidpKOV3, which contains a sacB gene for counter-selection, and achromosomal deletion of ydiO is made according to the method of Link etal., J. Bact. 179:6228-6237, 1997. The resulting strain will not becapable of degrading fatty acids and fatty acyl-CoAs. Additional methodsof generating a double knockout of fadE and ydiO are described inCampbell et al., Mol. Microbiol. 47:793-805, 2003.

It is also possible to avoid fatty acid degradation by using aproduction host that does not contain the beta-oxidation pathway. Forexample, several species of Streptococcus have been sequenced and noneof the genes involved in beta-oxidation have been found.

Example 20. Identification of Additional Ester Synthases

This example provides additional ester synthases and methods of usingsuch synthases for the production of fatty esters.

Using bioinformatics, additional ester synthases were identified. Theseester synthases contain motifs that differ from other known motifs, suchas the motifs found in ADP1. The differences in the motifs are noted inTable 21, below.

TABLE 21 Comparison of ester synthases motifs HHAXVDGV NDVVLA GALRXYLPLXAMVP ISNVPGP REPLYXNGA (SEQ ID NO: (SEQ ID (SEQ ID (SEQ ID (SEQ ID(SEQ ID NO: ADP1-motifs 25) NO: 26) NO: 27) NO: 28) NO: 29) 30)Hypothetical HHSLIDGY NDVALA GGLRRFL SLIVVLP VSNVPGP EDVLYLRGS protein(SEQ ID NO: (SEQ ID (SEQ ID (SEQ ID (SEQ ID (SEQ ID NO: BCG_3544c 31)NO: 32) NO: 33) NO: 34) NO: 35) 36) [Mycobacterium bovis BCG str.Pasteur 1173P2] gi/121639399 Protein of HHALVDGY NDVALA GGLRKFL SLIAFLPVSNVPGP REPLYFNGS unknown (SEQ ID NO: (SEQ ID (SEQ ID (SEQ ID (SEQ ID(SEQ ID NO: function 37) NO: 38) NO: 39) NO: 40) NO: 41) 42) UPF0089[Mycobacterium gilvum PYR-GCK] gi/145221651 Protein of HHALVDGY NDVALAGGLRKFL SLIAFLP VSNVPGP REPLYFNGS unknown (SEQ ID NO: (SEQ ID (SEQ ID(SEQ ID (SEQ ID (SEQ ID NO: function 43) NO: 44) NO: 45) NO: 46) NO: 47)48) UPF0089 [Mycobacterium vanbaalenii PYR-1] gi/120406715

The identified sequences can be cloned using standard molecular biologytechniques. These sequences can be expressed using the vectors describedherein and used to make various fatty esters. The motifs can also beused to identify other ester synthases.

Example 21. Product Characterization

To characterize and quantify the fatty alcohols and fatty esters, gaschromatography (GC) coupled with electron impact mass spectra (MS)detection was used. Fatty alcohol samples were first derivatized with anexcess of N-trimethylsilyl (TMS) imidazole to increase detectionsensitivity. Fatty esters did not required derivatization. Both fattyalcohol-TMS derivatives and fatty esters were dissolved in anappropriate volatile solvent, such as ethyl acetate.

The samples were analyzed on a 30 m DP-5 capillary column using thefollowing method. After a 1 μL, splitless injection onto the GC/MScolumn, the oven was held at 100° C. for 3 minutes. The temperature wasramped up to 320° C. at a rate of 20° C./minute. The oven was held at320° C. for an additional 5 minutes. The flow rate of the carrier gashelium was 1.3 mL/minute. The MS quadrapole scanned from 50 to 550 m/z.Retention times and fragmentation patterns of product peaks werecompared with authentic references to confirm peak identity.

For example, hexadeconic acid ethyl ester eluted at 10.18 minutes (FIG.16A and FIG. 16B). The parent ion of 284 mass units was readilyobserved. More abundent were the daughter ions produced during massfragmentation. This included the most prevalent daughter ion of 80 massunits. The derivatized fatty alcohol hexadecanol-TMS eluted at 10.29minutes and the parent ion of 313 could be observed. The most prevalention was the M-14 ion of 299 mass units.

Quantification was carried out by injecting various concentrations ofthe appropriate authentic references using the GC/MS method describedabove. This information was used to generate a standard curve withresponse (total integrated ion count) versus concentration.

EQUIVALENTS

While specific examples of the subject inventions are explicitlydisclosed herein, the above specification and examples herein areillustrative and not restrictive. Many variations of the inventions willbecome apparent to those skilled in the art upon review of thisspecification including the examples. The full scope of the inventionsshould be determined by reference to the examples, along with their fullscope of equivalents, and the specification, along with such variations.

All publications, patents, patent applications, and other referencescited in this application are herein incorporated by reference in theirentirety as if each publication, patent, patent application or otherreference were specifically and individually indicated to beincorporated by reference.

1. A composition comprising fatty acid derivatives, wherein one or moreof the fatty acid derivatives are fatty acid ethyl esters, and whereinthe fatty acid ethyl esters are members selected from the groupconsisting of unsaturated fatty acid ethyl esters and saturated fattyacid ethyl esters, and wherein the unsaturated fatty acid ethyl estershave a double bond at position 7 in the carbon chain from the reducedend of the fatty acid ethyl ester, and wherein the unsaturated fattyacid ethyl esters are present in an amount that is at least 50% byweight of the composition.
 2. The composition of claim 1, wherein theunsaturated fatty acid ethyl esters are present in an amount that is atleast 55% by weight of the composition.
 3. The composition of claim 1,wherein the unsaturated fatty acid ethyl esters are present in an amountthat is at least 60% by weight of the composition.
 4. The composition ofclaim 1, wherein the unsaturated fatty acid ethyl esters are present inan amount that is at least 65% by weight of the composition.
 5. Thecomposition of claim 1, wherein the unsaturated fatty acid ethyl estersare present in an amount that is at least 70% by weight of thecomposition.
 6. The composition of claim 1, wherein the unsaturatedfatty acid ethyl esters are present in an amount that is at least 75% byweight of the composition.
 7. The composition of claim 1, wherein theunsaturated fatty acid ethyl esters are present in an amount that is atleast 80% by weight of the composition.
 8. The composition of claim 1,wherein the unsaturated fatty acid ethyl esters are present in an amountthat is at least 85% by weight of the composition.
 9. The composition ofclaim 1, wherein the unsaturated fatty acid ethyl esters are present inan amount that is at least 90% by weight of the composition.
 10. Thecomposition of claim 1, wherein the unsaturated fatty acid ethyl estersare monounsaturated.
 11. The composition of claim 1, wherein one or moreof the fatty acid ethyl esters are C₁₆ fatty acid ethyl esters, andwherein the composition comprises a percentage by weight of the C₁₆fatty ethyl esters relative to total fatty esters of at least 30%. 12.The composition of claim 11, wherein the composition comprises apercentage by weight of the C₁₆ fatty ethyl esters relative to totalfatty esters of at least 40%.
 13. The composition of claim 11, whereinthe composition comprises a percentage by weight of the C₁₆ fatty ethylesters relative to total fatty esters of at least 50%.
 14. Thecomposition of claim 1, wherein one or more of the fatty acid ethylesters are C₁₈ fatty acid ethyl esters, and wherein the compositioncomprises a percentage by weight of the C₁₆ fatty ethyl esters relativeto total fatty esters of at least 30%.
 15. The composition of claim 11,wherein the composition comprises a percentage by weight of the C₁₈fatty ethyl esters relative to total fatty esters of at least 40%. 16.The composition of claim 11, wherein the composition comprises apercentage by weight of the C₁₈ fatty ethyl esters relative to totalfatty esters of at least 50%.
 17. The composition of claim 1, whereinthe fatty acid derivatives include one or more fatty acid derivativeshaving a carbon chain that is 8:0, 10:0, 12:0, 14:0, 14:1, 16:0, 16:1,18:0, 18:1, 18:2, 18:3, 20:0, 20:1, 20:2, 20:3, 22:0, 22:1 and 22:3 or acombination thereof.
 18. A method for production of fatty acidderivatives in a production host cell, the method comprising: culturingthe production host cell to produce fatty acid derivatives wherein, theproduction host cell expresses or over-expresses nucleotide sequencesthat encode fatty acid derivative enzymes, wherein the fatty acidderivative enzymes are members selected from the group consisting of anacyl-CoA synthase, a thioesterase and an ester synthase.
 19. The methodof claim 18, wherein the production host cell comprises a functionaldeletion of fabR.
 20. A composition made by the method of claim 18,wherein the composition comprises fatty acid derivatives, and whereinone or more of the fatty acid derivatives are fatty acid ethyl esters,and wherein the fatty acid ethyl esters are members selected from thegroup consisting of unsaturated fatty acid ethyl esters and saturatedfatty acid ethyl esters, and wherein the unsaturated fatty acid ethylesters have a double bond at position 7 in the carbon chain from thereduced end of the fatty acid ethyl ester, and wherein the unsaturatedfatty acid ethyl esters are present in an amount that is at least 50% byweight of the composition.